CONSOLIDATED SCHEDULE OF INVESTMENTS

v3.24.0.1

CONSOLIDATED SCHEDULE OF INVESTMENTS £ in Thousands		12 Months Ended
		Dec. 31, 2023 USD ($) shares		Dec. 31, 2022 USD ($) shares		Dec. 31, 2023 GBP (£) shares		Dec. 31, 2022 GBP (£) shares
Summary of Investment Holdings
Basis spread variable rate		8.50%				8.50%
Investment cost		$ 3,247,033,000		$ 3,005,696,000
Investments, at fair value:		3,248,046,000		$ 2,963,955,000
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units
Summary of Investment Holdings
Investment cost	[1],[2]	237,000
Investments, at fair value:	[1]	$ 184,000
Acquisition date	[1],[3]	Dec. 27, 2022
Shares | shares	[1]	69,239				69,239
Investment, Identifier [Axis]: Debt Investments (169.59%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	169.59%				169.59%
Investment cost	[2]	$ 3,058,370,000
Investments, at fair value:		3,057,299,000
Investment, Identifier [Axis]: Debt Investments (199.47%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			199.47%				199.47%
Investment cost	[6]			$ 2,818,060,000
Investments, at fair value:				$ 2,795,444,000
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.02%)
Summary of Investment Holdings
Investment cost	[2]	47,010,000
Investments, at fair value:		$ 48,027,000
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.31%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			2.31%				2.31%
Investment cost	[6]			$ 32,339,000
Investments, at fair value:				$ 32,339,000
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools (2.66%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	2.66%				2.66%
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Alamar Biosciences, Inc. Senior Secured, Maturity Date June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[7]			2026-06				2026-06
Basis spread variable rate	[7],[8]			3.00%				3.00%
Interest rate floor	[7],[8]			6.50%				6.50%
Interest rate paid in kind	[7],[8]			1.00%				1.00%
Exit fee rate	[7],[8]			5.95%				5.95%
Principal amount	[7]			$ 5,000,000
Investment cost	[6],[7]			4,951,000
Investments, at fair value:	[7]			$ 4,951,000
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and Alamar Biosciences, Inc., Senior Secured, June 2026, Prime + 3.00%, Floor rate 6.50%, PIK Interest 1.00%, 5.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[10]	2026-06				2026-06
Basis spread variable rate	[9],[10],[11]	3.00%				3.00%
Interest rate floor	[9],[10],[11]	6.50%				6.50%
Interest rate paid in kind	[9],[10],[11]	1.00%				1.00%
Exit fee rate	[9],[10],[11]	5.95%				5.95%
Principal amount	[9],[10]	$ 15,049,000
Investment cost	[2],[9],[10]	15,069,000
Investments, at fair value:	[9],[10]	$ 15,508,000
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, January 2027, Prime + 2.15%, Floor rate 9.15%, 9.81% Exit Fee
Summary of Investment Holdings
Maturity Date	[12]	2027-01				2027-01
Basis spread variable rate	[11],[12]	2.15%				2.15%
Interest rate floor	[11],[12]	9.15%				9.15%
Exit fee rate	[11],[12]	9.81%				9.81%
Principal amount	[12]	$ 32,000,000
Investment cost	[2],[12]	31,941,000
Investments, at fair value:	[12]	$ 32,519,000
Investment, Identifier [Axis]: Debt Investments Biotechnology Tools and PathAI, Inc., Senior Secured, Maturity Date January 2027, Prime + 2.15%, Floor rate 9.15%, 11.21% Exit Fee
Summary of Investment Holdings
Maturity Date	[7]			2027-01				2027-01
Basis spread variable rate	[7],[8]			2.15%				2.15%
Interest rate floor	[7],[8]			9.15%				9.15%
Exit fee rate	[7],[8]			11.21%				11.21%
Principal amount	[7]			$ 28,000,000
Investment cost	[6],[7]			27,388,000
Investments, at fair value:	[7]			$ 27,388,000
Investment, Identifier [Axis]: Debt Investments Communications & Networking (7.26%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			7.26%				7.26%
Investment cost	[6]			$ 99,167,000
Investments, at fair value:				$ 101,734,000
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Aryaka Networks, Inc. Senior Secured, Maturity Date July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[13],[14]			2026-07				2026-07
Basis spread variable rate	[7],[8],[13],[14]			3.25%				3.25%
Interest rate floor	[7],[8],[13],[14]			6.75%				6.75%
Interest rate paid in kind	[7],[8],[13],[14]			1.05%				1.05%
Exit fee rate	[7],[8],[13],[14]			3.55%				3.55%
Principal amount	[7],[13],[14]			$ 5,023,000
Investment cost	[6],[7],[13],[14]			4,969,000
Investments, at fair value:	[7],[13],[14]			$ 5,053,000
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Cytracom Holdings LLC Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.31%, Floor rate 10.31%
Summary of Investment Holdings
Maturity Date	[7],[15],[16]			2025-02				2025-02
Basis spread variable rate	[7],[8],[15],[16]			9.31%				9.31%
Interest rate floor	[7],[8],[15],[16]			10.31%				10.31%
Principal amount	[7],[15],[16]			$ 8,910,000
Investment cost	[6],[7],[15],[16]			8,768,000
Investments, at fair value:	[7],[15],[16]			$ 8,748,000
Investment, Identifier [Axis]: Debt Investments Communications & Networking and Rocket Lab Global Services, LLC Senior Secured, Maturity Date June 2024, Prime + 4.90%, Floor rate 8.15%, PIK Interest 1.25%, 3.25% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[15],[17],[18],[19]			2024-06				2024-06
Basis spread variable rate	[8],[14],[15],[17],[18],[19]			4.90%				4.90%
Interest rate floor	[8],[14],[15],[17],[18],[19]			8.15%				8.15%
Interest rate paid in kind	[8],[14],[15],[17],[18],[19]			1.25%				1.25%
Exit fee rate	[8],[14],[15],[17],[18],[19]			3.25%				3.25%
Principal amount	[14],[15],[17],[18],[19]			$ 84,581,000
Investment cost	[6],[14],[15],[17],[18],[19]			85,430,000
Investments, at fair value:	[14],[15],[17],[18],[19]			$ 87,933,000
Investment, Identifier [Axis]: Debt Investments Communications and Networking and Aryaka Networks, Inc., Senior Secured, July 2026, Prime + 3.25%, Floor rate 6.75%, PIK Interest 1.05%, 3.55% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12],[20]	2026-07				2026-07
Basis spread variable rate	[9],[11],[12],[20]	3.25%				3.25%
Interest rate floor	[9],[11],[12],[20]	6.75%				6.75%
Interest rate paid in kind	[9],[11],[12],[20]	1.05%				1.05%
Exit fee rate	[9],[11],[12],[20]	3.55%				3.55%
Principal amount	[9],[12],[20]	$ 25,153,000
Investment cost	[2],[9],[12],[20]	24,943,000
Investments, at fair value:	[9],[12],[20]	$ 26,000,000
Investment, Identifier [Axis]: Debt Investments Communications and Networking and Cytracom Holdings LLC, Senior Secured, February 2025, 3-month SOFR + 9.72%, Floor rate 10.62%
Summary of Investment Holdings
Maturity Date	[21],[22],[23]	2025-02				2025-02
Basis spread variable rate	[11],[21],[22],[23]	9.72%				9.72%
Interest rate floor	[11],[21],[22],[23]	10.62%				10.62%
Principal amount	[21],[22],[23]	$ 3,267,000
Investment cost	[2],[21],[22],[23]	3,239,000
Investments, at fair value:	[21],[22],[23]	$ 3,272,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (28.24%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	28.24%				28.24%
Investment cost	[2]	$ 507,063,000
Investments, at fair value:		$ 509,053,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services (30.59%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			30.59%				30.59%
Investment cost	[6]			$ 444,703,000
Investments, at fair value:				$ 428,750,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Altumint, Inc., Senior Secured, December 2027, Prime + 3.65%, Floor rate 12.15%, 2.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[22]	2027-12				2027-12
Basis spread variable rate	[1],[11],[22]	3.65%				3.65%
Interest rate floor	[1],[11],[22]	12.15%				12.15%
Exit fee rate	[1],[11],[22]	2.50%				2.50%
Principal amount	[1],[22]	$ 10,000,000
Investment cost	[1],[2],[22]	9,905,000
Investments, at fair value:	[1],[22]	$ 9,905,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc. Senior Secured, Maturity Date April 2026, Prime + 5.50%, Floor rate 8.8%, 8.29% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[18]			2026-04				2026-04
Basis spread variable rate	[7],[8],[18]			5.50%				5.50%
Interest rate floor	[7],[8],[18]			8.75%				8.75%
Exit fee rate	[7],[8],[18]			8.29%				8.29%
Principal amount	[7],[18]			$ 40,790,000
Investment cost	[6],[7],[18]			41,856,000
Investments, at fair value:	[7],[18]			$ 42,426,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and AppDirect, Inc., Senior Secured, April 2026, Prime + 5.50%, Floor rate 8.75%, 7.12% Exit Fee
Summary of Investment Holdings
Maturity Date	[12]	2026-04				2026-04
Basis spread variable rate	[11],[12]	5.50%				5.50%
Interest rate floor	[11],[12]	8.75%				8.75%
Exit fee rate	[11],[12]	7.12%				7.12%
Principal amount	[12]	$ 55,790,000
Investment cost	[2],[12]	57,653,000
Investments, at fair value:	[12]	$ 59,507,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD Senior Secured, Maturity Date December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[24],[25]			2024-12				2024-12
Basis spread variable rate	[8],[14],[24],[25]			4.70%				4.70%
Interest rate floor	[8],[14],[24],[25]			7.95%				7.95%
Interest rate paid in kind	[8],[14],[24],[25]			1.45%				1.45%
Exit fee rate	[8],[14],[24],[25]			4.95%				4.95%
Principal amount | £	[14],[24],[25]							£ 18,890
Investment cost	[6],[14],[24],[25]			$ 26,024,000
Investments, at fair value:	[14],[24],[25]			$ 22,971,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Carwow LTD, Senior Secured, December 2024, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[26],[27]	2024-12				2024-12
Basis spread variable rate	[9],[11],[26],[27]	4.70%				4.70%
Interest rate floor	[9],[11],[26],[27]	7.95%				7.95%
Interest rate paid in kind	[9],[11],[26],[27]	1.45%				1.45%
Exit fee rate	[9],[11],[26],[27]	4.95%				4.95%
Principal amount | £	[9],[26],[27]					£ 19,146
Investment cost	[2],[9],[26],[27]	$ 26,834,000
Investments, at fair value:	[9],[26],[27]	$ 25,157,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc. Convertible Debt, Maturity Date May 2028, PIK Interest 5.50%
Summary of Investment Holdings
Maturity Date	[14],[28]			2028-05				2028-05
Interest rate paid in kind	[8],[14],[28]			5.50%				5.50%
Principal amount	[14],[28]			$ 21,853,000
Investment cost	[6],[14],[28]			21,853,000
Investments, at fair value:	[14],[28]			$ 20,356,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Houzz, Inc., Convertible Debt, May 2028, PIK Interest 8.50%
Summary of Investment Holdings
Maturity Date	[9],[29]	2028-05				2028-05
Interest rate paid in kind	[9],[11],[29]	8.50%				8.50%
Principal amount	[9],[29]	$ 23,340,000
Investment cost	[2],[9],[29]	23,340,000
Investments, at fair value:	[9],[29]	$ 23,244,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc. Senior Secured, Maturity Date February 2025, 1-month SOFR + 8.86%, Floor rate 9.75%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[24],[25]			2025-02				2025-02
Basis spread variable rate	[8],[24],[25]			8.86%				8.86%
Interest rate floor	[8],[24],[25]			9.75%				9.75%
Exit fee rate	[8],[24],[25]			3.00%				3.00%
Principal amount	[24],[25]			$ 14,000,000
Investment cost	[6],[24],[25]			13,853,000
Investments, at fair value:	[24],[25]			$ 13,904,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Jobandtalent USA, Inc., Senior Secured, February 2025, 1-month SOFR + 8.86% Floor rate 9.75%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[26],[27]	2025-02				2025-02
Basis spread variable rate	[11],[26],[27]	8.86%				8.86%
Interest rate floor	[11],[26],[27]	9.75%				9.75%
Exit fee rate	[11],[26],[27]	3.00%				3.00%
Principal amount	[26],[27]	$ 14,000,000
Investment cost	[2],[26],[27]	14,095,000
Investments, at fair value:	[26],[27]	$ 14,259,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Plentific Ltd, Senior Secured, October 2026, Prime + 2.55%, Floor rate 11.05%, 2.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[22],[26],[27]	2026-10				2026-10
Basis spread variable rate	[11],[22],[26],[27]	2.55%				2.55%
Interest rate floor	[11],[22],[26],[27]	11.05%				11.05%
Exit fee rate	[11],[22],[26],[27]	2.95%				2.95%
Principal amount	[22],[26],[27]	$ 875,000
Investment cost	[2],[22],[26],[27]	853,000
Investments, at fair value:	[22],[26],[27]	$ 853,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[1]	2026-12				2026-12
Basis spread variable rate	[1],[11]	4.40%				4.40%
Interest rate floor	[1],[11]	10.65%				10.65%
Exit fee rate	[1],[11]	2.95%				2.95%
Principal amount	[1]	$ 15,000,000
Investment cost	[1],[2]	14,904,000
Investments, at fair value:	[1]	$ 15,046,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Provi, Senior Secured, Maturity Date December 2026, Prime + 4.40%, Floor rate 10.65%, 2.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[30]			2026-12				2026-12
Basis spread variable rate	[8],[30]			4.40%				4.40%
Interest rate floor	[8],[30]			10.65%				10.65%
Exit fee rate	[8],[30]			2.95%				2.95%
Principal amount	[30]			$ 15,000,000
Investment cost	[6],[30]			14,739,000
Investments, at fair value:	[30]			$ 14,739,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, December 2026, 3-month SOFR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%
Summary of Investment Holdings
Maturity Date	[1],[9],[10]	2026-12				2026-12
Basis spread variable rate	[1],[9],[10],[11]	5.50%				5.50%
Interest rate floor	[1],[9],[10],[11]	6.50%				6.50%
Interest rate paid in kind	[1],[9],[10],[11]	4.00%				4.00%
Principal amount	[1],[9],[10]	$ 28,876,000
Investment cost	[1],[2],[9],[10]	28,404,000
Investments, at fair value:	[1],[9],[10]	$ 28,888,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and RVShare, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 5.50%, Floor rate 6.50%, PIK Interest 4.00%
Summary of Investment Holdings
Maturity Date	[7],[14],[17],[30]			2026-12				2026-12
Basis spread variable rate	[7],[8],[14],[17],[30]			5.50%				5.50%
Interest rate floor	[7],[8],[14],[17],[30]			6.50%				6.50%
Interest rate paid in kind	[7],[8],[14],[17],[30]			4.00%				4.00%
Principal amount	[7],[14],[17],[30]			$ 27,730,000
Investment cost	[6],[7],[14],[17],[30]			27,265,000
Investments, at fair value:	[7],[14],[17],[30]			$ 27,256,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Rhino Labs, Inc. Senior Secured, Maturity Date March 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%
Summary of Investment Holdings
Maturity Date	[14],[30]			2024-03				2024-03
Basis spread variable rate	[8],[14],[30]			5.50%				5.50%
Interest rate floor	[8],[14],[30]			8.75%				8.75%
Interest rate paid in kind	[8],[14],[30]			2.25%				2.25%
Principal amount	[14],[30]			$ 16,500,000
Investment cost	[6],[14],[30]			16,328,000
Investments, at fair value:	[14],[30]			$ 16,496,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Rhino Labs, Inc., Senior Secured, June 2024, Prime + 5.50%, Floor rate 8.75%, PIK Interest 2.25%
Summary of Investment Holdings
Maturity Date	[1],[9]	2024-06				2024-06
Basis spread variable rate	[1],[9],[11]	5.50%				5.50%
Interest rate floor	[1],[9],[11]	8.75%				8.75%
Interest rate paid in kind	[1],[9],[11]	2.25%				2.25%
Principal amount	[1],[9]	$ 4,710,000
Investment cost	[1],[2],[9]	4,704,000
Investments, at fair value:	[1],[9]	$ 4,704,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Riviera Partners LLC, Senior Secured, April 2027, 3-month SOFR + 8.26%, Floor rate 9.26%
Summary of Investment Holdings
Maturity Date	[22],[23]	2027-04				2027-04
Basis spread variable rate	[11],[22],[23]	8.26%				8.26%
Interest rate floor	[11],[22],[23]	9.26%				9.26%
Principal amount	[22],[23]	$ 36,868,000
Investment cost	[2],[22],[23]	36,339,000
Investments, at fair value:	[22],[23]	$ 34,659,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Seat Geek, Inc., Senior Secured, July 2026, Prime + 2.50%, Floor rate 10.75%, PIK Interest 0.50%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12],[31]	2026-07				2026-07
Basis spread variable rate	[9],[11],[12],[31]	2.50%				2.50%
Interest rate floor	[9],[11],[12],[31]	10.75%				10.75%
Interest rate paid in kind	[9],[11],[12],[31]	0.50%				0.50%
Exit fee rate	[9],[11],[12],[31]	3.00%				3.00%
Principal amount	[9],[12],[31]	$ 77,642,000
Investment cost	[2],[9],[12],[31]	77,170,000
Investments, at fair value:	[9],[12],[31]	$ 79,119,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date June 2023, Prime + 5.00%, Floor rate 10.50%, PIK Interest 0.50%
Summary of Investment Holdings
Maturity Date	[14],[17],[18],[19]			2023-06				2023-06
Basis spread variable rate	[8],[14],[17],[18],[19]			5.00%				5.00%
Interest rate floor	[8],[14],[17],[18],[19]			10.50%				10.50%
Interest rate paid in kind	[8],[14],[17],[18],[19]			0.50%				0.50%
Principal amount	[14],[17],[18],[19]			$ 60,915,000
Investment cost	[6],[14],[17],[18],[19]			60,721,000
Investments, at fair value:	[14],[17],[18],[19]			$ 60,721,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc. Senior Secured, Maturity Date May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%
Summary of Investment Holdings
Maturity Date	[14],[15],[19]			2026-05				2026-05
Basis spread variable rate	[8],[14],[15],[19]			7.00%				7.00%
Interest rate floor	[8],[14],[15],[19]			10.50%				10.50%
Interest rate paid in kind	[8],[14],[15],[19]			0.50%				0.50%
Principal amount	[14],[15],[19]			$ 25,071,000
Investment cost	[6],[14],[15],[19]			24,912,000
Investments, at fair value:	[14],[15],[19]			$ 25,823,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and SeatGeek, Inc., Senior Secured, May 2026, Prime + 7.00%, Floor rate 10.50%, PIK Interest 0.50%, 4.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[21],[31]	2026-05				2026-05
Basis spread variable rate	[9],[11],[21],[31]	7.00%				7.00%
Interest rate floor	[9],[11],[21],[31]	10.50%				10.50%
Interest rate paid in kind	[9],[11],[21],[31]	0.50%				0.50%
Exit fee rate	[9],[11],[21],[31]	4.00%				4.00%
Principal amount	[9],[21],[31]	$ 25,199,000
Investment cost	[2],[9],[21],[31]	25,126,000
Investments, at fair value:	[9],[21],[31]	$ 25,869,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc. Senior Secured, Maturity Date November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[17]			2026-11				2026-11
Basis spread variable rate	[8],[14],[17]			2.75%				2.75%
Interest rate floor	[8],[14],[17]			9.25%				9.25%
Interest rate paid in kind	[8],[14],[17]			1.75%				1.75%
Exit fee rate	[8],[14],[17]			3.00%				3.00%
Principal amount	[14],[17]			$ 9,007,000
Investment cost	[6],[14],[17]			8,918,000
Investments, at fair value:	[14],[17]			$ 8,870,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Skyword, Inc., Senior Secured, November 2026, Prime + 2.75%, Floor rate 9.25%, PIK Interest 1.75%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[10]	2026-11				2026-11
Basis spread variable rate	[9],[10],[11]	2.75%				2.75%
Interest rate floor	[9],[10],[11]	9.25%				9.25%
Interest rate paid in kind	[9],[10],[11]	1.75%				1.75%
Exit fee rate	[9],[10],[11]	3.00%				3.00%
Principal amount	[9],[10]	$ 9,169,000
Investment cost	[2],[9],[10]	9,189,000
Investments, at fair value:	[9],[10]	$ 9,311,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, July 2024, FIXED 8.25%
Summary of Investment Holdings
Maturity Date	[32]	2024-07				2024-07
Interest rate paid in cash	[11],[32]	8.25%				8.25%
Principal amount	[32]	$ 8,250,000
Investment cost	[2],[32]	8,250,000
Investments, at fair value:	[32]	$ 8,250,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 One, PIK Interest 5.00%
Summary of Investment Holdings
Maturity Date	[14],[33],[34]			2024-07				2024-07
Interest rate paid in kind	[8],[14],[33],[34]			5.00%				5.00%
Principal amount	[14],[33],[34]			$ 10,680,000
Investment cost	[6],[14],[33],[34]			240,000
Investments, at fair value:	[14],[33],[34]			$ 0
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024 Two, PIK Interest 5.00%
Summary of Investment Holdings
Maturity Date	[14],[33],[34]			2024-07				2024-07
Interest rate paid in kind	[8],[14],[33],[34]			5.00%				5.00%
Principal amount	[14],[33],[34]			$ 13,023,000
Investment cost	[6],[14],[33],[34]			13,023,000
Investments, at fair value:	[14],[33],[34]			$ 0
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Tectura Corporation, Senior Secured, Maturity Date July 2024, FIXED 8.25%
Summary of Investment Holdings
Maturity Date	[14],[33],[34]			2024-07				2024-07
Interest rate paid in cash	[8],[14],[33],[34]			8.25%				8.25%
Principal amount	[14],[33],[34]			$ 8,250,000
Investment cost	[6],[14],[33],[34]			8,250,000
Investments, at fair value:	[14],[33],[34]			$ 8,042,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc. Senior Secured, Maturity Date April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[14],[18]			2026-04				2026-04
Basis spread variable rate	[7],[8],[14],[18]			4.95%				4.95%
Interest rate floor	[7],[8],[14],[18]			8.20%				8.20%
Interest rate paid in kind	[7],[8],[14],[18]			1.50%				1.50%
Exit fee rate	[7],[8],[14],[18]			3.95%				3.95%
Principal amount	[7],[14],[18]			$ 10,103,000
Investment cost	[6],[7],[14],[18]			10,050,000
Investments, at fair value:	[7],[14],[18]			$ 10,167,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Thumbtack, Inc., Senior Secured, April 2026, Prime + 4.95%, Floor rate 8.20%, PIK Interest 1.50%, 3.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12],[22]	2026-04				2026-04
Basis spread variable rate	[9],[11],[12],[22]	4.95%				4.95%
Interest rate floor	[9],[11],[12],[22]	8.20%				8.20%
Interest rate paid in kind	[9],[11],[12],[22]	1.50%				1.50%
Exit fee rate	[9],[11],[12],[22]	3.95%				3.95%
Principal amount	[9],[12],[22]	$ 10,258,000
Investment cost	[2],[9],[12],[22]	10,317,000
Investments, at fair value:	[9],[12],[22]	10,639,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total SeatGeek, Inc., Senior Secured
Summary of Investment Holdings
Principal amount		102,841,000
Investment cost	[2]	102,296,000
Investments, at fair value:		104,988,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total Veem, Inc.
Summary of Investment Holdings
Principal amount		10,217,000
Investment cost	[2]	10,365,000
Investments, at fair value:		10,516,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Total Worldremit Group Limited
Summary of Investment Holdings
Principal amount		94,500,000
Investment cost	[2]	95,626,000
Investments, at fair value:		$ 95,997,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Udacity, Inc. Senior Secured, Maturity Date September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[18]			2024-09				2024-09
Basis spread variable rate	[8],[14],[18]			4.50%				4.50%
Interest rate floor	[8],[14],[18]			7.75%				7.75%
Interest rate paid in kind	[8],[14],[18]			2.00%				2.00%
Exit fee rate	[8],[14],[18]			3.00%				3.00%
Principal amount	[14],[18]			$ 51,937,000
Investment cost	[6],[14],[18]			52,265,000
Investments, at fair value:	[14],[18]			$ 52,976,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Udacity, Inc., Senior Secured, September 2024, Prime + 4.50%, Floor rate 7.75%, PIK Interest 2.00%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12]	2024-09				2024-09
Basis spread variable rate	[9],[11],[12]	4.50%				4.50%
Interest rate floor	[9],[11],[12]	7.75%				7.75%
Interest rate paid in kind	[9],[11],[12]	2.00%				2.00%
Exit fee rate	[9],[11],[12]	3.00%				3.00%
Principal amount	[9],[12]	$ 53,000,000
Investment cost	[2],[9],[12]	53,989,000
Investments, at fair value:	[9],[12]	$ 53,130,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[17]			2025-03				2025-03
Basis spread variable rate	[8],[14],[17]			4.00%				4.00%
Interest rate floor	[8],[14],[17]			7.25%				7.25%
Interest rate paid in kind	[8],[14],[17]			1.25%				1.25%
Exit fee rate	[8],[14],[17]			4.50%				4.50%
Principal amount	[14],[17]			$ 5,043,000
Investment cost	[6],[14],[17]			5,000,000
Investments, at fair value:	[14],[17]			$ 5,042,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc. Senior Secured, Maturity Date March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[14]			2025-03				2025-03
Basis spread variable rate	[8],[14]			4.70%				4.70%
Interest rate floor	[8],[14]			7.95%				7.95%
Interest rate paid in kind	[8],[14]			1.50%				1.50%
Exit fee rate	[8],[14]			4.50%				4.50%
Principal amount	[14]			$ 5,033,000
Investment cost	[6],[14]			4,988,000
Investments, at fair value:	[14]			$ 5,124,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.00%, Floor rate 7.25%, PIK Interest 1.25%, 4.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[10]	2025-03				2025-03
Basis spread variable rate	[9],[10],[11]	4.00%				4.00%
Interest rate floor	[9],[10],[11]	7.25%				7.25%
Interest rate paid in kind	[9],[10],[11]	1.25%				1.25%
Exit fee rate	[9],[10],[11]	4.50%				4.50%
Principal amount	[9],[10]	$ 5,107,000
Investment cost	[2],[9],[10]	5,176,000
Investments, at fair value:	[9],[10]	$ 5,230,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Veem, Inc., Senior Secured, March 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.50%, 4.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12]	2025-03				2025-03
Basis spread variable rate	[9],[11],[12]	4.70%				4.70%
Interest rate floor	[9],[11],[12]	7.95%				7.95%
Interest rate paid in kind	[9],[11],[12]	1.50%				1.50%
Exit fee rate	[9],[11],[12]	4.50%				4.50%
Principal amount	[9],[12]	$ 5,110,000
Investment cost	[2],[9],[12]	5,189,000
Investments, at fair value:	[9],[12]	$ 5,286,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 1-month SOFR + 9.35%, Floor rate 10.25%, 3.20% Exit Fee
Summary of Investment Holdings
Maturity Date	[20],[26],[27],[31]	2025-02				2025-02
Basis spread variable rate	[11],[20],[26],[27],[31]	9.35%				9.35%
Interest rate floor	[11],[20],[26],[27],[31]	10.25%				10.25%
Exit fee rate	[11],[20],[26],[27],[31]	3.20%				3.20%
Principal amount	[20],[26],[27],[31]	$ 6,250,000
Investment cost	[2],[20],[26],[27],[31]	6,308,000
Investments, at fair value:	[20],[26],[27],[31]	$ 6,344,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, February 2025, 3-month SOFR + 9.40%, Floor rate 10.25%, 3.20% Exit Fee
Summary of Investment Holdings
Maturity Date	[12],[20],[21],[26],[27],[31]	2025-02				2025-02
Basis spread variable rate	[11],[12],[20],[21],[26],[27],[31]	9.40%				9.40%
Interest rate floor	[11],[12],[20],[21],[26],[27],[31]	10.25%				10.25%
Exit fee rate	[11],[12],[20],[21],[26],[27],[31]	3.20%				3.20%
Principal amount	[12],[20],[21],[26],[27],[31]	$ 88,250,000
Investment cost	[2],[12],[20],[21],[26],[27],[31]	89,318,000
Investments, at fair value:	[12],[20],[21],[26],[27],[31]	$ 89,653,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services and Worldremit Group Limited, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.25%, Floor rate 10.25%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[13],[15],[18],[19],[24],[25]			2025-02				2025-02
Basis spread variable rate	[8],[13],[15],[18],[19],[24],[25]			9.25%				9.25%
Interest rate floor	[8],[13],[15],[18],[19],[24],[25]			10.25%				10.25%
Exit fee rate	[8],[13],[15],[18],[19],[24],[25]			3.00%				3.00%
Principal amount	[13],[15],[18],[19],[24],[25]			$ 94,500,000
Investment cost	[6],[13],[15],[18],[19],[24],[25]			94,418,000
Investments, at fair value:	[13],[15],[18],[19],[24],[25]			93,837,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, SeatGeek, Inc.
Summary of Investment Holdings
Principal amount				85,986,000
Investment cost	[6]			85,633,000
Investments, at fair value:				86,544,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Tectura Corporation
Summary of Investment Holdings
Principal amount				31,953,000
Investment cost	[6]			21,513,000
Investments, at fair value:				8,042,000
Investment, Identifier [Axis]: Debt Investments Consumer & Business Services, Veem, Inc.
Summary of Investment Holdings
Principal amount				10,076,000
Investment cost	[6]			9,988,000
Investments, at fair value:				$ 10,166,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (2.40%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			2.40%				2.40%
Investment cost	[6]			$ 36,567,000
Investments, at fair value:				$ 33,700,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services (3.17%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	3.17%				3.17%
Investment cost	[2]	$ 56,764,000
Investments, at fair value:		57,096,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC)
Summary of Investment Holdings
Principal amount		35,000,000
Investment cost	[2]	34,478,000
Investments, at fair value:		$ 34,478,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), UnSecured, Maturity Date September 2026, FIXED + 11.95%
Summary of Investment Holdings
Maturity Date	[32],[35]	2026-09				2026-09
Interest rate paid in cash	[11],[32],[35]	11.95%				11.95%
Principal amount	[32],[35]	$ 10,000,000
Investment cost	[2],[32],[35]	9,815,000
Investments, at fair value:	[32],[35]	$ 9,815,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Unsecured, Maturity Date September 2026, FIXED 11.50%
Summary of Investment Holdings
Maturity Date	[32],[35]	2026-09				2026-09
Interest rate paid in cash	[11],[32],[35]	11.50%				11.50%
Principal amount	[32],[35]	$ 25,000,000
Investment cost	[2],[32],[35]	24,663,000
Investments, at fair value:	[32],[35]	$ 24,663,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 11.50%
Summary of Investment Holdings
Maturity Date	[34]			2026-09				2026-09
Interest rate paid in cash	[8],[34]			11.50%				11.50%
Principal amount	[34]			$ 10,000,000
Investment cost	[6],[34]			9,852,000
Investments, at fair value:	[34]			$ 8,898,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Unsecured, Maturity Date September 2026, FIXED 14.50%
Summary of Investment Holdings
Maturity Date	[34]			2026-09				2026-09
Interest rate paid in cash	[8],[34]			14.50%				14.50%
Principal amount	[34]			$ 15,000,000
Investment cost	[6],[34]			14,715,000
Investments, at fair value:	[34]			$ 12,802,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Hercules Adviser LLC, Unsecured, Maturity Date June 2025, FIXED 5.00%
Summary of Investment Holdings
Maturity Date		2025-06	[32],[36]	2025-06	[34]	2025-06	[32],[36]	2025-06	[34]
Interest rate paid in cash		5.00%	[11],[32],[36]	5.00%	[8],[34]	5.00%	[11],[32],[36]	5.00%	[8],[34]
Principal amount		$ 12,000,000	[32],[36]	$ 12,000,000	[34]
Investment cost		12,000,000	[2],[32],[36]	12,000,000	[6],[34]
Investments, at fair value:		$ 12,000,000	[32],[36]	12,000,000	[34]
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services and Next Insurance, Inc, Senior Secured, Maturity Date February 2028, Prime + -1.50%, Floor rate 4.75%, PIK Interest 5.50%
Summary of Investment Holdings
Maturity Date	[9],[20],[22]	2028-02				2028-02
Basis spread variable rate	[9],[11],[20],[22]	(1.50%)				(1.50%)
Interest rate floor	[9],[11],[20],[22]	4.75%				4.75%
Interest rate paid in kind	[9],[11],[20],[22]	5.50%				5.50%
Principal amount	[9],[20],[22]	$ 10,469,000
Investment cost	[2],[9],[20],[22]	10,286,000
Investments, at fair value:	[9],[20],[22]	$ 10,618,000
Investment, Identifier [Axis]: Debt Investments Diversified Financial Services, Gibraltar Business Capital, LLC, Unsecured
Summary of Investment Holdings
Principal amount				25,000,000
Investment cost	[6]			24,567,000
Investments, at fair value:				$ 21,700,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (66.60%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	66.60%				66.60%
Investment cost	[2]	$ 1,184,022,000
Investments, at fair value:		$ 1,200,667,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development (78.59%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			78.59%				78.59%
Investment cost	[6]			$ 1,107,352,000
Investments, at fair value:				$ 1,101,430,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and ATAI Life Sciences N.V. Senior Secured, Maturity Date August 2026, Prime + 4.55%, Floor rate 8.55%, 6.95% Exit Fee
Summary of Investment Holdings
Maturity Date		2026-08	[26],[27]	2026-08	[24],[25]	2026-08	[26],[27]	2026-08	[24],[25]
Basis spread variable rate		4.55%	[11],[26],[27]	4.55%	[8],[24],[25]	4.55%	[11],[26],[27]	4.55%	[8],[24],[25]
Interest rate floor		8.55%	[11],[26],[27]	8.55%	[8],[24],[25]	8.55%	[11],[26],[27]	8.55%	[8],[24],[25]
Exit fee rate		6.95%	[11],[26],[27]	6.95%	[8],[24],[25]	6.95%	[11],[26],[27]	6.95%	[8],[24],[25]
Principal amount		$ 10,500,000	[26],[27]	$ 10,500,000	[24],[25]
Investment cost		10,695,000	[2],[26],[27]	10,513,000	[6],[24],[25]
Investments, at fair value:		$ 10,904,000	[26],[27]	$ 10,513,000	[24],[25]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Akero Therapeutics, Inc. Senior Secured, Maturity Date January 2027, Prime + 3.65%, Floor rate 7.65%, 5.85% Exit Fee
Summary of Investment Holdings
Maturity Date		2027-01	[10],[22],[26]	2027-01	[7],[17],[24]	2027-01	[10],[22],[26]	2027-01	[7],[17],[24]
Basis spread variable rate		3.65%	[10],[11],[22],[26]	3.65%	[7],[8],[17],[24]	3.65%	[10],[11],[22],[26]	3.65%	[7],[8],[17],[24]
Interest rate floor		7.65%	[10],[11],[22],[26]	7.65%	[7],[8],[17],[24]	7.65%	[10],[11],[22],[26]	7.65%	[7],[8],[17],[24]
Exit fee rate		5.85%	[10],[11],[22],[26]	5.85%	[7],[8],[17],[24]	5.85%	[10],[11],[22],[26]	5.85%	[7],[8],[17],[24]
Principal amount		$ 12,500,000	[10],[22],[26]	$ 5,000,000	[7],[17],[24]
Investment cost		12,525,000	[2],[10],[22],[26]	4,986,000	[6],[7],[17],[24]
Investments, at fair value:		$ 13,065,000	[10],[22],[26]	$ 5,039,000	[7],[17],[24]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aldeyra Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 3.10%, Floor rate 8.60%, 8.90% Exit Fee
Summary of Investment Holdings
Maturity Date		2024-10	[21]	2024-10	[15]	2024-10	[21]	2024-10	[15]
Basis spread variable rate		3.10%	[11],[21]	3.10%	[8],[15]	3.10%	[11],[21]	3.10%	[8],[15]
Interest rate floor		8.60%	[11],[21]	8.60%	[8],[15]	8.60%	[11],[21]	8.60%	[8],[15]
Exit fee rate		8.90%	[11],[21]	8.90%	[8],[15]	8.90%	[11],[21]	8.90%	[8],[15]
Principal amount		$ 15,000,000	[21]	$ 15,000,000	[15]
Investment cost		15,152,000	[2],[21]	15,879,000	[6],[15]
Investments, at fair value:		$ 15,152,000	[21]	$ 15,974,000	[15]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 10.60% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[17]			2026-09				2026-09
Basis spread variable rate	[7],[8],[17]			3.65%				3.65%
Interest rate floor	[7],[8],[17]			8.40%				8.40%
Interest rate cap	[7],[8],[17]			10.90%				10.90%
Exit fee rate	[7],[8],[17]			10.60%				10.60%
Principal amount	[7],[17]			$ 15,000,000
Investment cost	[6],[7],[17]			14,920,000
Investments, at fair value:	[7],[17]			$ 14,920,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Alladapt Immunotherapeutics Inc. Senior Secured, Maturity Date September 2026, Prime + 3.65%, Floor rate 8.40%, Cap rate 10.90%, 5.30% Exit Fee
Summary of Investment Holdings
Maturity Date	[10]	2026-09				2026-09
Basis spread variable rate	[10],[11]	3.65%				3.65%
Interest rate floor	[10],[11]	8.40%				8.40%
Interest rate cap	[10],[11]	10.90%				10.90%
Exit fee rate	[10],[11]	5.30%				5.30%
Principal amount	[10]	$ 35,000,000
Investment cost	[2],[10]	35,173,000
Investments, at fair value:	[10]	$ 36,855,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and AmplifyBio, LLC, Senior Secured, Maturity Date January 2027, Prime + 2.50%, Floor rate 9.50%, Cap rate 10.75%, 5.85% Exit Fee
Summary of Investment Holdings
Maturity Date		2027-01	[1]	2027-01	[30]	2027-01	[1]	2027-01	[30]
Basis spread variable rate		2.50%	[1],[11]	2.50%	[8],[30]	2.50%	[1],[11]	2.50%	[8],[30]
Interest rate floor		9.50%	[1],[11]	9.50%	[8],[30]	9.50%	[1],[11]	9.50%	[8],[30]
Interest rate cap		10.75%	[1],[11]	10.75%	[8],[30]	10.75%	[1],[11]	10.75%	[8],[30]
Exit fee rate		5.85%	[1],[11]	5.85%	[8],[30]	5.85%	[1],[11]	5.85%	[8],[30]
Principal amount		$ 24,000,000	[1]	$ 24,000,000	[30]
Investment cost		24,120,000	[1],[2]	23,663,000	[6],[30]
Investments, at fair value:		$ 24,514,000	[1]	$ 23,663,000	[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc. Senior Secured, Maturity Date September 2024, Prime + 6.40%, Floor rate 9.65%, Cap rate 15.00%, 6.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[15],[30]			2024-09				2024-09
Basis spread variable rate	[8],[15],[30]			6.40%				6.40%
Interest rate floor	[8],[15],[30]			9.65%				9.65%
Interest rate cap	[8],[15],[30]			15.00%				15.00%
Exit fee rate	[8],[15],[30]			6.95%				6.95%
Principal amount	[15],[30]			$ 40,000,000
Investment cost	[6],[15],[30]			41,644,000
Investments, at fair value:	[15],[30]			$ 43,183,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date January 2028 Prime + 2.20%, Floor rate 9.95%, Cap rate 10.70%, 5.78% Exit Fee
Summary of Investment Holdings
Maturity Date	[12],[21],[26],[31]	2028-01				2028-01
Basis spread variable rate	[11],[12],[21],[26],[31]	2.20%				2.20%
Interest rate floor	[11],[12],[21],[26],[31]	9.95%				9.95%
Interest rate cap	[11],[12],[21],[26],[31]	10.70%				10.70%
Exit fee rate	[11],[12],[21],[26],[31]	5.78%				5.78%
Principal amount	[12],[21],[26],[31]	$ 143,350,000
Investment cost	[2],[12],[21],[26],[31]	143,646,000
Investments, at fair value:	[12],[21],[26],[31]	$ 150,255,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Axsome Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 5.70%, Floor rate 8.95%, Cap rate 10.70%, 5.31% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[15],[18],[19],[24]			2026-10				2026-10
Basis spread variable rate	[7],[8],[15],[18],[19],[24]			5.70%				5.70%
Interest rate floor	[7],[8],[15],[18],[19],[24]			8.95%				8.95%
Interest rate cap	[7],[8],[15],[18],[19],[24]			10.70%				10.70%
Exit fee rate	[7],[8],[15],[18],[19],[24]			5.31%				5.31%
Principal amount	[7],[15],[18],[19],[24]			$ 81,725,000
Investment cost	[6],[7],[15],[18],[19],[24]			81,631,000
Investments, at fair value:	[7],[15],[18],[19],[24]			$ 78,074,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Senior Secured, Maturity Date July 2025, Prime + 4.55%, Floor rate 8.05%, Cap rate 9.05%, 5.00% Exit Fee
Summary of Investment Holdings
Maturity Date		2025-07	[12],[21],[26],[27]	2025-07	[15],[18],[24],[25]	2025-07	[12],[21],[26],[27]	2025-07	[15],[18],[24],[25]
Basis spread variable rate		4.55%	[11],[12],[21],[26],[27]	4.55%	[8],[15],[18],[24],[25]	4.55%	[11],[12],[21],[26],[27]	4.55%	[8],[15],[18],[24],[25]
Interest rate floor		8.05%	[11],[12],[21],[26],[27]	8.05%	[8],[15],[18],[24],[25]	8.05%	[11],[12],[21],[26],[27]	8.05%	[8],[15],[18],[24],[25]
Interest rate cap		9.05%	[11],[12],[21],[26],[27]	9.05%	[8],[15],[18],[24],[25]	9.05%	[11],[12],[21],[26],[27]	9.05%	[8],[15],[18],[24],[25]
Exit fee rate		5.00%	[11],[12],[21],[26],[27]	5.00%	[8],[15],[18],[24],[25]	5.00%	[11],[12],[21],[26],[27]	5.00%	[8],[15],[18],[24],[25]
Principal amount		$ 11,500,000	[12],[21],[26],[27]	$ 11,500,000	[15],[18],[24],[25]
Investment cost		11,880,000	[2],[12],[21],[26],[27]	11,757,000	[6],[15],[18],[24],[25]
Investments, at fair value:		$ 11,783,000	[12],[21],[26],[27]	$ 11,435,000	[15],[18],[24],[25]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BiomX, INC, Senior Secured, Maturity Date September 2025, Prime + 5.70%, Floor rate 8.95%, 6.55% Exit Fee
Summary of Investment Holdings
Maturity Date		2025-09	[21],[26],[27]	2025-09	[15],[24],[25]	2025-09	[21],[26],[27]	2025-09	[15],[24],[25]
Basis spread variable rate		5.70%	[11],[21],[26],[27]	5.70%	[8],[15],[24],[25]	5.70%	[11],[21],[26],[27]	5.70%	[8],[15],[24],[25]
Interest rate floor		8.95%	[11],[21],[26],[27]	8.95%	[8],[15],[24],[25]	8.95%	[11],[21],[26],[27]	8.95%	[8],[15],[24],[25]
Exit fee rate		6.55%	[11],[21],[26],[27]	6.55%	[8],[15],[24],[25]	6.55%	[11],[21],[26],[27]	6.55%	[8],[15],[24],[25]
Principal amount		$ 6,448,000	[21],[26],[27]	$ 9,000,000	[15],[24],[25]
Investment cost		6,807,000	[2],[21],[26],[27]	9,174,000	[6],[15],[24],[25]
Investments, at fair value:		$ 6,790,000	[21],[26],[27]	$ 9,052,000	[15],[24],[25]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October 2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee
Summary of Investment Holdings
Basis spread variable rate	[9],[11]	2.45%				2.45%
Interest rate floor	[9],[11]	10.95%				10.95%
Interest rate paid in kind	[9],[11]	1.10%				1.10%
Exit fee rate	[9],[11]	5.45%				5.45%
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Braeburn, Inc., Senior Secured, Maturity Date October2028, Prime + 2.45%, Floor rate 10.95%, PIK Interest 1.10%, 5.45% Exit Fee
Summary of Investment Holdings
Maturity Date	[9]	2028-10				2028-10
Principal amount	[9]	$ 52,601,000
Investment cost	[2],[9]	52,185,000
Investments, at fair value:	[9]	$ 52,185,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and BridgeBio Pharma, Inc. Senior Secured, Maturity Date November 2026, FIXED 9.00%, 2.00% Exit Fee
Summary of Investment Holdings
Maturity Date		2026-11	[9],[10],[12]	2026-11	[14],[17],[18]	2026-11	[9],[10],[12]	2026-11	[14],[17],[18]
Interest rate paid in cash		9.00%	[9],[10],[11],[12]	9.00%	[8],[14],[17],[18]	9.00%	[9],[10],[11],[12]	9.00%	[8],[14],[17],[18]
Exit fee rate		2.00%	[9],[10],[11],[12]	2.00%	[8],[14],[17],[18]	2.00%	[9],[10],[11],[12]	2.00%	[8],[14],[17],[18]
Principal amount		$ 38,167,000	[9],[10],[12]	$ 37,312,000	[14],[17],[18]
Investment cost		38,124,000	[2],[9],[10],[12]	37,039,000	[6],[14],[17],[18]
Investments, at fair value:		$ 35,498,000	[9],[10],[12]	$ 33,344,000	[14],[17],[18]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and COMPASS Pathways plc Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.75%, PIK Interest 1.40%, 4.75% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[26],[27]	2027-07				2027-07
Basis spread variable rate	[9],[11],[26],[27]	1.50%				1.50%
Interest rate floor	[9],[11],[26],[27]	9.75%				9.75%
Interest rate paid in kind	[9],[11],[26],[27]	1.40%				1.40%
Exit fee rate	[9],[11],[26],[27]	4.75%				4.75%
Principal amount	[9],[26],[27]	$ 24,144,000
Investment cost	[2],[9],[26],[27]	23,798,000
Investments, at fair value:	[9],[26],[27]	$ 24,601,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Cellarity, Inc. Senior Secured, Maturity Date June 2026, Prime + 5.70%, Floor rate 8.95%, 3.75% Exit Fee
Summary of Investment Holdings
Maturity Date		2026-06	[1],[10]	2026-06	[17],[30]	2026-06	[1],[10]	2026-06	[17],[30]
Basis spread variable rate		5.70%	[1],[10],[11]	5.70%	[8],[17],[30]	5.70%	[1],[10],[11]	5.70%	[8],[17],[30]
Interest rate floor		8.95%	[1],[10],[11]	8.95%	[8],[17],[30]	8.95%	[1],[10],[11]	8.95%	[8],[17],[30]
Exit fee rate		3.75%	[1],[10],[11]	3.75%	[8],[17],[30]	3.75%	[1],[10],[11]	3.75%	[8],[17],[30]
Principal amount		$ 29,193,000	[1],[10]	$ 30,000,000	[17],[30]
Investment cost		29,482,000	[1],[2],[10]	29,841,000	[6],[17],[30]
Investments, at fair value:		$ 30,051,000	[1],[10]	$ 30,097,000	[17],[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Century Therapeutics, Inc. Senior Secured, Maturity Date April 2024, Prime + 6.30%, Floor rate 9.55%, 3.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[15]			2024-04				2024-04
Basis spread variable rate	[8],[15]			6.30%				6.30%
Interest rate floor	[8],[15]			9.55%				9.55%
Exit fee rate	[8],[15]			3.95%				3.95%
Principal amount	[15]			$ 10,000,000
Investment cost	[6],[15]			10,235,000
Investments, at fair value:	[15]			$ 10,292,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Codiak Biosciences, Inc. Senior Secured, Maturity Date October 2025, Prime + 5.00%, Floor rate 8.25%, 5.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[15]			2025-10				2025-10
Basis spread variable rate	[8],[15]			5.00%				5.00%
Interest rate floor	[8],[15]			8.25%				8.25%
Exit fee rate	[8],[15]			5.50%				5.50%
Principal amount	[15]			$ 25,000,000
Investment cost	[6],[15]			25,759,000
Investments, at fair value:	[15]			$ 25,177,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Corium, Inc. Senior Secured, Maturity Date September 2026, Prime + 5.70%, Floor rate 8.95%, 7.75% Exit Fee
Summary of Investment Holdings
Maturity Date		2026-09	[10],[31]	2026-09	[17],[19]	2026-09	[10],[31]	2026-09	[17],[19]
Basis spread variable rate		5.70%	[10],[11],[31]	5.70%	[8],[17],[19]	5.70%	[10],[11],[31]	5.70%	[8],[17],[19]
Interest rate floor		8.95%	[10],[11],[31]	8.95%	[8],[17],[19]	8.95%	[10],[11],[31]	8.95%	[8],[17],[19]
Exit fee rate		7.75%	[10],[11],[31]	7.75%	[8],[17],[19]	7.75%	[10],[11],[31]	7.75%	[8],[17],[19]
Principal amount		$ 105,225,000	[10],[31]	$ 132,675,000	[17],[19]
Investment cost		107,667,000	[2],[10],[31]	133,557,000	[6],[17],[19]
Investments, at fair value:		$ 108,545,000	[10],[31]	$ 135,619,000	[17],[19]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Curevo, Inc. Senior Secured, Maturity Date June 2027 Prime + 1.70%, Floor rate 9.70%, 6.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[1]	2027-06				2027-06
Basis spread variable rate	[1],[11]	1.70%				1.70%
Interest rate floor	[1],[11]	9.70%				9.70%
Exit fee rate	[1],[11]	6.95%				6.95%
Principal amount	[1]	$ 10,000,000
Investment cost	[1],[2]	9,821,000
Investments, at fair value:	[1]	$ 10,076,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Eloxx Pharmaceuticals, Inc. Senior Secured, Maturity Date April 2025, Prime + 6.25%, Floor rate 9.50%, 6.55% Exit Fee
Summary of Investment Holdings
Maturity Date		2025-04	[1]	2025-04	[30]	2025-04	[1]	2025-04	[30]
Basis spread variable rate		6.25%	[1],[11]	6.25%	[8],[30]	6.25%	[1],[11]	6.25%	[8],[30]
Interest rate floor		9.50%	[1],[11]	9.50%	[8],[30]	9.50%	[1],[11]	9.50%	[8],[30]
Exit fee rate		6.55%	[1],[11]	6.55%	[8],[30]	6.55%	[1],[11]	6.55%	[8],[30]
Principal amount		$ 3,099,000	[1]	$ 12,500,000	[30]
Investment cost		3,789,000	[1],[2]	12,753,000	[6],[30]
Investments, at fair value:		$ 3,731,000	[1]	$ 12,535,000	[30]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Finch Therapeutics Group, Inc. Senior Secured, Maturity Date November 2026, Prime + 4.05%, Floor rate 7.55%, Cap rate 8.80%, 5.50% Exit Fee
Summary of Investment Holdings
Maturity Date				2026-11				2026-11
Basis spread variable rate	[8]			4.05%				4.05%
Interest rate floor	[8]			7.55%				7.55%
Interest rate cap	[8]			8.80%				8.80%
Exit fee rate	[8]			5.50%				5.50%
Principal amount				$ 15,000,000
Investment cost	[6]			15,012,000
Investments, at fair value:				$ 13,940,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc. Senior Secured, Maturity Date November 2026, Prime + 5.90%, Floor rate 9.15%, 9.86% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[15],[18],[30]			2026-11				2026-11
Basis spread variable rate	[7],[8],[15],[18],[30]			5.90%				5.90%
Interest rate floor	[7],[8],[15],[18],[30]			9.15%				9.15%
Exit fee rate	[7],[8],[15],[18],[30]			9.86%				9.86%
Principal amount	[7],[15],[18],[30]			$ 58,125,000
Investment cost	[6],[7],[15],[18],[30]			58,674,000
Investments, at fair value:	[7],[15],[18],[30]			$ 58,407,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and G1 Therapeutics, Inc., Senior Secured, Maturity Date November 2026, Prime + 5.65%, Floor rate 9.15%, 11.41% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[12],[21]	2026-11				2026-11
Basis spread variable rate	[1],[11],[12],[21]	5.65%				5.65%
Interest rate floor	[1],[11],[12],[21]	9.15%				9.15%
Exit fee rate	[1],[11],[12],[21]	11.41%				11.41%
Principal amount	[1],[12],[21]	$ 38,750,000
Investment cost	[1],[2],[12],[21]	39,679,000
Investments, at fair value:	[1],[12],[21]	$ 40,421,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date April 2025, Prime + 4.50%, Floor rate 9.00%, 6.55% Exit Fee
Summary of Investment Holdings
Maturity Date	[10],[12],[26]	2025-04				2025-04
Basis spread variable rate	[10],[11],[12],[26]	4.50%				4.50%
Interest rate floor	[10],[11],[12],[26]	9.00%				9.00%
Exit fee rate	[10],[11],[12],[26]	6.55%				6.55%
Principal amount	[10],[12],[26]	$ 30,200,000
Investment cost	[2],[10],[12],[26]	31,005,000
Investments, at fair value:	[10],[12],[26]	$ 31,210,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Geron Corporation, Senior Secured, Maturity Date October 2024, Prime + 5.75%, Floor rate 9.00%, 6.55% Exit Fee
Summary of Investment Holdings
Maturity Date	[17],[18],[24]			2024-10				2024-10
Basis spread variable rate	[8],[17],[18],[24]			5.75%				5.75%
Interest rate floor	[8],[17],[18],[24]			9.00%				9.00%
Exit fee rate	[8],[17],[18],[24]			6.55%				6.55%
Principal amount	[17],[18],[24]			$ 18,500,000
Investment cost	[6],[17],[18],[24]			19,109,000
Investments, at fair value:	[17],[18],[24]			$ 19,174,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc. Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[14]			2027-07				2027-07
Basis spread variable rate	[7],[8],[14]			3.15%				3.15%
Interest rate floor	[7],[8],[14]			7.15%				7.15%
Interest rate cap	[7],[8],[14]			8.65%				8.65%
Interest rate paid in kind	[7],[8],[14]			2.00%				2.00%
Exit fee rate	[7],[8],[14]			5.75%				5.75%
Principal amount	[7],[14]			$ 15,113,000
Investment cost	[6],[7],[14]			15,109,000
Investments, at fair value:	[7],[14]			$ 15,109,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Gritstone Bio, Inc., Senior Secured, Maturity Date July 2027, Prime + 3.15%, Floor rate 7.15%, Cap rate 8.65%, PIK Interest 2.00%, 5.75% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[10]	2027-07				2027-07
Basis spread variable rate	[9],[10],[11]	3.15%				3.15%
Interest rate floor	[9],[10],[11]	7.15%				7.15%
Interest rate cap	[9],[10],[11]	8.65%				8.65%
Interest rate paid in kind	[9],[10],[11]	2.00%				2.00%
Exit fee rate	[9],[10],[11]	5.75%				5.75%
Principal amount	[9],[10]	$ 30,532,000
Investment cost	[2],[9],[10]	30,717,000
Investments, at fair value:	[9],[10]	$ 30,909,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Heron Therapeutics, Inc., Senior Secured, Maturity Date February 2026, Prime + 1.70%, Floor rate 9.95%, PIK Interest 1.50%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[9],[22]	2026-02				2026-02
Basis spread variable rate	[1],[9],[11],[22]	1.70%				1.70%
Interest rate floor	[1],[9],[11],[22]	9.95%				9.95%
Interest rate paid in kind	[1],[9],[11],[22]	1.50%				1.50%
Exit fee rate	[1],[9],[11],[22]	3.00%				3.00%
Principal amount	[1],[9],[22]	$ 20,095,000
Investment cost	[1],[2],[9],[22]	19,788,000
Investments, at fair value:	[1],[9],[22]	$ 19,788,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc. Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[17],[30]			2025-05				2025-05
Basis spread variable rate	[8],[17],[30]			5.40%				5.40%
Interest rate floor	[8],[17],[30]			8.65%				8.65%
Exit fee rate	[8],[17],[30]			4.95%				4.95%
Principal amount	[17],[30]			$ 17,000,000
Investment cost	[6],[17],[30]			17,313,000
Investments, at fair value:	[17],[30]			$ 17,265,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Hibercell, Inc., Senior Secured, Maturity Date May 2025, Prime + 5.40%, Floor rate 8.65%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[10]	2025-05				2025-05
Basis spread variable rate	[1],[10],[11]	5.40%				5.40%
Interest rate floor	[1],[10],[11]	8.65%				8.65%
Exit fee rate	[1],[10],[11]	4.95%				4.95%
Principal amount	[1],[10]	$ 12,535,000
Investment cost	[1],[2],[10]	13,117,000
Investments, at fair value:	[1],[10]	$ 13,181,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc. Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[14],[30]			2027-05				2027-05
Basis spread variable rate	[7],[8],[14],[30]			1.05%				1.05%
Interest rate floor	[7],[8],[14],[30]			4.55%				4.55%
Interest rate cap	[7],[8],[14],[30]			6.05%				6.05%
Interest rate paid in kind	[7],[8],[14],[30]			2.85%				2.85%
Exit fee rate	[7],[8],[14],[30]			7.15%				7.15%
Principal amount	[7],[14],[30]			$ 12,072,000
Investment cost	[6],[7],[14],[30]			12,043,000
Investments, at fair value:	[7],[14],[30]			$ 11,333,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and HilleVax, Inc., Senior Secured, Maturity Date May 2027, Prime + 1.05%, Floor rate 4.55%, Cap rate 6.05%, PIK Interest 2.85%, 7.15% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[9]	2027-05				2027-05
Basis spread variable rate	[1],[9],[11]	1.05%				1.05%
Interest rate floor	[1],[9],[11]	4.55%				4.55%
Interest rate cap	[1],[9],[11]	6.05%				6.05%
Interest rate paid in kind	[1],[9],[11]	2.85%				2.85%
Exit fee rate	[1],[9],[11]	7.15%				7.15%
Principal amount	[1],[9]	$ 20,524,000
Investment cost	[1],[2],[9]	20,685,000
Investments, at fair value:	[1],[9]	$ 20,335,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Iveric Bio, Inc. Senior Secured, Maturity Date August 2027, Prime + 4.00%, Floor rate 8.75%, Cap rate 10.25%, 4.25% Exit Fee
Summary of Investment Holdings
Maturity Date	[18],[24]			2027-08				2027-08
Basis spread variable rate	[8],[18],[24]			4.00%				4.00%
Interest rate floor	[8],[18],[24]			8.75%				8.75%
Interest rate cap	[8],[18],[24]			10.25%				10.25%
Exit fee rate	[8],[18],[24]			4.25%				4.25%
Principal amount	[18],[24]			$ 49,500,000
Investment cost	[6],[18],[24]			49,090,000
Investments, at fair value:	[18],[24]			$ 49,090,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc. Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[24],[30]			2027-11				2027-11
Basis spread variable rate	[7],[8],[24],[30]			2.40%				2.40%
Interest rate floor	[7],[8],[24],[30]			8.65%				8.65%
Exit fee rate	[7],[8],[24],[30]			15.13%				15.13%
Principal amount	[7],[24],[30]			$ 5,500,000
Investment cost	[6],[7],[24],[30]			5,448,000
Investments, at fair value:	[7],[24],[30]			$ 5,448,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Kura Oncology, Inc., Senior Secured, Maturity Date November 2027, Prime + 2.40%, Floor rate 8.65%, 15.13% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[22],[26]	2027-11				2027-11
Basis spread variable rate	[1],[11],[22],[26]	2.40%				2.40%
Interest rate floor	[1],[11],[22],[26]	8.65%				8.65%
Exit fee rate	[1],[11],[22],[26]	15.13%				15.13%
Principal amount	[1],[22],[26]	$ 5,500,000
Investment cost	[1],[2],[22],[26]	5,532,000
Investments, at fair value:	[1],[22],[26]	$ 5,752,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc. Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[30]			2025-07				2025-07
Basis spread variable rate	[8],[30]			6.10%				6.10%
Interest rate floor	[8],[30]			9.35%				9.35%
Exit fee rate	[8],[30]			4.95%				4.95%
Principal amount	[30]			$ 8,000,000
Investment cost	[6],[30]			8,120,000
Investments, at fair value:	[30]			$ 8,085,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Locus Biosciences, Inc., Senior Secured, Maturity Date July 2025, Prime + 6.10%, Floor rate 9.35%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[1]	2025-07				2025-07
Basis spread variable rate	[1],[11]	6.10%				6.10%
Interest rate floor	[1],[11]	9.35%				9.35%
Exit fee rate	[1],[11]	4.95%				4.95%
Principal amount	[1]	$ 5,399,000
Investment cost	[1],[2]	5,651,000
Investments, at fair value:	[1]	$ 5,686,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc. Senior Secured, Maturity Date May 2026, Prime + 3.95%, Floor rate 7.45%, 5.35% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[24]			2026-05				2026-05
Basis spread variable rate	[7],[8],[24]			3.95%				3.95%
Interest rate floor	[7],[8],[24]			7.45%				7.45%
Exit fee rate	[7],[8],[24]			5.35%				5.35%
Principal amount	[7],[24]			$ 34,000,000
Investment cost	[6],[7],[24]			33,945,000
Investments, at fair value:	[7],[24]			$ 33,987,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Senior Secured, Maturity Date May 2026, Prime + 2.45%, Floor rate 8.25%, 5.35% Exit Fee
Summary of Investment Holdings
Maturity Date	[26]	2026-05				2026-05
Basis spread variable rate	[11],[26]	2.45%				2.45%
Interest rate floor	[11],[26]	8.25%				8.25%
Exit fee rate	[11],[26]	5.35%				5.35%
Principal amount	[26]	$ 78,200,000
Investment cost	[2],[26]	78,728,000
Investments, at fair value:	[26]	$ 81,945,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Nabriva Therapeutics, Senior Secured, Maturity Date June 2023, Prime + 4.30%, Floor rate 9.80%, 9.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[17],[24],[25]			2023-06				2023-06
Basis spread variable rate	[8],[17],[24],[25]			4.30%				4.30%
Interest rate floor	[8],[17],[24],[25]			9.80%				9.80%
Exit fee rate	[8],[17],[24],[25]			9.95%				9.95%
Principal amount	[17],[24],[25]			$ 2,079,000
Investment cost	[6],[17],[24],[25]			2,734,000
Investments, at fair value:	[17],[24],[25]			$ 2,804,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc. Senior Secured, Maturity Date October 2026, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.35%, 7.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[14],[18],[19],[24],[30],[37]			2026-10				2026-10
Basis spread variable rate	[7],[8],[14],[18],[19],[24],[30],[37]			2.25%				2.25%
Interest rate floor	[7],[8],[14],[18],[19],[24],[30],[37]			5.50%				5.50%
Interest rate paid in kind	[7],[8],[14],[18],[19],[24],[30],[37]			3.35%				3.35%
Exit fee rate	[7],[8],[14],[18],[19],[24],[30],[37]			7.50%				7.50%
Principal amount	[7],[14],[18],[19],[24],[30],[37]			$ 94,737,000
Investment cost	[6],[7],[14],[18],[19],[24],[30],[37]			95,032,000
Investments, at fair value:	[7],[14],[18],[19],[24],[30],[37]			$ 93,916,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Senior Secured, Maturity Date December 2027, Prime + 1.35%, Floor rate 9.85%, PIK Interest 2.15%, 7.29% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[9],[12],[22],[26],[31],[38]	2027-12				2027-12
Basis spread variable rate	[1],[9],[11],[12],[22],[26],[31],[38]	1.35%				1.35%
Interest rate floor	[1],[9],[11],[12],[22],[26],[31],[38]	9.85%				9.85%
Interest rate paid in kind	[1],[9],[11],[12],[22],[26],[31],[38]	2.15%				2.15%
Exit fee rate	[1],[9],[11],[12],[22],[26],[31],[38]	7.29%				7.29%
Principal amount	[1],[9],[12],[22],[26],[31],[38]	$ 129,699,000
Investment cost	[1],[2],[9],[12],[22],[26],[31],[38]	130,934,000
Investments, at fair value:	[1],[9],[12],[22],[26],[31],[38]	$ 128,326,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Provention Bio, Inc. Senior Secured, Maturity Date September 2027, Prime + 2.70%, Floor rate 8.20%, 6.60% Exit Fee
Summary of Investment Holdings
Maturity Date	[7]			2027-09				2027-09
Basis spread variable rate	[7],[8]			2.70%				2.70%
Interest rate floor	[7],[8]			8.20%				8.20%
Exit fee rate	[7],[8]			6.60%				6.60%
Principal amount	[7]			$ 25,000,000
Investment cost	[6],[7]			24,670,000
Investments, at fair value:	[7]			$ 24,670,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc. Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee
Summary of Investment Holdings
Maturity Date	[30]			2026-01				2026-01
Basis spread variable rate	[8],[30]			4.25%				4.25%
Interest rate floor	[8],[30]			7.50%				7.50%
Exit fee rate	[8],[30]			3.80%				3.80%
Principal amount	[30]			$ 5,000,000
Investment cost	[6],[30]			4,957,000
Investments, at fair value:	[30]			$ 4,946,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Redshift Bioanalytics, Inc., Senior Secured, Maturity Date January 2026, Prime + 4.25%, Floor rate 7.50%, 3.80% Exit Fee
Summary of Investment Holdings
Maturity Date	[1]	2026-01				2026-01
Basis spread variable rate	[1],[11]	4.25%				4.25%
Interest rate floor	[1],[11]	7.50%				7.50%
Exit fee rate	[1],[11]	3.80%				3.80%
Principal amount	[1]	$ 5,000,000
Investment cost	[1],[2]	5,047,000
Investments, at fair value:	[1]	$ 5,119,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc. Senior Secured, Maturity Date October 2027, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[14],[24]			2027-10				2027-10
Basis spread variable rate	[7],[8],[14],[24]			1.75%				1.75%
Interest rate floor	[7],[8],[14],[24]			7.25%				7.25%
Interest rate cap	[7],[8],[14],[24]			9.00%				9.00%
Interest rate paid in kind	[7],[8],[14],[24]			1.50%				1.50%
Exit fee rate	[7],[8],[14],[24]			4.95%				4.95%
Principal amount	[7],[14],[24]			$ 20,754,000
Investment cost	[6],[7],[14],[24]			20,656,000
Investments, at fair value:	[7],[14],[24]			$ 20,656,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Replimune Group, Inc., Senior Secured, Maturity Date October 2026, Prime + 1.75%, Floor rate 7.25%, Cap rate 9.00%, PIK Interest 1.50%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12],[26]	2027-10				2027-10
Basis spread variable rate	[9],[11],[12],[26]	1.75%				1.75%
Interest rate floor	[9],[11],[12],[26]	7.25%				7.25%
Interest rate cap	[9],[11],[12],[26]	9.00%				9.00%
Interest rate paid in kind	[9],[11],[12],[26]	1.50%				1.50%
Exit fee rate	[9],[11],[12],[26]	4.95%				4.95%
Principal amount	[9],[12],[26]	$ 31,416,000
Investment cost	[2],[9],[12],[26]	31,450,000
Investments, at fair value:	[9],[12],[26]	$ 32,702,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Scynexis, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.80%, Floor rate 9.05%, 3.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[17],[18]			2025-03				2025-03
Basis spread variable rate	[8],[17],[18]			5.80%				5.80%
Interest rate floor	[8],[17],[18]			9.05%				9.05%
Exit fee rate	[8],[17],[18]			3.95%				3.95%
Principal amount	[17],[18]			$ 18,667,000
Investment cost	[6],[17],[18]			18,675,000
Investments, at fair value:	[17],[18]			$ 18,698,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Seres Therapeutics, Inc. Senior Secured, Maturity Date October 2024, Prime + 6.40%, Floor rate 9.65%, 4.98% Exit Fee
Summary of Investment Holdings
Maturity Date	[17],[18]			2024-10				2024-10
Basis spread variable rate	[8],[17],[18]			6.40%				6.40%
Interest rate floor	[8],[17],[18]			9.65%				9.65%
Exit fee rate	[8],[17],[18]			4.98%				4.98%
Principal amount	[17],[18]			$ 37,500,000
Investment cost	[6],[17],[18]			38,638,000
Investments, at fair value:	[17],[18]			$ 38,816,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc. Senior Secured, Maturity Date January 2026, Prime + 2.15%, Floor rate 5.40%, PIK Interest 3.45%, 5.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[15],[18],[24]			2026-01				2026-01
Basis spread variable rate	[8],[14],[15],[18],[24]			2.15%				2.15%
Interest rate floor	[8],[14],[15],[18],[24]			5.40%				5.40%
Interest rate paid in kind	[8],[14],[15],[18],[24]			3.45%				3.45%
Exit fee rate	[8],[14],[15],[18],[24]			5.95%				5.95%
Principal amount	[14],[15],[18],[24]			$ 47,983,000
Investment cost	[6],[14],[15],[18],[24]			47,889,000
Investments, at fair value:	[14],[15],[18],[24]			$ 48,649,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and TG Therapeutics, Inc., Senior Secured, Maturity Date January 2026, Prime + 1.20%, Floor rate 8.95%, PIK Interest 2.25%, 5.69% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12],[21],[26]	2026-01				2026-01
Basis spread variable rate	[9],[11],[12],[21],[26]	1.20%				1.20%
Interest rate floor	[9],[11],[12],[21],[26]	8.95%				8.95%
Interest rate paid in kind	[9],[11],[12],[21],[26]	2.25%				2.25%
Exit fee rate	[9],[11],[12],[21],[26]	5.69%				5.69%
Principal amount	[9],[12],[21],[26]	$ 65,770,000
Investment cost	[2],[9],[12],[21],[26]	66,439,000
Investments, at fair value:	[9],[12],[21],[26]	$ 67,610,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc. Senior Secured, Maturity Date February 2027, Prime + 5.20%, Floor rate 8.45%, 4.75% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[17],[24]			2027-02				2027-02
Basis spread variable rate	[7],[8],[17],[24]			5.20%				5.20%
Interest rate floor	[7],[8],[17],[24]			8.45%				8.45%
Exit fee rate	[7],[8],[17],[24]			4.75%				4.75%
Principal amount	[7],[17],[24]			$ 8,250,000
Investment cost	[6],[7],[17],[24]			8,274,000
Investments, at fair value:	[7],[17],[24]			$ 8,423,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Senior Secured, Maturity Date February 2027, Prime + 4.45%, Floor rate 8.45%, Cap rate 11.45%, 4.75% Exit Fee
Summary of Investment Holdings
Maturity Date	[10],[22],[26]	2027-02				2027-02
Basis spread variable rate	[10],[11],[22],[26]	4.45%				4.45%
Interest rate floor	[10],[11],[22],[26]	8.45%				8.45%
Interest rate cap	[10],[11],[22],[26]	11.45%				11.45%
Exit fee rate	[10],[11],[22],[26]	4.75%				4.75%
Principal amount	[10],[22],[26]	$ 12,375,000
Investment cost	[2],[10],[22],[26]	12,488,000
Investments, at fair value:	[10],[22],[26]	$ 12,916,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Unity Biotechnology, Inc. Senior Secured, Maturity Date August 2024, Prime + 6.10%, Floor rate 9.35%, 6.25% Exit Fee
Summary of Investment Holdings
Maturity Date	[17]			2024-08				2024-08
Basis spread variable rate	[8],[17]			6.10%				6.10%
Interest rate floor	[8],[17]			9.35%				9.35%
Exit fee rate	[8],[17]			6.25%				6.25%
Principal amount	[17]			$ 20,000,000
Investment cost	[6],[17]			21,079,000
Investments, at fair value:	[17]			$ 20,967,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Valo Health, LLC, Senior Secured, Maturity Date May 2024, Prime + 6.45%, Floor rate 9.70%, 3.85% Exit Fee
Summary of Investment Holdings
Maturity Date		2024-05	[10],[21]	2024-05	[15],[17]	2024-05	[10],[21]	2024-05	[15],[17]
Basis spread variable rate		6.45%	[10],[11],[21]	6.45%	[8],[15],[17]	6.45%	[10],[11],[21]	6.45%	[8],[15],[17]
Interest rate floor		9.70%	[10],[11],[21]	9.70%	[8],[15],[17]	9.70%	[10],[11],[21]	9.70%	[8],[15],[17]
Exit fee rate		3.85%	[10],[11],[21]	3.85%	[8],[15],[17]	3.85%	[10],[11],[21]	3.85%	[8],[15],[17]
Principal amount		$ 2,396,000	[10],[21]	$ 8,146,000	[15],[17]
Investment cost		2,808,000	[2],[10],[21]	8,416,000	[6],[15],[17]
Investments, at fair value:		$ 2,808,000	[10],[21]	$ 8,410,000	[15],[17]
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Verona Pharma, Inc., Senior Secured, Maturity Date December 2028, 1-month SOFR + 5.85%, Floor rate 11.19%, Cap rate 13.19%, 3.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[26],[27]	2028-12				2028-12
Basis spread variable rate	[11],[26],[27]	5.85%				5.85%
Interest rate floor	[11],[26],[27]	11.19%				11.19%
Interest rate cap	[11],[26],[27]	13.19%				13.19%
Exit fee rate	[11],[26],[27]	3.50%				3.50%
Principal amount	[26],[27]	$ 15,750,000
Investment cost	[2],[26],[27]	15,646,000
Investments, at fair value:	[26],[27]	$ 15,646,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc. Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 4.76% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[17],[24]			2026-10				2026-10
Basis spread variable rate	[7],[8],[17],[24]			4.20%				4.20%
Interest rate floor	[7],[8],[17],[24]			7.45%				7.45%
Interest rate cap	[7],[8],[17],[24]			8.95%				8.95%
Exit fee rate	[7],[8],[17],[24]			4.76%				4.76%
Principal amount	[7],[17],[24]			$ 2,000,000
Investment cost	[6],[7],[17],[24]			2,012,000
Investments, at fair value:	[7],[17],[24]			$ 1,934,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Senior Secured, Maturity Date October 2026, Prime + 4.20%, Floor rate 7.45%, Cap rate 8.95%, 6.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[10],[26]	2026-10				2026-10
Basis spread variable rate	[10],[11],[26]	4.20%				4.20%
Interest rate floor	[10],[11],[26]	7.45%				7.45%
Interest rate cap	[10],[11],[26]	8.95%				8.95%
Exit fee rate	[10],[11],[26]	6.00%				6.00%
Principal amount	[10],[26]	$ 8,000,000
Investment cost	[2],[10],[26]	8,057,000
Investments, at fair value:	[10],[26]	$ 8,023,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc. Senior Secured, Maturity Date July 2024, Prime + 3.75%, Floor rate 8.75%, 8.80% Exit Fee
Summary of Investment Holdings
Maturity Date	[15],[17],[18]			2024-07				2024-07
Basis spread variable rate	[8],[15],[17],[18]			3.75%				3.75%
Interest rate floor	[8],[15],[17],[18]			8.75%				8.75%
Exit fee rate	[8],[15],[17],[18]			8.80%				8.80%
Principal amount	[15],[17],[18]			$ 32,500,000
Investment cost	[6],[15],[17],[18]			33,705,000
Investments, at fair value:	[15],[17],[18]			$ 33,700,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Senior Secured, Maturity Date October 2026, Prime + 3.15%, Floor rate 10.15%, 3.80% Exit Fee
Summary of Investment Holdings
Maturity Date	[10],[12],[21]	2026-10				2026-10
Basis spread variable rate	[10],[11],[12],[21]	3.15%				3.15%
Interest rate floor	[10],[11],[12],[21]	10.15%				10.15%
Exit fee rate	[10],[11],[12],[21]	3.80%				3.80%
Principal amount	[10],[12],[21]	$ 55,000,000
Investment cost	[2],[10],[12],[21]	54,680,000
Investments, at fair value:	[10],[12],[21]	$ 55,417,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date January 2028, Prime + 0.75%, Floor rate 9.25%, Cap rate 9.75%, PIK Interest 1.15%, 5.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[26],[27]	2028-01				2028-01
Basis spread variable rate	[11],[26],[27]	0.75%				0.75%
Interest rate floor	[11],[26],[27]	9.25%				9.25%
Interest rate cap	[11],[26],[27]	9.75%				9.75%
Interest rate paid in kind	[11],[26],[27]	1.15%				1.15%
Exit fee rate	[11],[26],[27]	5.50%				5.50%
Principal amount	[26],[27]	$ 15,750,000
Investment cost	[2],[26],[27]	15,550,000
Investments, at fair value:	[26],[27]	$ 15,550,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and enGene, Inc. Senior Secured, Maturity Date July 2025, Prime + 5.00%, Floor rate 8.25%, 6.35% Exit Fee
Summary of Investment Holdings
Maturity Date	[17],[18],[24],[25]			2025-07				2025-07
Basis spread variable rate	[8],[17],[18],[24],[25]			5.00%				5.00%
Interest rate floor	[8],[17],[18],[24],[25]			8.25%				8.25%
Exit fee rate	[8],[17],[18],[24],[25]			6.35%				6.35%
Principal amount	[17],[18],[24],[25]			$ 11,000,000
Investment cost	[6],[17],[18],[24],[25]			11,072,000
Investments, at fair value:	[17],[18],[24],[25]			$ 11,067,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V. Senior Secured, Maturity Date December 2025, Prime + 4.70%, Floor rate 7.95%, 7.28% Exit Fee
Summary of Investment Holdings
Maturity Date	[15],[18],[19],[24],[25]			2025-12				2025-12
Basis spread variable rate	[8],[15],[18],[19],[24],[25]			4.70%				4.70%
Interest rate floor	[8],[15],[18],[19],[24],[25]			7.95%				7.95%
Exit fee rate	[8],[15],[18],[19],[24],[25]			7.28%				7.28%
Principal amount	[15],[18],[19],[24],[25]			$ 70,000,000
Investment cost	[6],[15],[18],[19],[24],[25]			72,329,000
Investments, at fair value:	[15],[18],[19],[24],[25]			$ 73,019,000
Investment, Identifier [Axis]: Debt Investments Drug Discovery & Development and uniQure B.V., Senior Secured, Maturity Date January 2027, Prime + 4.70%, Floor rate 7.95%, 6.10% Exit Fee
Summary of Investment Holdings
Maturity Date	[12],[21],[26],[27]	2027-01				2027-01
Basis spread variable rate	[11],[12],[21],[26],[27]	4.70%				4.70%
Interest rate floor	[11],[12],[21],[26],[27]	7.95%				7.95%
Exit fee rate	[11],[12],[21],[26],[27]	6.10%				6.10%
Principal amount	[12],[21],[26],[27]	$ 70,000,000
Investment cost	[2],[12],[21],[26],[27]	71,157,000
Investments, at fair value:	[12],[21],[26],[27]	$ 73,318,000
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.05%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	1.05%				1.05%
Investment cost	[2]	$ 18,348,000
Investments, at fair value:		$ 18,982,000
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware (1.34%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			1.34%				1.34%
Investment cost	[6]			$ 18,171,000
Investments, at fair value:				$ 18,723,000
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp. Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 1.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[13]			2026-06				2026-06
Basis spread variable rate	[8],[13]			4.50%				4.50%
Interest rate floor	[8],[13]			8.00%				8.00%
Exit fee rate	[8],[13]			1.00%				1.00%
Principal amount	[13]			$ 18,281,000
Investment cost	[6],[13]			18,171,000
Investments, at fair value:	[13]			$ 18,723,000
Investment, Identifier [Axis]: Debt Investments Electronics & Computer Hardware and Locus Robotics Corp., Senior Secured, Maturity Date June 2026, Prime + 4.50%, Floor rate 8.00%, 4.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[20]	2026-06				2026-06
Basis spread variable rate	[11],[20]	4.50%				4.50%
Interest rate floor	[11],[20]	8.00%				8.00%
Exit fee rate	[11],[20]	4.00%				4.00%
Principal amount	[20]	$ 18,281,000
Investment cost	[2],[20]	18,348,000
Investments, at fair value:	[20]	$ 18,982,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (13.98%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			13.98%				13.98%
Investment cost	[6]			$ 196,342,000
Investments, at fair value:				$ 195,855,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other (16.56%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	16.56%				16.56%
Investment cost	[2]	$ 301,164,000
Investments, at fair value:		$ 298,523,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Better Therapeutics, Inc. Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[30]			2025-08				2025-08
Basis spread variable rate	[8],[30]			5.70%				5.70%
Interest rate floor	[8],[30]			8.95%				8.95%
Exit fee rate	[8],[30]			5.95%				5.95%
Principal amount	[30]			$ 12,000,000
Investment cost	[6],[30]			12,162,000
Investments, at fair value:	[30]			$ 12,053,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Better Therapeutics, Inc., Senior Secured, Maturity Date August 2025, Prime + 5.70%, Floor rate 8.95%, 5.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[1]	2025-08				2025-08
Basis spread variable rate	[1],[11]	5.70%				5.70%
Interest rate floor	[1],[11]	8.95%				8.95%
Exit fee rate	[1],[11]	5.95%				5.95%
Principal amount	[1]	$ 10,865,000
Investment cost	[1],[2]	11,285,000
Investments, at fair value:	[1]	$ 8,455,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc. Senior Secured, Maturity Date November 2026, 1-month LIBOR + 5.00%, Floor rate 6.00%, PIK Interest 4.45%
Summary of Investment Holdings
Maturity Date	[14],[15],[17]			2026-11				2026-11
Basis spread variable rate	[8],[14],[15],[17]			5.00%				5.00%
Interest rate floor	[8],[14],[15],[17]			6.00%				6.00%
Interest rate paid in kind	[8],[14],[15],[17]			4.45%				4.45%
Principal amount	[14],[15],[17]			$ 51,480,000
Investment cost	[6],[14],[15],[17]			50,813,000
Investments, at fair value:	[14],[15],[17]			$ 49,732,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Blue Sprig Pediatrics, Inc., Senior Secured, Maturity Date November 2026, 1-month SOFR + 5.11%, Floor rate 6.00%, PIK Interest 4.45%
Summary of Investment Holdings
Maturity Date	[9],[10],[21]	2026-11				2026-11
Basis spread variable rate	[9],[10],[11],[21]	5.11%				5.11%
Interest rate floor	[9],[10],[11],[21]	6.00%				6.00%
Interest rate paid in kind	[9],[10],[11],[21]	4.45%				4.45%
Principal amount	[9],[10],[21]	$ 69,032,000
Investment cost	[2],[9],[10],[21]	68,277,000
Investments, at fair value:	[9],[10],[21]	$ 68,393,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc. Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee
Summary of Investment Holdings
Maturity Date	[13],[15],[17]			2025-03				2025-03
Basis spread variable rate	[8],[13],[15],[17]			5.60%				5.60%
Interest rate floor	[8],[13],[15],[17]			8.85%				8.85%
Exit fee rate	[8],[13],[15],[17]			4.61%				4.61%
Principal amount	[13],[15],[17]			$ 46,125,000
Investment cost	[6],[13],[15],[17]			46,552,000
Investments, at fair value:	[13],[15],[17]			$ 46,548,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Senior Secured, Maturity Date March 2025, Prime + 5.60%, Floor rate 8.85%, 4.61% Exit Fee
Summary of Investment Holdings
Maturity Date	[10],[21]	2025-03				2025-03
Basis spread variable rate	[10],[11],[21]	5.60%				5.60%
Interest rate floor	[10],[11],[21]	8.85%				8.85%
Exit fee rate	[10],[11],[21]	4.61%				4.61%
Principal amount	[10],[21]	$ 46,125,000
Investment cost	[2],[10],[21]	47,193,000
Investments, at fair value:	[10],[21]	$ 46,242,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Equality Health, LLC, Senior Secured, Maturity Date February 2026, Prime + 6.25%, Floor rate 9.50%, PIK Interest 1.55%
Summary of Investment Holdings
Maturity Date		2026-02	[9],[12],[21]	2026-02	[14],[18]	2026-02	[9],[12],[21]	2026-02	[14],[18]
Basis spread variable rate		6.25%	[9],[11],[12],[21]	6.25%	[8],[14],[18]	6.25%	[9],[11],[12],[21]	6.25%	[8],[14],[18]
Interest rate floor		9.50%	[9],[11],[12],[21]	9.50%	[8],[14],[18]	9.50%	[9],[11],[12],[21]	9.50%	[8],[14],[18]
Interest rate paid in kind		1.55%	[9],[11],[12],[21]	1.55%	[8],[14],[18]	1.55%	[9],[11],[12],[21]	1.55%	[8],[14],[18]
Principal amount		$ 54,425,000	[9],[12],[21]	$ 53,587,000	[14],[18]
Investment cost		54,142,000	[2],[9],[12],[21]	53,164,000	[6],[14],[18]
Investments, at fair value:		$ 54,697,000	[9],[12],[21]	$ 53,871,000	[14],[18]
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Main Street Rural, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.95%, Floor rate 9.95%, 6.85% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[22]	2027-07				2027-07
Basis spread variable rate	[1],[11],[22]	1.95%				1.95%
Interest rate floor	[1],[11],[22]	9.95%				9.95%
Exit fee rate	[1],[11],[22]	6.85%				6.85%
Principal amount	[1],[22]	$ 24,500,000
Investment cost	[1],[2],[22]	24,476,000
Investments, at fair value:	[1],[22]	$ 24,929,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Modern Life, Inc., Senior Secured, Maturity Date February 2027, Prime + 2.75%, Floor rate 8.75%, 5.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[10],[22]	2027-02				2027-02
Basis spread variable rate	[10],[11],[22]	2.75%				2.75%
Interest rate floor	[10],[11],[22]	8.75%				8.75%
Exit fee rate	[10],[11],[22]	5.00%				5.00%
Principal amount	[10],[22]	$ 13,000,000
Investment cost	[2],[10],[22]	12,888,000
Investments, at fair value:	[10],[22]	$ 13,111,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Oak Street Health, Inc. Senior Secured, Maturity Date October 2027, Prime + 2.45%, Floor rate 7.95%, Cap rate 9.45%, PIK Interest 1.00%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[14],[24]			2027-10				2027-10
Basis spread variable rate	[7],[8],[14],[24]			2.45%				2.45%
Interest rate floor	[7],[8],[14],[24]			7.95%				7.95%
Interest rate cap	[7],[8],[14],[24]			9.45%				9.45%
Interest rate paid in kind	[7],[8],[14],[24]			1.00%				1.00%
Exit fee rate	[7],[8],[14],[24]			4.95%				4.95%
Principal amount	[7],[14],[24]			$ 33,808,000
Investment cost	[6],[7],[14],[24]			33,651,000
Investments, at fair value:	[7],[14],[24]			$ 33,651,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Recover Together, Inc., Senior Secured, Maturity Date July 2027, Prime + 1.90%, Floor rate 10.15%, 7.50% Exit Fee
Summary of Investment Holdings
Maturity Date		2027-07				2027-07
Basis spread variable rate	[11]	1.90%				1.90%
Interest rate floor	[11]	10.15%				10.15%
Exit fee rate	[11]	7.50%				7.50%
Principal amount		$ 35,000,000
Investment cost	[2]	34,683,000
Investments, at fair value:		$ 34,683,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Strive Health Holdings, LLC, Senior Secured, Maturity Date September 2027, Prime + 0.70%, Floor rate 9.20%, 5.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[1]	2027-09				2027-09
Basis spread variable rate	[1],[11]	0.70%				0.70%
Interest rate floor	[1],[11]	9.20%				9.20%
Exit fee rate	[1],[11]	5.95%				5.95%
Principal amount	[1]	$ 12,000,000
Investment cost	[1],[2]	11,868,000
Investments, at fair value:	[1]	$ 11,868,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[21]	2026-03				2026-03
Basis spread variable rate	[11],[21]	3.25%				3.25%
Interest rate floor	[11],[21]	9.20%				9.20%
Interest rate cap	[11],[21]	10.20%				10.20%
Exit fee rate	[11],[21]	4.95%				4.95%
Principal amount	[21]	$ 36,500,000
Investment cost	[2],[21]	36,352,000
Investments, at fair value:	[21]	$ 36,145,000
Investment, Identifier [Axis]: Debt Investments Healthcare Services, Other and Vida Health, Inc., Senior Secured, Maturity Date March 2026, 9.20% + Lower of (Prime - 3.25%) or 1.00%, Floor rate 9.20%, Cap rate 10.20%, 4.95% Exit Fee | Minimum
Summary of Investment Holdings
Basis spread variable rate	[11],[21]	1.00%				1.00%
Investment, Identifier [Axis]: Debt Investments Information Services (3.72%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			3.72%				3.72%
Investment cost	[6]			$ 52,619,000
Investments, at fair value:				$ 52,075,000
Investment, Identifier [Axis]: Debt Investments Information Services (6.65%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	6.65%				6.65%
Investment cost	[2]	$ 117,099,000
Investments, at fair value:		$ 119,876,000
Investment, Identifier [Axis]: Debt Investments Information Services and Capella Space Corp. Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[13],[14],[30]			2025-11				2025-11
Basis spread variable rate	[8],[13],[14],[30]			5.00%				5.00%
Interest rate floor	[8],[13],[14],[30]			8.25%				8.25%
Interest rate paid in kind	[8],[13],[14],[30]			1.10%				1.10%
Exit fee rate	[8],[13],[14],[30]			7.00%				7.00%
Principal amount	[13],[14],[30]			$ 20,250,000
Investment cost	[6],[13],[14],[30]			20,506,000
Investments, at fair value:	[13],[14],[30]			$ 20,574,000
Investment, Identifier [Axis]: Debt Investments Information Services and Capella Space Corp., Senior Secured, Maturity Date November 2025, Prime + 5.00%, Floor rate 8.25%, PIK Interest 1.10%, 7.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[9]	2025-11				2025-11
Basis spread variable rate	[1],[9],[11]	5.00%				5.00%
Interest rate floor	[1],[9],[11]	8.25%				8.25%
Interest rate paid in kind	[1],[9],[11]	1.10%				1.10%
Exit fee rate	[1],[9],[11]	7.00%				7.00%
Principal amount	[1],[9]	$ 20,477,000
Investment cost	[1],[2],[9]	21,166,000
Investments, at fair value:	[1],[9]	$ 21,351,000
Investment, Identifier [Axis]: Debt Investments Information Services and Checkr Group, Inc., Senior Secured, Maturity Date August 2028, Prime + 1.45%, Floor rate 8.00%, PIK Interest 2.00%, 2.75% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[22]	2028-08				2028-08
Basis spread variable rate	[9],[11],[22]	1.45%				1.45%
Interest rate floor	[9],[11],[22]	8.00%				8.00%
Interest rate paid in kind	[9],[11],[22]	2.00%				2.00%
Exit fee rate	[9],[11],[22]	2.75%				2.75%
Principal amount	[9],[22]	$ 47,621,000
Investment cost	[2],[9],[22]	47,460,000
Investments, at fair value:	[9],[22]	$ 49,382,000
Investment, Identifier [Axis]: Debt Investments Information Services and Saama Technologies, LLC, Senior Secured, Maturity Date July 2027, Prime + 0.70%, Floor rate 8.95%, PIK Interest 2.00%, 2.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[22]	2027-07				2027-07
Basis spread variable rate	[9],[11],[22]	0.70%				0.70%
Interest rate floor	[9],[11],[22]	8.95%				8.95%
Interest rate paid in kind	[9],[11],[22]	2.00%				2.00%
Exit fee rate	[9],[11],[22]	2.95%				2.95%
Principal amount	[9],[22]	$ 11,725,000
Investment cost	[2],[9],[22]	11,627,000
Investments, at fair value:	[9],[22]	$ 11,876,000
Investment, Identifier [Axis]: Debt Investments Information Services and Signal Media Limited, Senior Secured, Maturity Date June 2025, Prime + 5.50%, Floor rate 9.00%, Cap rate 12.00%, 3.45% Exit Fee
Summary of Investment Holdings
Maturity Date		2025-06	[26],[27]	2025-06	[7],[24],[25]	2025-06	[26],[27]	2025-06	[7],[24],[25]
Basis spread variable rate		5.50%	[11],[26],[27]	5.50%	[7],[8],[24],[25]	5.50%	[11],[26],[27]	5.50%	[7],[8],[24],[25]
Interest rate floor		9.00%	[11],[26],[27]	9.00%	[7],[8],[24],[25]	9.00%	[11],[26],[27]	9.00%	[7],[8],[24],[25]
Interest rate cap		12.00%	[11],[26],[27]	12.00%	[7],[8],[24],[25]	12.00%	[11],[26],[27]	12.00%	[7],[8],[24],[25]
Exit fee rate		3.45%	[11],[26],[27]	3.45%	[7],[8],[24],[25]	3.45%	[11],[26],[27]	3.45%	[7],[8],[24],[25]
Principal amount		$ 5,400,000	[26],[27]	$ 750,000	[7],[24],[25]
Investment cost		5,364,000	[2],[26],[27]	742,000	[6],[7],[24],[25]
Investments, at fair value:		$ 5,392,000	[26],[27]	$ 738,000	[7],[24],[25]
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 8.45%, Floor rate 9.35%
Summary of Investment Holdings
Maturity Date	[22],[23]	2026-09				2026-09
Basis spread variable rate	[11],[22],[23]	8.45%				8.45%
Interest rate floor	[11],[22],[23]	9.35%				9.35%
Principal amount	[22],[23]	$ 31,875,000
Investment cost	[2],[22],[23]	31,482,000
Investments, at fair value:	[22],[23]	$ 31,875,000
Investment, Identifier [Axis]: Debt Investments Information Services and Yipit, LLC, Senior Secured, Maturity Date September 2026, 1-month SOFR + 9.08%, Floor rate 10.08%
Summary of Investment Holdings
Maturity Date	[7],[16]			2026-09				2026-09
Basis spread variable rate	[7],[8],[16]			9.08%				9.08%
Interest rate floor	[7],[8],[16]			10.08%				10.08%
Principal amount	[7],[16]			$ 31,875,000
Investment cost	[6],[7],[16]			31,371,000
Investments, at fair value:	[7],[16]			$ 30,763,000
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (0.44%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.44%				0.44%
Investment cost	[2]	$ 8,064,000
Investments, at fair value:		$ 8,006,000
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology (2.99%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			2.99%				2.99%
Investment cost	[6]			$ 41,568,000
Investments, at fair value:				$ 41,953,000
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Bright Machines, Inc. Senior Secured, Maturity Date April 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[17]			2025-04				2025-04
Basis spread variable rate	[8],[17]			4.00%				4.00%
Interest rate floor	[8],[17]			9.50%				9.50%
Exit fee rate	[8],[17]			5.00%				5.00%
Principal amount	[17]			$ 11,050,000
Investment cost	[6],[17]			10,832,000
Investments, at fair value:	[17]			$ 10,832,000
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Bright Machines, Inc., Senior Secured, Maturity Date May 2025, Prime + 4.00%, Floor rate 9.50%, 5.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[10]	2025-05				2025-05
Basis spread variable rate	[10],[11]	4.00%				4.00%
Interest rate floor	[10],[11]	9.50%				9.50%
Exit fee rate	[10],[11]	5.00%				5.00%
Principal amount	[10]	$ 7,827,000
Investment cost	[2],[10]	8,064,000
Investments, at fair value:	[10]	$ 8,006,000
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and MacroFab, Inc. Senior Secured, Maturity Date March 2026, Prime + 4.35%, Floor rate 7.60%, PIK Interest 1.25%, 4.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[14]			2026-03				2026-03
Basis spread variable rate	[7],[8],[14]			4.35%				4.35%
Interest rate floor	[7],[8],[14]			7.60%				7.60%
Interest rate paid in kind	[7],[8],[14]			1.25%				1.25%
Exit fee rate	[7],[8],[14]			4.50%				4.50%
Principal amount	[7],[14]			$ 17,137,000
Investment cost	[6],[7],[14]			16,766,000
Investments, at fair value:	[7],[14]			$ 16,917,000
Investment, Identifier [Axis]: Debt Investments Manufacturing Technology and Ouster, Inc. Senior Secured, Maturity Date May 2026, Prime + 6.15%, Floor rate 9.40%, 7.45% Exit Fee
Summary of Investment Holdings
Maturity Date	[17],[24]			2026-05				2026-05
Basis spread variable rate	[8],[17],[24]			6.15%				6.15%
Interest rate floor	[8],[17],[24]			9.40%				9.40%
Exit fee rate	[8],[17],[24]			7.45%				7.45%
Principal amount	[17],[24]			$ 14,000,000
Investment cost	[6],[17],[24]			13,970,000
Investments, at fair value:	[17],[24]			$ 14,204,000
Investment, Identifier [Axis]: Debt Investments Media/Content/Info (0.69%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.69%				0.69%
Investment cost	[2]	$ 12,340,000
Investments, at fair value:		$ 12,469,000
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date December 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[20]	2025-12				2025-12
Basis spread variable rate	[11],[20]	3.50%				3.50%
Interest rate floor	[11],[20]	9.00%				9.00%
Exit fee rate	[11],[20]	3.00%				3.00%
Principal amount	[20]	$ 1,333,000
Investment cost	[2],[20]	1,342,000
Investments, at fair value:	[20]	$ 1,351,000
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date June 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[20]	2026-06				2026-06
Basis spread variable rate	[11],[20]	3.50%				3.50%
Interest rate floor	[11],[20]	9.00%				9.00%
Exit fee rate	[11],[20]	3.00%				3.00%
Principal amount	[20]	$ 1,667,000
Investment cost	[2],[20]	1,647,000
Investments, at fair value:	[20]	$ 1,653,000
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[20]	2026-03				2026-03
Basis spread variable rate	[11],[20]	3.50%				3.50%
Interest rate floor	[11],[20]	9.00%				9.00%
Exit fee rate	[11],[20]	3.00%				3.00%
Principal amount	[20]	$ 1,500,000
Investment cost	[2],[20]	1,501,000
Investments, at fair value:	[20]	$ 1,509,000
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date September 2025, Prime + 3.50%, Floor rate 9.00%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[20]	2025-09				2025-09
Basis spread variable rate	[11],[20]	3.50%				3.50%
Interest rate floor	[11],[20]	9.00%				9.00%
Exit fee rate	[11],[20]	3.00%				3.00%
Principal amount	[20]	$ 1,167,000
Investment cost	[2],[20]	1,178,000
Investments, at fair value:	[20]	$ 1,188,000
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Fever Labs, Inc., Senior Secured, Maturity Date September 2026, Prime + 3.50%, Floor rate 9.00%, 4.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[20]	2026-09				2026-09
Basis spread variable rate	[11],[20]	3.50%				3.50%
Interest rate floor	[11],[20]	9.00%				9.00%
Exit fee rate	[11],[20]	4.00%				4.00%
Principal amount	[20]	$ 6,667,000
Investment cost	[2],[20]	6,672,000
Investments, at fair value:	[20]	6,768,000
Investment, Identifier [Axis]: Debt Investments Media/Content/Info and Total Fever Labs, Inc.
Summary of Investment Holdings
Principal amount		12,334,000
Investment cost	[2]	12,340,000
Investments, at fair value:		$ 12,469,000
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment (1.20%)
Summary of Investment Holdings
Investment owned, percent of net assets		1.20%				1.20%
Investment cost	[2]	$ 21,572,000
Investments, at fair value:		$ 21,572,000
Investment, Identifier [Axis]: Debt Investments Medical Devices & Equipment and Senseonics Holdings, Inc. Maturity Date September 2027, Prime + 1.40%, Floor rate 9.90%, 6.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[22]	2027-09				2027-09
Basis spread variable rate	[11],[22]	1.40%				1.40%
Interest rate floor	[11],[22]	9.90%				9.90%
Exit fee rate	[11],[22]	6.95%				6.95%
Principal amount	[22]	$ 21,875,000
Investment cost	[2],[22]	21,572,000
Investments, at fair value:	[22]	$ 21,572,000
Investment, Identifier [Axis]: Debt Investments Semiconductors (1.51%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			1.51%				1.51%
Investment cost	[6]			$ 19,639,000
Investments, at fair value:				$ 21,192,000
Investment, Identifier [Axis]: Debt Investments Semiconductors and Fungible, Inc. Senior Secured, Maturity Date December 2024, Prime + 5.00%, Floor rate 8.25%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[13],[30]			2024-12				2024-12
Basis spread variable rate	[8],[13],[30]			5.00%				5.00%
Interest rate floor	[8],[13],[30]			8.25%				8.25%
Exit fee rate	[8],[13],[30]			4.95%				4.95%
Principal amount	[13],[30]			$ 20,000,000
Investment cost	[6],[13],[30]			19,639,000
Investments, at fair value:	[13],[30]			$ 21,192,000
Investment, Identifier [Axis]: Debt Investments Software (40.39%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	40.39%				40.39%
Investment cost	[2]	$ 751,108,000
Investments, at fair value:		728,139,000
Investment, Identifier [Axis]: Debt Investments Software (54.28%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			54.28%				54.28%
Investment cost	[6]			$ 762,371,000
Investments, at fair value:				760,679,000
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC
Summary of Investment Holdings
Principal amount		15,100,000		13,176,000
Investment cost		15,017,000	[2]	13,035,000	[6]
Investments, at fair value:		$ 15,089,000		$ 12,998,000
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 6.57%, Floor rate 7.57%
Summary of Investment Holdings
Maturity Date	[16]			2025-02				2025-02
Basis spread variable rate	[8],[16]			6.57%				6.57%
Interest rate floor	[8],[16]			7.57%				7.57%
Principal amount	[16]			$ 2,750,000
Investment cost	[6],[16]			2,744,000
Investments, at fair value:	[16]			$ 2,681,000
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month LIBOR + 9.28%, Floor rate 10.28%
Summary of Investment Holdings
Maturity Date	[15],[16]			2025-02				2025-02
Basis spread variable rate	[8],[15],[16]			9.28%				9.28%
Interest rate floor	[8],[15],[16]			10.28%				10.28%
Principal amount	[15],[16]			$ 10,426,000
Investment cost	[6],[15],[16]			10,291,000
Investments, at fair value:	[15],[16]			$ 10,317,000
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 6.88%, Floor rate 7.78%
Summary of Investment Holdings
Maturity Date	[22],[23]	2025-02				2025-02
Basis spread variable rate	[11],[22],[23]	6.88%				6.88%
Interest rate floor	[11],[22],[23]	7.78%				7.78%
Principal amount	[22],[23]	$ 1,990,000
Investment cost	[2],[22],[23]	1,988,000
Investments, at fair value:	[22],[23]	$ 1,986,000
Investment, Identifier [Axis]: Debt Investments Software and 3GTMS, LLC, Senior Secured, Maturity Date February 2025, 3-month SOFR + 9.70%, Floor rate 10.60%
Summary of Investment Holdings
Maturity Date	[21],[22],[23]	2025-02				2025-02
Basis spread variable rate	[11],[21],[22],[23]	9.70%				9.70%
Interest rate floor	[11],[21],[22],[23]	10.60%				10.60%
Principal amount	[21],[22],[23]	$ 13,110,000
Investment cost	[2],[21],[22],[23]	13,029,000
Investments, at fair value:	[21],[22],[23]	$ 13,103,000
Investment, Identifier [Axis]: Debt Investments Software and Agilence, Inc. Senior Secured, Maturity Date October 2026, 1-month BSBY + 9.00%, Floor rate 10.00%
Summary of Investment Holdings
Maturity Date		2026-10	[12],[22],[23]	2026-10	[7],[16],[18]	2026-10	[12],[22],[23]	2026-10	[7],[16],[18]
Basis spread variable rate		9.00%	[11],[12],[22],[23]	9.00%	[7],[8],[16],[18]	9.00%	[11],[12],[22],[23]	9.00%	[7],[8],[16],[18]
Interest rate floor		10.00%	[11],[12],[22],[23]	10.00%	[7],[8],[16],[18]	10.00%	[11],[12],[22],[23]	10.00%	[7],[8],[16],[18]
Principal amount		$ 9,212,000	[12],[22],[23]	$ 9,306,000	[7],[16],[18]
Investment cost		9,040,000	[2],[12],[22],[23]	9,088,000	[6],[7],[16],[18]
Investments, at fair value:		$ 9,212,000	[12],[22],[23]	$ 8,977,000	[7],[16],[18]
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 7.89%, Floor rate 8.89%
Summary of Investment Holdings
Maturity Date	[7],[16]			2028-05				2028-05
Basis spread variable rate	[7],[8],[16]			7.89%				7.89%
Interest rate floor	[7],[8],[16]			8.89%				8.89%
Principal amount	[7],[16]			$ 20,463,000
Investment cost	[6],[7],[16]			19,999,000
Investments, at fair value:	[7],[16]			$ 20,123,000
Investment, Identifier [Axis]: Debt Investments Software and Alchemer LLC, Senior Secured, Maturity Date May 2028, 1-month SOFR + 8.14%, Floor rate 9.14%
Summary of Investment Holdings
Maturity Date	[10],[22],[23]	2028-05				2028-05
Basis spread variable rate	[10],[11],[22],[23]	8.14%				8.14%
Interest rate floor	[10],[11],[22],[23]	9.14%				9.14%
Principal amount	[10],[22],[23]	$ 20,908,000
Investment cost	[2],[10],[22],[23]	20,508,000
Investments, at fair value:	[10],[22],[23]	$ 21,297,000
Investment, Identifier [Axis]: Debt Investments Software and Allvue Systems, LLC, Senior Secured, Maturity Date September 2029, 6-month SOFR + 7.25%, Floor rate 8.25%
Summary of Investment Holdings
Maturity Date	[22]	2029-09				2029-09
Basis spread variable rate	[11],[22]	7.25%				7.25%
Interest rate floor	[11],[22]	8.25%				8.25%
Principal amount	[22]	$ 36,410,000
Investment cost	[2],[22]	35,530,000
Investments, at fair value:	[22]	$ 35,530,000
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 8.99%, Floor rate 10.00%
Summary of Investment Holdings
Maturity Date	[7],[17]			2027-02				2027-02
Basis spread variable rate	[7],[8],[17]			8.99%				8.99%
Interest rate floor	[7],[8],[17]			10.00%				10.00%
Principal amount	[7],[17]			$ 8,500,000
Investment cost	[6],[7],[17]			8,292,000
Investments, at fair value:	[7],[17]			$ 8,176,000
Investment, Identifier [Axis]: Debt Investments Software and Annex Cloud, Senior Secured, Maturity Date February 2027, 1-month BSBY + 9.41%, Floor rate 10.41%
Summary of Investment Holdings
Maturity Date	[10],[22]	2027-02				2027-02
Basis spread variable rate	[10],[11],[22]	9.41%				9.41%
Interest rate floor	[10],[11],[22]	10.41%				10.41%
Principal amount	[10],[22]	$ 9,823,000
Investment cost	[2],[10],[22]	9,649,000
Investments, at fair value:	[10],[22]	$ 9,761,000
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 2.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[13],[15]			2027-09				2027-09
Basis spread variable rate	[7],[8],[13],[15]			4.25%				4.25%
Interest rate floor	[7],[8],[13],[15]			9.00%				9.00%
Exit fee rate	[7],[8],[13],[15]			2.50%				2.50%
Principal amount	[7],[13],[15]			$ 19,600,000
Investment cost	[6],[7],[13],[15]			19,059,000
Investments, at fair value:	[7],[13],[15]			$ 19,059,000
Investment, Identifier [Axis]: Debt Investments Software and Automation Anywhere, Inc. Senior Secured, Maturity Date September 2027, Prime + 4.25%, Floor rate 9.00%, 4.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[20],[21],[22]	2027-09				2027-09
Basis spread variable rate	[11],[20],[21],[22]	4.25%				4.25%
Interest rate floor	[11],[20],[21],[22]	9.00%				9.00%
Exit fee rate	[11],[20],[21],[22]	4.50%				4.50%
Principal amount	[20],[21],[22]	$ 19,600,000
Investment cost	[2],[20],[21],[22]	19,345,000
Investments, at fair value:	[20],[21],[22]	$ 20,269,000
Investment, Identifier [Axis]: Debt Investments Software and Babel Street, Senior Secured, Maturity Date December 2027, 3-month SOFR + 7.89%, Floor rate 8.89%
Summary of Investment Holdings
Maturity Date		2027-12	[1],[22],[23]	2027-12	[7],[16],[30]	2027-12	[1],[22],[23]	2027-12	[7],[16],[30]
Basis spread variable rate		7.89%	[1],[11],[22],[23]	7.89%	[7],[8],[16],[30]	7.89%	[1],[11],[22],[23]	7.89%	[7],[8],[16],[30]
Interest rate floor		8.89%	[1],[11],[22],[23]	8.89%	[7],[8],[16],[30]	8.89%	[1],[11],[22],[23]	8.89%	[7],[8],[16],[30]
Principal amount		$ 45,000,000	[1],[22],[23]	$ 45,000,000	[7],[16],[30]
Investment cost		43,983,000	[1],[2],[22],[23]	43,801,000	[6],[7],[16],[30]
Investments, at fair value:		$ 44,928,000	[1],[22],[23]	$ 43,801,000	[7],[16],[30]
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2025, PRIME + 3.70%, Floor rate 6.95%, PIK Interest 1.00%, 3.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[14],[17],[30]			2025-04				2025-04
Basis spread variable rate	[7],[8],[14],[17],[30]			3.70%				3.70%
Interest rate floor	[7],[8],[14],[17],[30]			6.95%				6.95%
Interest rate paid in kind	[7],[8],[14],[17],[30]			1.00%				1.00%
Exit fee rate	[7],[8],[14],[17],[30]			3.95%				3.95%
Principal amount	[7],[14],[17],[30]			$ 20,166,000
Investment cost	[6],[7],[14],[17],[30]			20,242,000
Investments, at fair value:	[7],[14],[17],[30]			$ 20,138,000
Investment, Identifier [Axis]: Debt Investments Software and Brain Corporation, Senior Secured, Maturity Date April 2026, Prime + 3.70%, Floor rate 9.20%, PIK Interest 1.00%, 3.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[9],[10],[22]	2026-04				2026-04
Basis spread variable rate	[1],[9],[10],[11],[22]	3.70%				3.70%
Interest rate floor	[1],[9],[10],[11],[22]	9.20%				9.20%
Interest rate paid in kind	[1],[9],[10],[11],[22]	1.00%				1.00%
Exit fee rate	[1],[9],[10],[11],[22]	3.95%				3.95%
Principal amount	[1],[9],[10],[22]	$ 30,415,000
Investment cost	[1],[2],[9],[10],[22]	30,678,000
Investments, at fair value:	[1],[9],[10],[22]	$ 30,989,000
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.05%, Floor rate 9.90%
Summary of Investment Holdings
Maturity Date	[10],[20]	2025-11				2025-11
Basis spread variable rate	[10],[11],[20]	9.05%				9.05%
Interest rate floor	[10],[11],[20]	9.90%				9.90%
Principal amount	[10],[20]	$ 33,000,000
Investment cost	[2],[10],[20]	32,706,000
Investments, at fair value:	[10],[20]	$ 33,000,000
Investment, Identifier [Axis]: Debt Investments Software and Campaign Monitor Limited, Senior Secured, Maturity Date November 2025, 6-month SOFR + 8.90%, Floor rate 9.90%
Summary of Investment Holdings
Maturity Date	[13],[17]			2025-11				2025-11
Basis spread variable rate	[8],[13],[17]			8.90%				8.90%
Interest rate floor	[8],[13],[17]			9.90%				9.90%
Principal amount	[13],[17]			$ 33,000,000
Investment cost	[6],[13],[17]			32,578,000
Investments, at fair value:	[13],[17]			$ 33,000,000
Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date June 2026, 3-month SOFR + 8.86%, Floor rate 9.76%
Summary of Investment Holdings
Maturity Date	[16]			2026-06				2026-06
Basis spread variable rate	[8],[16]			8.86%				8.86%
Interest rate floor	[8],[16]			9.76%				9.76%
Principal amount	[16]			$ 10,175,000
Investment cost	[6],[16]			9,980,000
Investments, at fair value:	[16]			$ 9,996,000
Investment, Identifier [Axis]: Debt Investments Software and Catchpoint Systems, Inc., Senior Secured, Maturity Date November 2025, 3-month SOFR + 9.41%, Floor rate 11.81%
Summary of Investment Holdings
Maturity Date	[23]	2025-11				2025-11
Basis spread variable rate	[11],[23]	9.41%				9.41%
Interest rate floor	[11],[23]	11.81%				11.81%
Principal amount	[23]	$ 10,073,000
Investment cost	[2],[23]	9,931,000
Investments, at fair value:	[23]	$ 9,940,000
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 8.99%, Floor rate 9.89%
Summary of Investment Holdings
Maturity Date	[22],[23]	2026-09				2026-09
Basis spread variable rate	[11],[22],[23]	8.99%				8.99%
Interest rate floor	[11],[22],[23]	9.89%				9.89%
Principal amount	[22],[23]	$ 22,867,000
Investment cost	[2],[22],[23]	22,498,000
Investments, at fair value:	[22],[23]	$ 23,075,000
Investment, Identifier [Axis]: Debt Investments Software and Ceros, Inc., Senior Secured, Maturity Date September 2026, 6-month LIBOR + 9.67%, Floor rate 10.67%
Summary of Investment Holdings
Maturity Date	[7],[16]			2026-09				2026-09
Basis spread variable rate	[7],[8],[16]			9.67%				9.67%
Interest rate floor	[7],[8],[16]			10.67%				10.67%
Principal amount	[7],[16]			$ 21,445,000
Investment cost	[6],[7],[16]			21,003,000
Investments, at fair value:	[7],[16]			$ 21,050,000
Investment, Identifier [Axis]: Debt Investments Software and CloudBolt Software, Inc., Senior Secured, Maturity Date October 2024, Prime + 6.70%, Floor rate 9.95%, 3.45% Exit Fee
Summary of Investment Holdings
Maturity Date	[13],[15]			2024-10				2024-10
Basis spread variable rate	[8],[13],[15]			6.70%				6.70%
Interest rate floor	[8],[13],[15]			9.95%				9.95%
Exit fee rate	[8],[13],[15]			3.45%				3.45%
Principal amount	[13],[15]			$ 10,000,000
Investment cost	[6],[13],[15]			10,069,000
Investments, at fair value:	[13],[15]			$ 10,498,000
Investment, Identifier [Axis]: Debt Investments Software and Constructor Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%
Summary of Investment Holdings
Maturity Date	[10],[22],[23]	2027-07				2027-07
Basis spread variable rate	[10],[11],[22],[23]	8.44%				8.44%
Interest rate floor	[10],[11],[22],[23]	9.44%				9.44%
Principal amount	[10],[22],[23]	$ 4,688,000
Investment cost	[2],[10],[22],[23]	4,592,000
Investments, at fair value:	[10],[22],[23]	$ 4,790,000
Investment, Identifier [Axis]: Debt Investments Software and Constructor.io Corporation, Senior Secured, Maturity Date July 2027, 1-month SOFR + 8.44%, Floor rate 9.44%
Summary of Investment Holdings
Maturity Date	[7],[16]			2027-07				2027-07
Basis spread variable rate	[7],[8],[16]			8.44%				8.44%
Interest rate floor	[7],[8],[16]			9.44%				9.44%
Principal amount	[7],[16]			$ 4,688,000
Investment cost	[6],[7],[16]			4,573,000
Investments, at fair value:	[7],[16]			$ 4,573,000
Investment, Identifier [Axis]: Debt Investments Software and Convoy, Inc., Senior Secured, Maturity Date March 2026, Prime + 3.20%, Floor rate 6.45%, PIK Interest 1.95%, 4.55% Exit Fee
Summary of Investment Holdings
Maturity Date		2026-03	[9],[20],[39]	2026-03	[13],[14],[19]	2026-03	[9],[20],[39]	2026-03	[13],[14],[19]
Basis spread variable rate		3.20%	[9],[11],[20],[39]	3.20%	[8],[13],[14],[19]	3.20%	[9],[11],[20],[39]	3.20%	[8],[13],[14],[19]
Interest rate floor		6.45%	[9],[11],[20],[39]	6.45%	[8],[13],[14],[19]	6.45%	[9],[11],[20],[39]	6.45%	[8],[13],[14],[19]
Interest rate paid in kind		1.95%	[9],[11],[20],[39]	1.95%	[8],[13],[14],[19]	1.95%	[9],[11],[20],[39]	1.95%	[8],[13],[14],[19]
Exit fee rate		4.55%	[9],[11],[20],[39]	4.55%	[8],[13],[14],[19]	4.55%	[9],[11],[20],[39]	4.55%	[8],[13],[14],[19]
Principal amount		$ 31,049,000	[9],[20],[39]	$ 73,987,000	[13],[14],[19]
Investment cost		30,916,000	[2],[9],[20],[39]	73,060,000	[6],[13],[14],[19]
Investments, at fair value:		$ 0	[9],[20],[39]	$ 73,498,000	[13],[14],[19]
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 3.96% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[21]	2025-03				2025-03
Basis spread variable rate	[9],[11],[21]	4.50%				4.50%
Interest rate floor	[9],[11],[21]	8.25%				8.25%
Interest rate cap	[9],[11],[21]	10.25%				10.25%
Interest rate paid in kind	[9],[11],[21]	1.95%				1.95%
Exit fee rate	[9],[11],[21]	3.96%				3.96%
Principal amount	[9],[21]	$ 9,141,000
Investment cost	[2],[9],[21]	9,307,000
Investments, at fair value:	[9],[21]	$ 9,153,000
Investment, Identifier [Axis]: Debt Investments Software and Copper CRM, Inc, Senior Secured, Maturity Date March 2025, Prime + 4.50%, Floor rate 8.25%, Cap rate 10.25%, PIK Interest 1.95%, 4.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[15]			2025-03				2025-03
Basis spread variable rate	[8],[14],[15]			4.50%				4.50%
Interest rate floor	[8],[14],[15]			8.25%				8.25%
Interest rate cap	[8],[14],[15]			10.25%				10.25%
Interest rate paid in kind	[8],[14],[15]			1.95%				1.95%
Exit fee rate	[8],[14],[15]			4.50%				4.50%
Principal amount	[14],[15]			$ 10,144,000
Investment cost	[6],[14],[15]			10,150,000
Investments, at fair value:	[14],[15]			$ 9,820,000
Investment, Identifier [Axis]: Debt Investments Software and Cutover, Inc., Senior Secured, Maturity Date October 2025, Prime + 5.20%, Floor rate 9.95%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date		2025-10	[12],[22],[26],[27]	2025-10	[7],[18],[24],[25]	2025-10	[12],[22],[26],[27]	2025-10	[7],[18],[24],[25]
Basis spread variable rate		5.20%	[11],[12],[22],[26],[27]	5.20%	[7],[8],[18],[24],[25]	5.20%	[11],[12],[22],[26],[27]	5.20%	[7],[8],[18],[24],[25]
Interest rate floor		9.95%	[11],[12],[22],[26],[27]	9.95%	[7],[8],[18],[24],[25]	9.95%	[11],[12],[22],[26],[27]	9.95%	[7],[8],[18],[24],[25]
Exit fee rate		4.95%	[11],[12],[22],[26],[27]	4.95%	[7],[8],[18],[24],[25]	4.95%	[11],[12],[22],[26],[27]	4.95%	[7],[8],[18],[24],[25]
Principal amount		$ 5,500,000	[12],[22],[26],[27]	$ 5,000,000	[7],[18],[24],[25]
Investment cost		5,544,000	[2],[12],[22],[26],[27]	4,949,000	[6],[7],[18],[24],[25]
Investments, at fair value:		5,715,000	[12],[22],[26],[27]	$ 4,949,000	[7],[18],[24],[25]
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc.
Summary of Investment Holdings
Principal amount		10,501,000
Investment cost	[2]	10,324,000
Investments, at fair value:		$ 10,334,000
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 12.36%, Floor rate 13.11%
Summary of Investment Holdings
Maturity Date	[22]	2026-08				2026-08
Basis spread variable rate	[11],[22]	12.36%				12.36%
Interest rate floor	[11],[22]	13.11%				13.11%
Principal amount	[22]	$ 2,546,000
Investment cost	[2],[22]	2,494,000
Investments, at fair value:	[22]	$ 2,556,000
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 8.63%, Floor rate 9.38%
Summary of Investment Holdings
Maturity Date	[10],[22]	2026-08				2026-08
Basis spread variable rate	[10],[11],[22]	8.63%				8.63%
Interest rate floor	[10],[11],[22]	9.38%				9.38%
Principal amount	[10],[22]	$ 7,955,000
Investment cost	[2],[10],[22]	7,830,000
Investments, at fair value:	[10],[22]	$ 7,778,000
Investment, Identifier [Axis]: Debt Investments Software and Cybermaxx Intermediate Holdings, Inc., Senior Secured, Maturity Date August 2026, 6-month SOFR + 9.53%, Floor rate 10.28%
Summary of Investment Holdings
Maturity Date	[7],[17]			2026-08				2026-08
Basis spread variable rate	[7],[8],[17]			9.53%				9.53%
Interest rate floor	[7],[8],[17]			10.28%				10.28%
Principal amount	[7],[17]			$ 10,528,000
Investment cost	[6],[7],[17]			10,298,000
Investments, at fair value:	[7],[17]			$ 10,114,000
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 11.55%, PIK Interest 1.10%, 7.26% Exit Fee
Summary of Investment Holdings
Maturity Date	[10],[20],[21],[22]	2027-12				2027-12
Basis spread variable rate	[10],[11],[20],[21],[22]	3.05%				3.05%
Interest rate floor	[10],[11],[20],[21],[22]	11.55%				11.55%
Interest rate paid in kind	[10],[11],[20],[21],[22]	1.10%				1.10%
Exit fee rate	[10],[11],[20],[21],[22]	7.26%				7.26%
Principal amount	[10],[20],[21],[22]	$ 42,863,000
Investment cost	[2],[10],[20],[21],[22]	43,087,000
Investments, at fair value:	[10],[20],[21],[22]	$ 43,087,000
Investment, Identifier [Axis]: Debt Investments Software and Dashlane, Inc., Senior Secured, Maturity Date July 2025, Prime + 3.05%, Floor rate 7.55%, PIK Interest 1.10%, 4.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[13],[14],[15],[17]			2025-07				2025-07
Basis spread variable rate	[7],[8],[13],[14],[15],[17]			3.05%				3.05%
Interest rate floor	[7],[8],[13],[14],[15],[17]			7.55%				7.55%
Interest rate paid in kind	[7],[8],[13],[14],[15],[17]			1.10%				1.10%
Exit fee rate	[7],[8],[13],[14],[15],[17]			4.95%				4.95%
Principal amount	[7],[13],[14],[15],[17]			$ 31,930,000
Investment cost	[6],[7],[13],[14],[15],[17]			32,346,000
Investments, at fair value:	[7],[13],[14],[15],[17]			$ 32,012,000
Investment, Identifier [Axis]: Debt Investments Software and Demandbase, Inc., Senior Secured, Maturity Date August 2025, Prime + 2.25%, Floor rate 5.50%, PIK Interest 3.00%, 5.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[13],[14],[17]			2025-08				2025-08
Basis spread variable rate	[7],[8],[13],[14],[17]			2.25%				2.25%
Interest rate floor	[7],[8],[13],[14],[17]			5.50%				5.50%
Interest rate paid in kind	[7],[8],[13],[14],[17]			3.00%				3.00%
Exit fee rate	[7],[8],[13],[14],[17]			5.00%				5.00%
Principal amount	[7],[13],[14],[17]			$ 28,503,000
Investment cost	[6],[7],[13],[14],[17]			28,442,000
Investments, at fair value:	[7],[13],[14],[17]			$ 28,664,000
Investment, Identifier [Axis]: Debt Investments Software and Dispatch Technologies, Inc., Senior Secured, Maturity Date April 2028, 3-month SOFR + 8.01%, Floor rate 8.76%
Summary of Investment Holdings
Maturity Date		2028-04	[22],[23]	2028-04	[7],[16]	2028-04	[22],[23]	2028-04	[7],[16]
Basis spread variable rate		8.01%	[11],[22],[23]	8.01%	[7],[8],[16]	8.01%	[11],[22],[23]	8.01%	[7],[8],[16]
Interest rate floor		8.76%	[11],[22],[23]	8.76%	[7],[8],[16]	8.76%	[11],[22],[23]	8.76%	[7],[8],[16]
Principal amount		$ 8,125,000	[22],[23]	$ 7,500,000	[7],[16]
Investment cost		7,949,000	[2],[22],[23]	7,295,000	[6],[7],[16]
Investments, at fair value:		$ 8,127,000	[22],[23]	$ 7,339,000	[7],[16]
Investment, Identifier [Axis]: Debt Investments Software and DroneDeploy, Inc., Senior Secured, Maturity Date July 2026, Prime + 4.50%, Floor rate 8.75%, 4.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[22]	2026-07				2026-07
Basis spread variable rate	[11],[22]	4.50%				4.50%
Interest rate floor	[11],[22]	8.75%				8.75%
Exit fee rate	[11],[22]	4.00%				4.00%
Principal amount	[22]	$ 6,250,000
Investment cost	[2],[22]	6,083,000
Investments, at fair value:	[22]	$ 6,153,000
Investment, Identifier [Axis]: Debt Investments Software and Eigen Technologies Ltd., Senior Secured, Maturity Date April 2025, Prime + 5.10%, Floor rate 8.35%, 2.95% Exit Fee
Summary of Investment Holdings
Maturity Date		2025-04	[26],[27]	2025-04	[24],[25]	2025-04	[26],[27]	2025-04	[24],[25]
Basis spread variable rate		5.10%	[11],[26],[27]	5.10%	[8],[24],[25]	5.10%	[11],[26],[27]	5.10%	[8],[24],[25]
Interest rate floor		8.35%	[11],[26],[27]	8.35%	[8],[24],[25]	8.35%	[11],[26],[27]	8.35%	[8],[24],[25]
Exit fee rate		2.95%	[11],[26],[27]	2.95%	[8],[24],[25]	2.95%	[11],[26],[27]	2.95%	[8],[24],[25]
Principal amount		$ 3,750,000	[26],[27]	$ 3,750,000	[24],[25]
Investment cost		3,801,000	[2],[26],[27]	3,744,000	[6],[24],[25]
Investments, at fair value:		$ 3,730,000	[26],[27]	$ 3,746,000	[24],[25]
Investment, Identifier [Axis]: Debt Investments Software and Elation Health, Inc., Senior Secured, Maturity Date March 2026, Prime + 4.25%, Floor rate 9.00%, PIK Interest 1.95%, 3.95% Exit Fee
Summary of Investment Holdings
Maturity Date		2026-03	[9],[20],[22]	2026-03	[7],[13],[14]	2026-03	[9],[20],[22]	2026-03	[7],[13],[14]
Basis spread variable rate		4.25%	[9],[11],[20],[22]	4.25%	[7],[8],[13],[14]	4.25%	[9],[11],[20],[22]	4.25%	[7],[8],[13],[14]
Interest rate floor		9.00%	[9],[11],[20],[22]	9.00%	[7],[8],[13],[14]	9.00%	[9],[11],[20],[22]	9.00%	[7],[8],[13],[14]
Interest rate paid in kind		1.95%	[9],[11],[20],[22]	1.95%	[7],[8],[13],[14]	1.95%	[9],[11],[20],[22]	1.95%	[7],[8],[13],[14]
Exit fee rate		3.95%	[9],[11],[20],[22]	3.95%	[7],[8],[13],[14]	3.95%	[9],[11],[20],[22]	3.95%	[7],[8],[13],[14]
Principal amount		$ 12,629,000	[9],[20],[22]	$ 5,021,000	[7],[13],[14]
Investment cost		12,253,000	[2],[9],[20],[22]	4,839,000	[6],[7],[13],[14]
Investments, at fair value:		$ 12,692,000	[9],[20],[22]	$ 4,839,000	[7],[13],[14]
Investment, Identifier [Axis]: Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month LIBOR + 6.77%, Floor rate 7.77%, PIK Interest 2.16%
Summary of Investment Holdings
Maturity Date	[7],[14],[15],[16]			2026-09				2026-09
Basis spread variable rate	[7],[8],[14],[15],[16]			6.77%				6.77%
Interest rate floor	[7],[8],[14],[15],[16]			7.77%				7.77%
Interest rate paid in kind	[7],[8],[14],[15],[16]			2.16%				2.16%
Principal amount	[7],[14],[15],[16]			$ 8,223,000
Investment cost	[6],[7],[14],[15],[16]			8,054,000
Investments, at fair value:	[7],[14],[15],[16]			$ 8,043,000
Investment, Identifier [Axis]: Debt Investments Software and Enmark Systems, Inc., Senior Secured, Maturity Date September 2026, 3-month SOFR + 6.73%, Floor rate 7.73%, PIK Interest 2.13%
Summary of Investment Holdings
Maturity Date	[9],[21],[22],[23]	2026-09				2026-09
Basis spread variable rate	[9],[11],[21],[22],[23]	6.73%				6.73%
Interest rate floor	[9],[11],[21],[22],[23]	7.73%				7.73%
Interest rate paid in kind	[9],[11],[21],[22],[23]	2.13%				2.13%
Principal amount	[9],[21],[22],[23]	$ 8,363,000
Investment cost	[2],[9],[21],[22],[23]	8,230,000
Investments, at fair value:	[9],[21],[22],[23]	$ 8,363,000
Investment, Identifier [Axis]: Debt Investments Software and Esentire, Inc., Senior Secured, Maturity Date May 2024, 3-month LIBOR + 9.96%, Floor rate 10.96%
Summary of Investment Holdings
Maturity Date	[15],[16],[24],[25]			2024-05				2024-05
Basis spread variable rate	[8],[15],[16],[24],[25]			9.96%				9.96%
Interest rate floor	[8],[15],[16],[24],[25]			10.96%				10.96%
Principal amount	[15],[16],[24],[25]			$ 8,436,000
Investment cost	[6],[15],[16],[24],[25]			8,361,000
Investments, at fair value:	[15],[16],[24],[25]			$ 8,376,000
Investment, Identifier [Axis]: Debt Investments Software and Esme Learning Solutions, Inc., Senior Secured, Maturity Date February 2025, Prime + 5.50%, Floor rate 8.75%, PIK Interest 1.50%, 3.00% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[33]			2025-02				2025-02
Basis spread variable rate	[8],[14],[33]			5.50%				5.50%
Interest rate floor	[8],[14],[33]			8.75%				8.75%
Interest rate paid in kind	[8],[14],[33]			1.50%				1.50%
Exit fee rate	[8],[14],[33]			3.00%				3.00%
Principal amount	[14],[33]			$ 4,892,000
Investment cost	[6],[14],[33]			4,737,000
Investments, at fair value:	[14],[33]			$ 1,671,000
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.79%, Floor rate 8.70%
Summary of Investment Holdings
Maturity Date	[7],[16]			2027-10				2027-10
Basis spread variable rate	[7],[8],[16]			7.79%				7.79%
Interest rate floor	[7],[8],[16]			8.70%				8.70%
Principal amount	[7],[16]			$ 5,948,000
Investment cost	[6],[7],[16]			5,771,000
Investments, at fair value:	[7],[16]			$ 5,771,000
Investment, Identifier [Axis]: Debt Investments Software and Flight Schedule Pro, LLC, Senior Secured, Maturity Date October 2027, 1-month SOFR + 7.80%, Floor rate 8.70%
Summary of Investment Holdings
Maturity Date	[22],[23]	2027-10				2027-10
Basis spread variable rate	[11],[22],[23]	7.80%				7.80%
Interest rate floor	[11],[22],[23]	8.70%				8.70%
Principal amount	[22],[23]	$ 6,587,000
Investment cost	[2],[22],[23]	6,420,000
Investments, at fair value:	[22],[23]	$ 6,553,000
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.64%, Floor rate 8.54%
Summary of Investment Holdings
Maturity Date	[21],[22],[23]	2027-12				2027-12
Basis spread variable rate	[11],[21],[22],[23]	7.64%				7.64%
Interest rate floor	[11],[21],[22],[23]	8.54%				8.54%
Principal amount	[21],[22],[23]	$ 7,000,000
Investment cost	[2],[21],[22],[23]	6,851,000
Investments, at fair value:	[21],[22],[23]	$ 6,910,000
Investment, Identifier [Axis]: Debt Investments Software and Fortified Health Security, Senior Secured, Maturity Date December 2027, 6-month SOFR + 7.79%, Floor rate 8.54%
Summary of Investment Holdings
Maturity Date	[7],[16]			2027-12				2027-12
Basis spread variable rate	[7],[8],[16]			7.79%				7.79%
Interest rate floor	[7],[8],[16]			8.54%				8.54%
Principal amount	[7],[16]			$ 7,000,000
Investment cost	[6],[7],[16]			6,824,000
Investments, at fair value:	[7],[16]			$ 6,824,000
Investment, Identifier [Axis]: Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month Eurodollar + 9.00%, Floor rate 10.00%
Summary of Investment Holdings
Maturity Date	[7],[16],[24],[25]			2024-10				2024-10
Basis spread variable rate	[7],[8],[16],[24],[25]			9.00%				9.00%
Interest rate floor	[7],[8],[16],[24],[25]			10.00%				10.00%
Principal amount	[7],[16],[24],[25]			$ 6,563,000
Investment cost	[6],[7],[16],[24],[25]			6,422,000
Investments, at fair value:	[7],[16],[24],[25]			$ 6,484,000
Investment, Identifier [Axis]: Debt Investments Software and Ikon Science Limited, Senior Secured, Maturity Date October 2024, 3-month SOFR + 9.26%, Floor rate 10.00%
Summary of Investment Holdings
Maturity Date	[22],[23],[26],[27]	2024-10				2024-10
Basis spread variable rate	[11],[22],[23],[26],[27]	9.26%				9.26%
Interest rate floor	[11],[22],[23],[26],[27]	10.00%				10.00%
Principal amount	[22],[23],[26],[27]	$ 6,213,000
Investment cost	[2],[22],[23],[26],[27]	6,148,000
Investments, at fair value:	[22],[23],[26],[27]	$ 6,148,000
Investment, Identifier [Axis]: Debt Investments Software and Imperva, Inc., Senior Secured, Maturity Date January 2027, 3-month LIBOR + 7.75%, Floor rate 8.75%
Summary of Investment Holdings
Maturity Date	[13]			2027-01				2027-01
Basis spread variable rate	[8],[13]			7.75%				7.75%
Interest rate floor	[8],[13]			8.75%				8.75%
Principal amount	[13]			$ 20,000,000
Investment cost	[6],[13]			19,875,000
Investments, at fair value:	[13]			$ 20,200,000
Investment, Identifier [Axis]: Debt Investments Software and Kazoo, Inc. (p.k.a. YouEarnedIt, Inc.), Senior Secured, Maturity Date July 2023, 3-month SOFR + 10.14%, Floor rate 11.14%
Summary of Investment Holdings
Maturity Date	[16]			2023-07				2023-07
Basis spread variable rate	[8],[16]			10.14%				10.14%
Interest rate floor	[8],[16]			11.14%				11.14%
Principal amount	[16]			$ 10,681,000
Investment cost	[6],[16]			10,593,000
Investments, at fair value:	[16]			$ 10,593,000
Investment, Identifier [Axis]: Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2024, 3-month SOFR + 8.00%, Floor rate 9.00%
Summary of Investment Holdings
Maturity Date	[7]			2024-01				2024-01
Basis spread variable rate	[7],[8]			8.00%				8.00%
Interest rate floor	[7],[8]			9.00%				9.00%
Principal amount	[7]			$ 56,208,000
Investment cost	[6],[7]			56,062,000
Investments, at fair value:	[7]			$ 55,520,000
Investment, Identifier [Axis]: Debt Investments Software and Khoros (p.k.a Lithium Technologies), Senior Secured, Maturity Date January 2025, 3-month SOFR + 4.50%, Floor rate 5.50%, PIK Interest 4.50%
Summary of Investment Holdings
Maturity Date	[9]	2025-01				2025-01
Basis spread variable rate	[9],[11]	4.50%				4.50%
Interest rate floor	[9],[11]	5.50%				5.50%
Interest rate paid in kind	[9],[11]	4.50%				4.50%
Principal amount	[9]	$ 57,770,000
Investment cost	[2],[9]	57,730,000
Investments, at fair value:	[9]	$ 56,293,000
Investment, Identifier [Axis]: Debt Investments Software and Leapwork ApS., Senior Secured, Maturity Date February 2026, Prime + 0.25%, Floor rate 7.25%, PIK Interest 1.95%, 2.70% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12],[22],[26],[27]	2026-02				2026-02
Basis spread variable rate	[9],[11],[12],[22],[26],[27]	0.25%				0.25%
Interest rate floor	[9],[11],[12],[22],[26],[27]	7.25%				7.25%
Interest rate paid in kind	[9],[11],[12],[22],[26],[27]	1.95%				1.95%
Exit fee rate	[9],[11],[12],[22],[26],[27]	2.70%				2.70%
Principal amount	[9],[12],[22],[26],[27]	$ 3,813,000
Investment cost	[2],[9],[12],[22],[26],[27]	3,810,000
Investments, at fair value:	[9],[12],[22],[26],[27]	$ 3,907,000
Investment, Identifier [Axis]: Debt Investments Software and LinenMaster, LLC., Senior Secured, Maturity Date August 2028 1-month SOFR + 6.25%, Floor rate 7.25%, PIK Interest 2.15%
Summary of Investment Holdings
Maturity Date	[9],[22]	2028-08				2028-08
Basis spread variable rate	[9],[11],[22]	6.25%				6.25%
Interest rate floor	[9],[11],[22]	7.25%				7.25%
Interest rate paid in kind	[9],[11],[22]	2.15%				2.15%
Principal amount	[9],[22]	$ 15,083,000
Investment cost	[2],[9],[22]	14,799,000
Investments, at fair value:	[9],[22]	$ 14,799,000
Investment, Identifier [Axis]: Debt Investments Software and Loftware, Inc., Senior Secured, Maturity Date March 2028, 3-month SOFR + 7.88%, Floor rate 8.88%
Summary of Investment Holdings
Maturity Date	[22],[23]	2028-03				2028-03
Basis spread variable rate	[11],[22],[23]	7.88%				7.88%
Interest rate floor	[11],[22],[23]	8.88%				8.88%
Principal amount	[22],[23]	$ 26,469,000
Investment cost	[2],[22],[23]	25,897,000
Investments, at fair value:	[22],[23]	$ 26,566,000
Investment, Identifier [Axis]: Debt Investments Software and LogicSource, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.93%, Floor rate 9.93%
Summary of Investment Holdings
Maturity Date		2027-07	[22],[23]	2027-07	[7]	2027-07	[22],[23]	2027-07	[7]
Basis spread variable rate		8.93%	[11],[22],[23]	8.93%	[7],[8]	8.93%	[11],[22],[23]	8.93%	[7],[8]
Interest rate floor		9.93%	[11],[22],[23]	9.93%	[7],[8]	9.93%	[11],[22],[23]	9.93%	[7],[8]
Principal amount		$ 13,300,000	[22],[23]	$ 13,300,000	[7]
Investment cost		13,074,000	[2],[22],[23]	13,028,000	[6],[7]
Investments, at fair value:		$ 13,493,000	[22],[23]	$ 13,028,000	[7]
Investment, Identifier [Axis]: Debt Investments Software and Logicworks, Senior Secured, Maturity Date January 2024, Prime + 7.50%, Floor rate 10.75%
Summary of Investment Holdings
Maturity Date	[18]			2024-01				2024-01
Basis spread variable rate	[8],[18]			7.50%				7.50%
Interest rate floor	[8],[18]			10.75%				10.75%
Principal amount	[18]			$ 14,500,000
Investment cost	[6],[18]			14,398,000
Investments, at fair value:	[18]			$ 14,473,000
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month LIBOR + 9.06%, Floor rate 10.06%
Summary of Investment Holdings
Maturity Date	[7],[16]			2025-12				2025-12
Basis spread variable rate	[7],[8],[16]			9.06%				9.06%
Interest rate floor	[7],[8],[16]			10.06%				10.06%
Principal amount	[7],[16]			$ 17,915,000
Investment cost	[6],[7],[16]			17,556,000
Investments, at fair value:	[7],[16]			$ 17,474,000
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date December 2025, 3-month SOFR + 9.31%, Floor rate 10.06%
Summary of Investment Holdings
Maturity Date	[23]	2025-12				2025-12
Basis spread variable rate	[11],[23]	9.31%				9.31%
Interest rate floor	[11],[23]	10.06%				10.06%
Principal amount	[23]	$ 18,366,000
Investment cost	[2],[23]	18,116,000
Investments, at fair value:	[23]	$ 18,176,000
Investment, Identifier [Axis]: Debt Investments Software and Mobile Solutions Services, Senior Secured, Maturity Date November 2030, 3-month SOFR + 6.75%, Floor rate 7.75%
Summary of Investment Holdings
Maturity Date	[22]	2030-11				2030-11
Basis spread variable rate	[11],[22]	6.75%				6.75%
Interest rate floor	[11],[22]	7.75%				7.75%
Principal amount	[22]	$ 20,890,000
Investment cost	[2],[22]	20,375,000
Investments, at fair value:	[22]	$ 20,375,000
Investment, Identifier [Axis]: Debt Investments Software and Nextroll, Inc., Senior Secured, Maturity Date July 2023, Prime + 3.75%, Floor rate 7.75%, PIK Interest 2.95%, 1.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[18]			2023-07				2023-07
Basis spread variable rate	[8],[14],[18]			3.75%				3.75%
Interest rate floor	[8],[14],[18]			7.75%				7.75%
Interest rate paid in kind	[8],[14],[18]			2.95%				2.95%
Exit fee rate	[8],[14],[18]			1.95%				1.95%
Principal amount	[14],[18]			$ 22,211,000
Investment cost	[6],[14],[18]			22,284,000
Investments, at fair value:	[14],[18]			$ 22,284,000
Investment, Identifier [Axis]: Debt Investments Software and Nuvolo Technologies Corporation, Senior Secured, Maturity Date July 2025, Prime + 5.25%, Floor rate 8.50%, 2.42% Exit Fee
Summary of Investment Holdings
Maturity Date	[7],[13],[17],[18]			2025-07				2025-07
Basis spread variable rate	[7],[8],[13],[17],[18]			5.25%				5.25%
Interest rate floor	[7],[8],[13],[17],[18]			8.50%				8.50%
Exit fee rate	[7],[8],[13],[17],[18]			2.42%				2.42%
Principal amount	[7],[13],[17],[18]			$ 22,500,000
Investment cost	[6],[7],[13],[17],[18]			22,508,000
Investments, at fair value:	[7],[13],[17],[18]			$ 22,817,000
Investment, Identifier [Axis]: Debt Investments Software and Omeda Holdings, LLC, Senior Secured, Maturity Date July 2027, 3-month SOFR + 8.05%, Floor rate 9.05%
Summary of Investment Holdings
Maturity Date		2027-07	[21],[22],[23]	2027-07	[7],[16]	2027-07	[21],[22],[23]	2027-07	[7],[16]
Basis spread variable rate		8.05%	[11],[21],[22],[23]	8.05%	[7],[8],[16]	8.05%	[11],[21],[22],[23]	8.05%	[7],[8],[16]
Interest rate floor		9.05%	[11],[21],[22],[23]	9.05%	[7],[8],[16]	9.05%	[11],[21],[22],[23]	9.05%	[7],[8],[16]
Principal amount		$ 7,706,000	[21],[22],[23]	$ 7,500,000	[7],[16]
Investment cost		7,508,000	[2],[21],[22],[23]	7,261,000	[6],[7],[16]
Investments, at fair value:		$ 7,702,000	[21],[22],[23]	$ 7,261,000	[7],[16]
Investment, Identifier [Axis]: Debt Investments Software and Onna Technologies, Inc., Senior Secured, Maturity Date March 2026, Prime + 1.35%, Floor rate 8.85%, PIK Interest, 1.75%, 4.45% Exit Fee
Summary of Investment Holdings
Maturity Date	[9]	2026-03				2026-03
Basis spread variable rate	[9],[11]	1.35%				1.35%
Interest rate floor	[9],[11]	8.85%				8.85%
Interest rate paid in kind	[9],[11]	1.75%				1.75%
Exit fee rate	[9],[11]	4.45%				4.45%
Principal amount	[9]	$ 3,853,000
Investment cost	[2],[9]	3,814,000
Investments, at fair value:	[9]	$ 3,810,000
Investment, Identifier [Axis]: Debt Investments Software and Riviera Partners LLC, Senior Secured, Maturity Date April 2027, 6-month SOFR + 7.53%, Floor rate 8.53%
Summary of Investment Holdings
Maturity Date	[7],[16]			2027-04				2027-04
Basis spread variable rate	[7],[8],[16]			7.53%				7.53%
Interest rate floor	[7],[8],[16]			8.53%				8.53%
Principal amount	[7],[16]			$ 26,184,000
Investment cost	[6],[7],[16]			25,622,000
Investments, at fair value:	[7],[16]			$ 25,487,000
Investment, Identifier [Axis]: Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 3-month SOFR + 8.00%, Floor rate 9.00%
Summary of Investment Holdings
Maturity Date	[23]	2027-09				2027-09
Basis spread variable rate	[11],[23]	8.00%				8.00%
Interest rate floor	[11],[23]	9.00%				9.00%
Principal amount	[23]	$ 22,185,000
Investment cost	[2],[23]	21,814,000
Investments, at fair value:	[23]	$ 22,048,000
Investment, Identifier [Axis]: Debt Investments Software and Salary.com, LLC, Senior Secured, Maturity Date September 2027, 6-month SOFR + 8.00%, Floor rate 9.00%
Summary of Investment Holdings
Maturity Date	[16]			2027-09				2027-09
Basis spread variable rate	[8],[16]			8.00%				8.00%
Interest rate floor	[8],[16]			9.00%				9.00%
Principal amount	[16]			$ 18,000,000
Investment cost	[6],[16]			17,654,000
Investments, at fair value:	[16]			$ 17,654,000
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 3-month LIBOR + 9.00%, Floor rate 10.00%
Summary of Investment Holdings
Maturity Date	[7],[16]			2026-12				2026-12
Basis spread variable rate	[7],[8],[16]			9.00%				9.00%
Interest rate floor	[7],[8],[16]			10.00%				10.00%
Principal amount	[7],[16]			$ 5,985,000
Investment cost	[6],[7],[16]			5,841,000
Investments, at fair value:	[7],[16]			$ 5,830,000
Investment, Identifier [Axis]: Debt Investments Software and ShadowDragon, LLC, Senior Secured, Maturity Date December 2026, 6-month SOFR + 9.01%, Floor rate 9.91%
Summary of Investment Holdings
Maturity Date	[22],[23]	2026-12				2026-12
Basis spread variable rate	[11],[22],[23]	9.01%				9.01%
Interest rate floor	[11],[22],[23]	9.91%				9.91%
Principal amount	[22],[23]	$ 6,000,000
Investment cost	[2],[22],[23]	5,883,000
Investments, at fair value:	[22],[23]	$ 5,921,000
Investment, Identifier [Axis]: Debt Investments Software and Simon Data, Inc., Senior Secured, Maturity Date March 2027, Prime + 1.00%, Floor rate 8.75%, PIK Interest 1.95%, 2.92% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[12]	2027-03				2027-03
Basis spread variable rate	[9],[11],[12]	1.00%				1.00%
Interest rate floor	[9],[11],[12]	8.75%				8.75%
Interest rate paid in kind	[9],[11],[12]	1.95%				1.95%
Exit fee rate	[9],[11],[12]	2.92%				2.92%
Principal amount	[9],[12]	$ 15,065,000
Investment cost	[2],[9],[12]	14,982,000
Investments, at fair value:	[9],[12]	$ 15,037,000
Investment, Identifier [Axis]: Debt Investments Software and Sisense Ltd., Senior Secured, Maturity Date July 2027, Prime + 1.50%, Floor rate 9.50%, PIK Interest 1.95%, 5.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[26],[27]	2027-07				2027-07
Basis spread variable rate	[9],[11],[26],[27]	1.50%				1.50%
Interest rate cap	[9],[11],[26],[27]	9.50%				9.50%
Interest rate paid in kind	[9],[11],[26],[27]	1.95%				1.95%
Exit fee rate	[9],[11],[26],[27]	5.95%				5.95%
Principal amount	[9],[26],[27]	$ 34,830,000
Investment cost	[2],[9],[26],[27]	34,584,000
Investments, at fair value:	[9],[26],[27]	$ 34,881,000
Investment, Identifier [Axis]: Debt Investments Software and Streamline Healthcare Solutions, Senior Secured, Maturity Date March 2028, 1-month SOFR + 7.25%, Floor rate 8.25%
Summary of Investment Holdings
Maturity Date	[22],[23]	2028-03				2028-03
Basis spread variable rate	[11],[22],[23]	7.25%				7.25%
Interest rate floor	[11],[22],[23]	8.25%				8.25%
Principal amount	[22],[23]	$ 13,200,000
Investment cost	[2],[22],[23]	12,953,000
Investments, at fair value:	[22],[23]	$ 13,327,000
Investment, Identifier [Axis]: Debt Investments Software and Sumo Logic, Inc., Senior Secured, Maturity Date May 2030, 3-month SOFR + 6.50%, Floor rate 7.50%
Summary of Investment Holdings
Maturity Date	[22]	2030-05				2030-05
Basis spread variable rate	[11],[22]	6.50%				6.50%
Interest rate floor	[11],[22]	7.50%				7.50%
Principal amount	[22]	$ 23,000,000
Investment cost	[2],[22]	22,460,000
Investments, at fair value:	[22]	$ 23,105,000
Investment, Identifier [Axis]: Debt Investments Software and Suzy, Inc.., Senior Secured, Maturity Date August 2027, Prime + 1.75%, Floor rate 10.00%, PIK Interest 1.95%, 3.45% Exit Fee
Summary of Investment Holdings
Maturity Date	[1],[9],[22]	2027-08				2027-08
Basis spread variable rate	[1],[9],[11],[22]	1.75%				1.75%
Interest rate floor	[1],[9],[11],[22]	10.00%				10.00%
Interest rate paid in kind	[1],[9],[11],[22]	1.95%				1.95%
Exit fee rate	[1],[9],[11],[22]	3.45%				3.45%
Principal amount	[1],[9],[22]	$ 12,064,000
Investment cost	[1],[2],[9],[22]	11,837,000
Investments, at fair value:	[1],[9],[22]	$ 11,837,000
Investment, Identifier [Axis]: Debt Investments Software and Tact.ai Technologies, Inc., Senior Secured, Maturity Date February 2024, Prime + 4.00%, Floor rate 8.75%, PIK Interest 2.00%, 5.50% Exit Fee
Summary of Investment Holdings
Maturity Date	[14]			2024-02				2024-02
Basis spread variable rate	[8],[14]			4.00%				4.00%
Interest rate floor	[8],[14]			8.75%				8.75%
Interest rate paid in kind	[8],[14]			2.00%				2.00%
Exit fee rate	[8],[14]			5.50%				5.50%
Principal amount	[14]			$ 4,250,000
Investment cost	[6],[14]			4,481,000
Investments, at fair value:	[14]			$ 4,446,000
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month LIBOR + 9.00%, Floor rate 10.00%
Summary of Investment Holdings
Maturity Date	[7],[16]			2026-05				2026-05
Basis spread variable rate	[7],[8],[16]			9.00%				9.00%
Interest rate floor	[7],[8],[16]			10.00%				10.00%
Principal amount	[7],[16]			$ 11,032,000
Investment cost	[6],[7],[16]			10,778,000
Investments, at fair value:	[7],[16]			$ 10,793,000
Investment, Identifier [Axis]: Debt Investments Software and ThreatConnect, Inc., Senior Secured, Maturity Date May 2026, 6-month SOFR + 9.25%, Floor rate 10.00%
Summary of Investment Holdings
Maturity Date	[22],[23]	2026-05				2026-05
Basis spread variable rate	[11],[22],[23]	9.25%				9.25%
Interest rate floor	[11],[22],[23]	10.00%				10.00%
Principal amount	[22],[23]	$ 10,920,000
Investment cost	[2],[22],[23]	10,730,000
Investments, at fair value:	[22],[23]	$ 10,920,000
Investment, Identifier [Axis]: Debt Investments Software and Tipalti Solutions Ltd., Senior Secured, Maturity Date April 2027, Prime + 0.45%, Floor rate 7.95%, PIK Interest 2.00%, 3.75% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[22],[26],[27]	2027-04				2027-04
Basis spread variable rate	[9],[11],[22],[26],[27]	0.45%				0.45%
Interest rate floor	[9],[11],[22],[26],[27]	7.95%				7.95%
Interest rate paid in kind	[9],[11],[22],[26],[27]	2.00%				2.00%
Exit fee rate	[9],[11],[22],[26],[27]	3.75%				3.75%
Principal amount	[9],[22],[26],[27]	$ 10,649,000
Investment cost	[2],[9],[22],[26],[27]	10,578,000
Investments, at fair value:	[9],[22],[26],[27]	$ 10,835,000
Investment, Identifier [Axis]: Debt Investments Software and VideoAmp, Inc., Senior Secured, Maturity Date February 2025, Prime + 3.70%, Floor rate 6.95%, PIK Interest 1.25%, 5.25% Exit Fee
Summary of Investment Holdings
Maturity Date	[13],[14],[30]			2025-02				2025-02
Basis spread variable rate	[8],[13],[14],[30]			3.70%				3.70%
Interest rate floor	[8],[13],[14],[30]			6.95%				6.95%
Interest rate paid in kind	[8],[13],[14],[30]			1.25%				1.25%
Exit fee rate	[8],[13],[14],[30]			5.25%				5.25%
Principal amount	[13],[14],[30]			$ 63,187,000
Investment cost	[6],[13],[14],[30]			62,640,000
Investments, at fair value:	[13],[14],[30]			$ 63,429,000
Investment, Identifier [Axis]: Debt Investments Software and Zappi, Inc., Senior Secured, Maturity Date December 2027, 3-month SOFR + 8.03%, Floor rate 9.03%
Summary of Investment Holdings
Maturity Date		2027-12	[10],[22],[23],[26],[27]	2027-12	[7],[16],[24],[25]	2027-12	[10],[22],[23],[26],[27]	2027-12	[7],[16],[24],[25]
Basis spread variable rate		8.03%	[10],[11],[22],[23],[26],[27]	8.03%	[7],[8],[16],[24],[25]	8.03%	[10],[11],[22],[23],[26],[27]	8.03%	[7],[8],[16],[24],[25]
Interest rate floor		9.03%	[10],[11],[22],[23],[26],[27]	9.03%	[7],[8],[16],[24],[25]	9.03%	[10],[11],[22],[23],[26],[27]	9.03%	[7],[8],[16],[24],[25]
Principal amount		$ 9,000,000	[10],[22],[23],[26],[27]	$ 9,000,000	[7],[16],[24],[25]
Investment cost		8,816,000	[2],[10],[22],[23],[26],[27]	8,779,000	[6],[7],[16],[24],[25]
Investments, at fair value:		$ 8,967,000	[10],[22],[23],[26],[27]	$ 8,779,000	[7],[16],[24],[25]
Investment, Identifier [Axis]: Debt Investments Software and Zimperium, Inc., Senior Secured, Maturity Date May 2027, 3-month SOFR + 8.31%, Floor rate 9.31%
Summary of Investment Holdings
Maturity Date		2027-05	[22],[23]	2027-05	[7],[16]	2027-05	[22],[23]	2027-05	[7],[16]
Basis spread variable rate		8.31%	[11],[22],[23]	8.31%	[7],[8],[16]	8.31%	[11],[22],[23]	8.31%	[7],[8],[16]
Interest rate floor		9.31%	[11],[22],[23]	9.31%	[7],[8],[16]	9.31%	[11],[22],[23]	9.31%	[7],[8],[16]
Principal amount		$ 16,313,000	[22],[23]	$ 16,313,000	[7],[16]
Investment cost		16,057,000	[2],[22],[23]	16,000,000	[6],[7],[16]
Investments, at fair value:		$ 16,394,000	[22],[23]	$ 16,072,000	[7],[16]
Investment, Identifier [Axis]: Debt Investments Software and iGrafx,LLC, Senior Secured, Maturity Date May 2027, 1-month SOFR + 8.66%, Floor rate 9.56%
Summary of Investment Holdings
Maturity Date	[23]	2027-05				2027-05
Basis spread variable rate	[11],[23]	8.66%				8.66%
Interest rate floor	[11],[23]	9.56%				9.56%
Principal amount	[23]	$ 5,000,000
Investment cost	[2],[23]	4,901,000
Investments, at fair value:	[23]	$ 4,901,000
Investment, Identifier [Axis]: Debt Investments Subtotal: Communications & Networking (1.62%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	1.62%				1.62%
Investment cost	[2]	$ 28,182,000
Investments, at fair value:		$ 29,272,000
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.31%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.31%				0.31%
Investment cost	[2]	$ 5,634,000
Investments, at fair value:		$ 5,617,000
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology (0.50%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.50%				0.50%
Investment cost	[6]			$ 7,222,000
Investments, at fair value:				$ 7,014,000
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.78% Exit Fee
Summary of Investment Holdings
Maturity Date	[9],[10]	2025-05				2025-05
Basis spread variable rate	[9],[10],[11]	4.70%				4.70%
Interest rate floor	[9],[10],[11]	7.95%				7.95%
Interest rate paid in kind	[9],[10],[11]	1.45%				1.45%
Exit fee rate	[9],[10],[11]	3.78%				3.78%
Principal amount	[9],[10]	$ 3,926,000
Investment cost	[2],[9],[10]	3,952,000
Investments, at fair value:	[9],[10]	$ 3,939,000
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Ampion, PBC, Senior Secured, Maturity Date May 2025, Prime + 4.70%, Floor rate 7.95%, PIK Interest 1.45%, 3.95% Exit Fee
Summary of Investment Holdings
Maturity Date	[14],[17]			2025-05				2025-05
Basis spread variable rate	[8],[14],[17]			4.70%				4.70%
Interest rate floor	[8],[14],[17]			7.95%				7.95%
Interest rate paid in kind	[8],[14],[17]			1.45%				1.45%
Exit fee rate	[8],[14],[17]			3.95%				3.95%
Principal amount	[14],[17]			$ 4,037,000
Investment cost	[6],[14],[17]			3,985,000
Investments, at fair value:	[14],[17]			$ 4,008,000
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date December 2024, PIK Interest 10.00%
Summary of Investment Holdings
Maturity Date	[14]			2024-12				2024-12
Interest rate paid in kind	[8],[14]			10.00%				10.00%
Principal amount	[14]			$ 3,237,000
Investment cost	[6],[14]			3,237,000
Investments, at fair value:	[14]			$ 3,006,000
Investment, Identifier [Axis]: Debt Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Senior Secured, Maturity Date June 2027, FIXED 10.00%
Summary of Investment Holdings
Maturity Date	[20]	2027-06				2027-06
Interest rate paid in kind	[11],[20]	10.00%				10.00%
Principal amount	[20]	$ 1,682,000
Investment cost	[2],[20]	1,682,000
Investments, at fair value:	[20]	$ 1,678,000
Investment, Identifier [Axis]: Equity Investments (8.44%)
Summary of Investment Holdings
Investment owned, percent of net assets		8.44%				8.44%
Investment cost	[2]	$ 155,226,000
Investments, at fair value:		$ 152,170,000
Investment, Identifier [Axis]: Equity Investments (9.56%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			9.56%				9.56%
Investment cost	[6]			$ 153,173,000
Investments, at fair value:				$ 133,972,000
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.04%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.04%				0.04%
Investment cost	[6]			$ 663,000
Investments, at fair value:				498,000
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products (0.13%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.13%				0.13%
Investment cost	[2]	$ 1,764,000
Investments, at fair value:		2,264,000
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc.
Summary of Investment Holdings
Investment cost	[2]	1,229,000
Investments, at fair value:		$ 796,000
Shares | shares		173,180				173,180
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Summary of Investment Holdings
Investment cost	[2]	$ 128,000
Investments, at fair value:		$ 96,000
Acquisition date	[3]	Apr. 30, 2010
Shares | shares		42,989				42,989
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Fabletics, Inc., Equity, Acquisition Date 7/16/2013, Series Preferred Series B
Summary of Investment Holdings
Investment cost	[2]	$ 1,101,000
Investments, at fair value:		$ 700,000
Acquisition date	[3]	Jul. 16, 2013
Shares | shares		130,191				130,191
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Grove Collaborative, Inc., Equity, Acquisition Date 4/30/2021, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 433,000	[2],[3]	433,000	[6],[40]
Investments, at fair value:		$ 21,000	[3]	$ 24,000	[40]
Acquisition date		Apr. 30, 2021	[3]	Apr. 30, 2021	[40]
Shares | shares		12,260	[3]	61,300	[40]	12,260	[3]	61,300	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and Savage X Holding, LLC, Equity, Acquisition Date 4/30/2010, Series Class A Units
Summary of Investment Holdings
Investment cost		$ 13,000	[2]	$ 13,000	[6]
Investments, at fair value:		$ 863,000		$ 226,000
Acquisition date		Apr. 30, 2010	[3]	Apr. 30, 2010	[40]
Shares | shares		172,328		42,137		172,328		42,137
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TFG Holding, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 89,000	[2]	$ 89,000	[6]
Investments, at fair value:		$ 584,000		$ 116,000
Acquisition date		Apr. 30, 2010	[3]	Apr. 30, 2010	[40]
Shares | shares		173,180		42,989		173,180		42,989
Investment, Identifier [Axis]: Equity Investments Consumer & Business Products and TechStyle, Inc., Equity, Acquisition Date 4/30/2010, Series Common Stock
Summary of Investment Holdings
Investment cost	[6]			$ 128,000
Investments, at fair value:				$ 132,000
Acquisition date	[40]			Apr. 30, 2010
Shares | shares				42,989				42,989
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.57%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.57%				0.57%
Investment cost	[6]			$ 13,488,000
Investments, at fair value:				7,995,000
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services (0.70%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.70%				0.70%
Investment cost	[2]	$ 26,145,000
Investments, at fair value:		12,703,000
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Carwow LTD, Equity, Acquisition Date 12/15/2021, Series Preferred Series D-4
Summary of Investment Holdings
Investment cost		1,151,000	[2],[26],[27]	1,151,000	[6],[24],[25]
Investments, at fair value:		$ 679,000	[26],[27]	$ 257,000	[24],[25]
Acquisition date		Dec. 15, 2021	[3],[26],[27]	Dec. 15, 2021	[24],[25],[40]
Shares | shares		199,742	[26],[27]	199,742	[24],[25]	199,742	[26],[27]	199,742	[24],[25]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and DoorDash, Inc., Equity, Acquisition Date 12/20/2018, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 657,000	[2],[3]	$ 945,000	[6],[40]
Investments, at fair value:		$ 5,636,000	[3]	$ 4,003,000	[40]
Acquisition date		Dec. 20, 2018	[3]	Dec. 20, 2018	[40]
Shares | shares		56,996	[3]	81,996	[40]	56,996	[3]	81,996	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Lyft, Inc., Equity, Acquisition Date 12/26/2018, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 5,263,000	[2],[3]	$ 5,263,000	[6],[40]
Investments, at fair value:		$ 1,510,000	[3]	$ 1,110,000	[40]
Acquisition date		Dec. 26, 2018	[3]	Dec. 26, 2018	[40]
Shares | shares		100,738	[3]	100,738	[40]	100,738	[3]	100,738	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Nerdy Inc., Equity, Acquisition Date 9/17/2021, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 1,000,000	[2],[3]	$ 1,000,000	[6],[40]
Investments, at fair value:		$ 343,000	[3]	$ 225,000	[40]
Acquisition date		Sep. 17, 2021	[3]	Sep. 17, 2021	[40]
Shares | shares		100,000	[3]	100,000	[40]	100,000	[3]	100,000	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A
Summary of Investment Holdings
Investment cost		$ 1,663,000	[2]	$ 1,663,000	[6]
Investments, at fair value:		$ 377,000		$ 372,000
Acquisition date		Oct. 25, 2016	[3]	Oct. 25, 2016	[40]
Shares | shares		286,080		286,080		286,080		286,080
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and OfferUp, Inc., Equity, Acquisition Date 10/25/2016, Series Preferred Series A-1
Summary of Investment Holdings
Investment cost		$ 632,000	[2]	$ 632,000	[6]
Investments, at fair value:		$ 143,000		$ 141,000
Acquisition date		Oct. 25, 2016	[3]	Oct. 25, 2016	[40]
Shares | shares		108,710		108,710		108,710		108,710
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Oportun, Equity, Acquisition Date 6/28/2013, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 577,000	[2],[3]	$ 577,000	[6],[40]
Investments, at fair value:		$ 189,000	[3]	$ 266,000	[40]
Acquisition date		Jun. 28, 2013	[3]	Jun. 28, 2013	[40]
Shares | shares		48,365	[3]	48,365	[40]	48,365	[3]	48,365	[40]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Reischling Press, Inc., Equity, Acquisition Date 7/31/2020, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 39,000	[2]	$ 39,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Jul. 31, 2020	[3]	Jul. 31, 2020	[40]
Shares | shares		3,095		3,095		3,095		3,095
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Common Stock
Summary of Investment Holdings
Investment cost	[2]	$ 1,000,000
Investments, at fair value:		$ 559,000
Acquisition date	[3]	Jan. 24, 2022
Shares | shares		7,063				7,063
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Rhino Labs, Inc., Equity, Acquisition Date 1/24/2022, Series Preferred Series B-2
Summary of Investment Holdings
Investment cost	[6]			$ 1,000,000
Investments, at fair value:				$ 805,000
Acquisition date	[40]			Jan. 24, 2022
Shares | shares				7,063				7,063
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 12/29/2023, Series Preferred Series C
Summary of Investment Holdings
Investment cost	[2],[32]	$ 13,263,000
Investments, at fair value:	[32]	$ 3,251,000
Acquisition date	[3],[32]	Dec. 29, 2023
Shares | shares	[32]	3,235,298				3,235,298
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 5/23/2018, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 900,000	[2],[32]	$ 900,000	[6],[34]
Investments, at fair value:		$ 4,000	[32]	$ 0	[34]
Acquisition date		May 23, 2018	[3],[32]	May 23, 2018	[34],[40]
Shares | shares		414,994,863	[32]	414,994,863	[34]	414,994,863	[32]	414,994,863	[34]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Tectura Corporation, Equity, Acquisition Date 6/6/2016, Series Preferred Series BB
Summary of Investment Holdings
Investment cost		$ 0	[2],[32]	$ 0	[6],[34]
Investments, at fair value:		$ 12,000	[32]	$ 0	[34]
Acquisition date		Jun. 06, 2016	[3],[32]	Jun. 06, 2016	[34],[40]
Shares | shares		1,000,000	[32]	1,000,000	[34]	1,000,000	[32]	1,000,000	[34]
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total OfferUp, Inc.
Summary of Investment Holdings
Investment cost		$ 2,295,000	[2]	$ 2,295,000	[6]
Investments, at fair value:		$ 520,000		$ 513,000
Shares | shares		394,790		394,790		394,790		394,790
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Total Tectura Corporation
Summary of Investment Holdings
Investment cost		$ 14,163,000	[2]	$ 900,000	[6]
Investments, at fair value:		$ 3,267,000		$ 0
Shares | shares		419,230,161		415,994,863		419,230,161		415,994,863
Investment, Identifier [Axis]: Equity Investments Consumer & Business Services and Uber Technologies, Inc., Equity, Acquisition Date 12/1/2020, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 318,000
Investments, at fair value:	[40]			$ 816,000
Acquisition date	[40]			Dec. 01, 2020
Shares | shares	[40]			32,991				32,991
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (2.49%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			2.49%				2.49%
Investment cost	[6]			$ 28,444,000
Investments, at fair value:				34,869,000
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services (3.17%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	3.17%				3.17%
Investment cost	[2]	$ 34,444,000
Investments, at fair value:		57,072,000
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Acquisition, LLC (p.k.a. Gibraltar Business Capital, LLC), Equity, Acquisition Date 3/1/2018, Series Member Units
Summary of Investment Holdings
Investment cost	[2],[32],[35]	34,006,000
Investments, at fair value:	[32],[35]	$ 28,034,000
Acquisition date	[3],[32],[35]	Mar. 01, 2018
Shares | shares	[32],[35]	1				1
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[34]			1,884,000
Investments, at fair value:	[34]			$ 1,107,000
Acquisition date	[34],[40]			Mar. 01, 2018
Shares | shares	[34]			830,000				830,000
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Gibraltar Business Capital, LLC, Equity, Acquisition Date 3/1/2018, Series Preferred Series A
Summary of Investment Holdings
Investment cost	[6],[34]			$ 26,122,000
Investments, at fair value:	[34]			$ 14,137,000
Acquisition date	[34],[40]			Mar. 01, 2018
Shares | shares	[34]			10,602,752				10,602,752
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Hercules Adviser LLC, Equity, Acquisition Date 3/26/2021, Series Member Units
Summary of Investment Holdings
Investment cost		$ 35,000	[2],[32],[36]	$ 35,000	[6],[34]
Investments, at fair value:		$ 28,713,000	[32],[36]	$ 19,153,000	[34]
Acquisition date		Mar. 26, 2021	[3],[32],[36]	Mar. 26, 2021	[34],[40]
Shares | shares		1	[32],[36]	1	[34]	1	[32],[36]	1	[34]
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services and Newfront Insurance Holdings, Inc., Equity, Acquisition Date 9/30/2021, Series Preferred Series D-2
Summary of Investment Holdings
Investment cost		$ 403,000	[2]	$ 403,000	[6]
Investments, at fair value:		$ 325,000		$ 472,000
Acquisition date		Sep. 30, 2021	[3]	Sep. 30, 2021	[40]
Shares | shares		210,282		210,282		210,282		210,282
Investment, Identifier [Axis]: Equity Investments Diversified Financial Services, Gibraltar Business Capital, LLC
Summary of Investment Holdings
Investment cost	[6]			$ 28,006,000
Investments, at fair value:				$ 15,244,000
Shares | shares				11,432,752				11,432,752
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.00%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.00%				0.00%
Investment cost	[2]	$ 3,638,000
Investments, at fair value:		21,000
Investment, Identifier [Axis]: Equity Investments Drug Delivery (0.01%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.01%				0.01%
Investment cost	[6]			$ 3,638,000
Investments, at fair value:				89,000
Investment, Identifier [Axis]: Equity Investments Drug Delivery and AcelRx Pharmaceuticals, Inc., Equity, Acquisition Date 12/10/2018, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			1,329,000
Investments, at fair value:	[40]			$ 20,000
Acquisition date	[40]			Dec. 10, 2018
Shares | shares	[40]			8,836				8,836
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Aytu BioScience, Inc., Equity, Acquisition Date 3/28/2014, Series Common Stock
Summary of Investment Holdings
Investment cost		1,500,000	[2],[3]	$ 1,500,000	[6],[40]
Investments, at fair value:		$ 2,000	[3]	$ 3,000	[40]
Acquisition date		Mar. 28, 2014	[3]	Mar. 28, 2014	[40]
Shares | shares		680	[3]	13,600	[40]	680	[3]	13,600	[40]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and BioQ Pharma Incorporated, Equity, Acquisition Date 12/8/2015, Series Preferred Series D
Summary of Investment Holdings
Investment cost		$ 500,000	[2]	$ 500,000	[6]
Investments, at fair value:		$ 0		$ 33,000
Acquisition date		Dec. 08, 2015	[3]	Dec. 08, 2015	[40]
Shares | shares		165,000		165,000		165,000		165,000
Investment, Identifier [Axis]: Equity Investments Drug Delivery and PDS Biotechnology Corporation, Equity, Acquisition Date 4/6/2015, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 309,000	[2],[3]	$ 309,000	[6],[40]
Investments, at fair value:		$ 12,000	[3]	$ 33,000	[40]
Acquisition date		Apr. 06, 2015	[3]	Apr. 06, 2015	[40]
Shares | shares		2,498	[3]	2,498	[40]	2,498	[3]	2,498	[40]
Investment, Identifier [Axis]: Equity Investments Drug Delivery and Talphera, Inc (p.k.a. AcelRx Pharmaceuticals, Inc. ), Equity, Acquisition Date 12/10/2018, Series Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 1,329,000
Investments, at fair value:	[3]	$ 7,000
Acquisition date	[3]	Dec. 10, 2018
Shares | shares	[3]	8,836				8,836
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.47%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	2.47%				2.47%
Investment cost	[2]	$ 40,735,000
Investments, at fair value:		44,500,000
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development (2.66%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			2.66%				2.66%
Investment cost	[6]			$ 43,971,000
Investments, at fair value:				37,315,000
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Akero Therapeutics, Inc., Equity, Acquisition Date 9/19/2022, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[40]			1,000,000
Investments, at fair value:	[24],[40]			$ 2,108,000
Acquisition date	[24],[40]			Sep. 19, 2022
Shares | shares	[24],[40]			38,461				38,461
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Albireo Pharma, Inc., Equity, Acquisition Date 9/14/2020, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[40]			$ 1,000,000
Investments, at fair value:	[24],[40]			$ 540,000
Acquisition date	[24],[40]			Sep. 14, 2020
Shares | shares	[24],[40]			25,000				25,000
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Applied Molecular Transport, Equity, Acquisition Date 4/6/2021, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[40]			$ 42,000
Investments, at fair value:	[24],[40]			$ 0
Acquisition date	[24],[40]			Apr. 06, 2021
Shares | shares	[24],[40]			1,000				1,000
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, 8/19/2014, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	1,000,000
Investments, at fair value:	[3]	$ 0
Acquisition date	[3]	Aug. 19, 2014
Shares | shares	[3]	42				42
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Avalo Therapeutics, Inc., Equity, Acquisition Date 8/19/2014, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 1,000,000
Investments, at fair value:	[40]			$ 50,000
Acquisition date	[40]			Aug. 19, 2014
Shares | shares	[40]			9,924				9,924
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Aveo Pharmaceuticals, Inc., Equity, Acquisition Date 7/31/2011, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 1,715,000
Investments, at fair value:	[40]			$ 2,843,000
Acquisition date	[40]			Jul. 31, 2011
Shares | shares	[40]			190,179				190,179
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, 5/9/2022, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26],[31]	$ 4,165,000
Investments, at fair value:	[3],[26],[31]	$ 10,110,000
Acquisition date	[3],[26],[31]	May 09, 2022
Shares | shares	[3],[26],[31]	127,021				127,021
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Axsome Therapeutics, Inc., Equity, Acquisition Date 5/9/2022, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[19],[24],[40]			$ 4,165,000
Investments, at fair value:	[19],[24],[40]			$ 9,797,000
Acquisition date	[19],[24],[40]			May 09, 2022
Shares | shares	[19],[24],[40]			127,021				127,021
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, 10/5/2020, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26],[27]	$ 1,871,000
Investments, at fair value:	[3],[26],[27]	$ 1,774,000
Acquisition date	[3],[26],[27]	Oct. 05, 2020
Shares | shares	[3],[26],[27]	98,100				98,100
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Bicycle Therapeutics PLC, Equity, Acquisition Date 10/5/2020, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[25],[40]			$ 1,871,000
Investments, at fair value:	[24],[25],[40]			$ 2,904,000
Acquisition date	[24],[25],[40]			Oct. 05, 2020
Shares | shares	[24],[25],[40]			98,100				98,100
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, 6/21/2018, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 2,255,000
Investments, at fair value:	[3]	$ 9,339,000
Acquisition date	[3]	Jun. 21, 2018
Shares | shares	[3]	231,329				231,329
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Concert Pharmaceuticals, Inc., Equity, Acquisition Date 2/13/2019, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[40]			$ 1,367,000
Investments, at fair value:	[24],[40]			$ 413,000
Acquisition date	[24],[40]			Feb. 13, 2019
Shares | shares	[24],[40]			70,796				70,796
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Cyclo Therapeutics, Inc. (p.k.a. Applied Molecular Transport), Equity, 4/6/2021, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26]	$ 42,000
Investments, at fair value:	[3],[26]	$ 0
Acquisition date	[3],[26]	Apr. 06, 2021
Shares | shares	[3],[26]	134				134
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, 1/8/2015, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 1,000,000
Investments, at fair value:	[3]	$ 4,000
Acquisition date	[3]	Jan. 08, 2015
Shares | shares	[3]	13,550				13,550
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dare Biosciences, Inc., Equity, Acquisition Date 1/8/2015, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 1,000,000
Investments, at fair value:	[40]			$ 11,000
Acquisition date	[40]			Jan. 08, 2015
Shares | shares	[40]			13,550				13,550
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, 7/22/2015, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26]	$ 550,000
Investments, at fair value:	[3],[26]	$ 280,000
Acquisition date	[3],[26]	Jul. 22, 2015
Shares | shares	[3],[26]	20,000				20,000
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Dynavax Technologies, Equity, Acquisition Date 7/22/2015, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[40]			$ 550,000
Investments, at fair value:	[24],[40]			$ 213,000
Acquisition date	[24],[40]			Jul. 22, 2015
Shares | shares	[24],[40]			20,000				20,000
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, 10/26/2022, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 1,000,000
Investments, at fair value:	[3]	$ 903,000
Acquisition date	[3]	Oct. 26, 2022
Shares | shares	[3]	442,477				442,477
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Gritstone Bio, Inc., Equity, Acquisition Date 10/26/2022, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 1,000,000
Investments, at fair value:	[40]			$ 1,527,000
Acquisition date	[40]			Oct. 26, 2022
Shares | shares	[40]			442,477				442,477
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Heron Therapeutics, Inc., Equity, 7/25/2015, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 500,000
Investments, at fair value:	[3]	$ 620,000
Acquisition date	[3]	Jul. 25, 2023
Shares | shares	[3]	364,963				364,963
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, 5/7/2021, Preferred Series B
Summary of Investment Holdings
Investment cost	[1],[2]	$ 4,250,000
Investments, at fair value:	[1]	$ 1,834,000
Acquisition date	[1],[3]	May 07, 2021
Shares | shares	[1]	3,466,840				3,466,840
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Hibercell, Inc., Equity, Acquisition Date 5/7/2021, Series Preferred Series B
Summary of Investment Holdings
Investment cost	[6],[30]			$ 4,250,000
Investments, at fair value:	[30]			$ 2,233,000
Acquisition date	[30],[40]			May 07, 2021
Shares | shares	[30]			3,466,840				3,466,840
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc, Equity, Acquisition Date 5/3/2022, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 4,000,000
Investments, at fair value:	[40]			$ 3,937,000
Acquisition date	[40]			May 03, 2022
Shares | shares	[40]			235,295				235,295
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and HilleVax, Inc., Equity, 5/3/2022, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 4,000,000
Investments, at fair value:	[3]	$ 3,777,000
Acquisition date	[3]	May 03, 2022
Shares | shares	[3]	235,295				235,295
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, 3/31/2021, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26]	$ 800,000
Investments, at fair value:	[3],[26]	$ 0
Acquisition date	[3],[26]	Mar. 31, 2021
Shares | shares	[3],[26]	43,243				43,243
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Humanigen, Inc., Equity, Acquisition Date 3/31/2021, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[40]			$ 800,000
Investments, at fair value:	[24],[40]			$ 5,000
Acquisition date	[24],[40]			Mar. 31, 2021
Shares | shares	[24],[40]			43,243				43,243
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Kura Oncology, Inc., Equity, 6/16/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26]	$ 550,000
Investments, at fair value:	[3],[26]	$ 688,000
Acquisition date	[3],[26]	Jun. 16, 2023
Shares | shares	[3],[26]	47,826				47,826
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Equity, 9/29/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26]	$ 773,000
Investments, at fair value:	[3],[26]	$ 1,180,000
Acquisition date	[3],[26]	Sep. 29, 2023
Shares | shares	[3],[26]	5,100				5,100
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, 12/15/2021, Preferred Series C
Summary of Investment Holdings
Investment cost	[2],[26],[27]	$ 2,000,000
Investments, at fair value:	[26],[27]	$ 1,427,000
Acquisition date	[3],[26],[27]	Dec. 15, 2021
Shares | shares	[26],[27]	983				983
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and NorthSea Therapeutics, Equity, Acquisition Date 12/15/2021, Series Preferred Series C
Summary of Investment Holdings
Investment cost	[6],[24],[25]			$ 2,000,000
Investments, at fair value:	[24],[25]			$ 1,476,000
Acquisition date	[24],[25],[40]			Dec. 15, 2021
Shares | shares	[24],[25]			983				983
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Equity, Acquisition Date 2/26/2007, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 2,744,000
Investments, at fair value:	[40]			$ 143,000
Acquisition date	[40]			Feb. 26, 2007
Shares | shares	[40]			76,362				76,362
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Equity, 6/9/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26],[31]	$ 1,730,000
Investments, at fair value:	[3],[26],[31]	$ 1,344,000
Acquisition date	[3],[26],[31]	Jun. 09, 2023
Shares | shares	[3],[26],[31]	147,233				147,233
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, 8/22/2007, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 1,500,000
Investments, at fair value:	[3]	$ 28,000
Acquisition date	[3]	Aug. 22, 2007
Shares | shares	[3]	944				944
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Rocket Pharmaceuticals, Ltd., Equity, Acquisition Date 8/22/2007, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 1,500,000
Investments, at fair value:	[40]			$ 18,000
Acquisition date	[40]			Aug. 22, 2007
Shares | shares	[40]			944				944
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, 8/11/2015, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 203,000
Investments, at fair value:	[3]	$ 52,000
Acquisition date	[3]	Aug. 11, 2015
Shares | shares	[3]	11,119				11,119
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Savara, Inc., Equity, Acquisition Date 8/11/2015, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 203,000
Investments, at fair value:	[40]			$ 17,000
Acquisition date	[40]			Aug. 11, 2015
Shares | shares	[40]			11,119				11,119
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, 2/2/2017, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 1,269,000
Investments, at fair value:	[3]	$ 6,000
Acquisition date	[3]	Feb. 02, 2017
Shares | shares	[3]	16,228				16,228
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Sio Gene Therapies, Inc., Equity, Acquisition Date 2/2/2017, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 1,269,000
Investments, at fair value:	[40]			$ 7,000
Acquisition date	[40]			Feb. 02, 2017
Shares | shares	[40]			16,228				16,228
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, 5/5/2022, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26]	$ 2,100,000
Investments, at fair value:	[3],[26]	$ 3,150,000
Acquisition date	[3],[26]	May 05, 2022
Shares | shares	[3],[26]	155,555				155,555
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tarsus Pharmaceuticals, Inc., Equity, Acquisition Date 5/5/2022, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[40]			$ 2,100,000
Investments, at fair value:	[24],[40]			$ 2,280,000
Acquisition date	[24],[40]			May 05, 2022
Shares | shares	[24],[40]			155,555				155,555
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Total Valo Health, LLC
Summary of Investment Holdings
Investment cost	[2]	$ 4,000,000
Investments, at fair value:		$ 4,098,000
Shares | shares		680,410				680,410
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Tricida, Inc., Equity, Acquisition Date 2/28/2018, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 863,000
Investments, at fair value:	[40]			$ 11,000
Acquisition date	[40]			Feb. 28, 2018
Shares | shares	[40]			68,816				68,816
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, 12/11/2020, Preferred Series B
Summary of Investment Holdings
Investment cost	[2]	$ 3,000,000
Investments, at fair value:		$ 2,911,000
Acquisition date	[3]	Dec. 11, 2020
Shares | shares		510,308				510,308
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 10/31/2022, Series Preferred Series C
Summary of Investment Holdings
Investment cost	[6]			$ 1,000,000
Investments, at fair value:				$ 1,012,000
Acquisition date	[40]			Oct. 31, 2022
Shares | shares				170,102				170,102
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC, Equity, Acquisition Date 12/11/2020, Series Preferred Series B
Summary of Investment Holdings
Investment cost	[6]			$ 3,000,000
Investments, at fair value:				$ 2,063,000
Acquisition date	[40]			Dec. 11, 2020
Shares | shares				510,308				510,308
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Valo Health, LLC., Equity, 10/31/2022, Preferred Series C
Summary of Investment Holdings
Investment cost	[2]	$ 1,000,000
Investments, at fair value:		$ 1,187,000
Acquisition date	[3]	Oct. 31, 2022
Shares | shares		170,102				170,102
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Verge Analytics, Inc., Equity, 9/6/2023, Preferred Series C
Summary of Investment Holdings
Investment cost	[2]	$ 1,500,000
Investments, at fair value:		$ 1,753,000
Acquisition date	[3]	Sep. 06, 2023
Shares | shares		208,588				208,588
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and Viridian Therapeutics, Inc., Equity, 11/6/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26]	$ 400,000
Investments, at fair value:	[3],[26]	$ 704,000
Acquisition date	[3],[26]	Nov. 06, 2023
Shares | shares	[3],[26]	32,310				32,310
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, 11/26/2019, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 2,945,000
Investments, at fair value:	[3]	$ 1,313,000
Acquisition date	[3]	Nov. 26, 2019
Shares | shares	[3]	1,566,064				1,566,064
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and X4 Pharmaceuticals, Inc., Equity, Acquisition Date 11/26/2019, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 2,945,000
Investments, at fair value:	[40]			$ 1,555,000
Acquisition date	[40]			Nov. 26, 2019
Shares | shares	[40]			1,566,064				1,566,064
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, 1/31/2019, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26],[27]	$ 332,000
Investments, at fair value:	[3],[26],[27]	$ 116,000
Acquisition date	[3],[26],[27]	Jan. 31, 2019
Shares | shares	[3],[26],[27]	17,175				17,175
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development and uniQure B.V., Equity, Acquisition Date 1/31/2019, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[19],[24],[25],[40]			$ 332,000
Investments, at fair value:	[19],[24],[25],[40]			$ 389,000
Acquisition date	[19],[24],[25],[40]			Jan. 31, 2019
Shares | shares	[19],[24],[25],[40]			17,175				17,175
Investment, Identifier [Axis]: Equity Investments Drug Discovery & Development, Valo Health LLC
Summary of Investment Holdings
Investment cost	[6]			$ 4,000,000
Investments, at fair value:				$ 3,075,000
Shares | shares				680,410				680,410
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.05%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.05%				0.05%
Investment cost	[2]	$ 2,150,000
Investments, at fair value:		951,000
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware (0.11%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.11%				0.11%
Investment cost	[6]			$ 2,150,000
Investments, at fair value:				1,521,000
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Locus Robotics Corp., Equity, Acquisition Date 11/17/2022, Series Preferred Series F
Summary of Investment Holdings
Investment cost		650,000	[2]	650,000	[6]
Investments, at fair value:		$ 407,000		$ 606,000
Acquisition date		Nov. 17, 2022	[3]	Nov. 17, 2022	[40]
Shares | shares		15,116		15,116		15,116		15,116
Investment, Identifier [Axis]: Equity Investments Electronics & Computer Hardware and Skydio, Inc., Equity, Acquisition Date 3/8/2022, Series Preferred Series E
Summary of Investment Holdings
Investment cost		$ 1,500,000	[2]	$ 1,500,000	[6]
Investments, at fair value:		$ 544,000		$ 915,000
Acquisition date		Mar. 08, 2022	[3]	Mar. 08, 2022	[40]
Shares | shares		248,900		248,900		248,900		248,900
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.05%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.05%				0.05%
Investment cost	[2]	$ 6,782,000
Investments, at fair value:		960,000
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other (0.21%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.21%				0.21%
Investment cost	[6]			$ 6,781,000
Investments, at fair value:				2,894,000
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and 23andMe, Inc., Equity, Acquisition Date 3/11/2019, Series Common Stock
Summary of Investment Holdings
Investment cost		5,094,000	[2],[3]	5,094,000	[6],[40]
Investments, at fair value:		$ 754,000	[3]	$ 1,784,000	[40]
Acquisition date		Mar. 11, 2019	[3]	Mar. 11, 2019	[40]
Shares | shares		825,732	[3]	825,732	[40]	825,732	[3]	825,732	[40]
Investment, Identifier [Axis]: Equity Investments Healthcare Services, Other and Carbon Health Technologies, Inc., Equity, Acquisition Date 3/30/2021, Series Preferred Series C
Summary of Investment Holdings
Investment cost		$ 1,688,000	[2]	$ 1,687,000	[6]
Investments, at fair value:		$ 206,000		$ 1,110,000
Acquisition date		Mar. 30, 2021	[3]	Mar. 30, 2021	[40]
Shares | shares		217,880		217,880		217,880		217,880
Investment, Identifier [Axis]: Equity Investments Information Services (0.35%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.35%				0.35%
Investment cost	[2]	$ 4,440,000
Investments, at fair value:		6,243,000
Investment, Identifier [Axis]: Equity Investments Information Services (0.58%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.58%				0.58%
Investment cost	[6]			$ 4,440,000
Investments, at fair value:				8,175,000
Investment, Identifier [Axis]: Equity Investments Information Services and Planet Labs, Inc., Equity, Acquisition Date 6/21/2019, Series Common Stock
Summary of Investment Holdings
Investment cost		615,000	[2],[3]	615,000	[6],[40]
Investments, at fair value:		$ 1,353,000	[3]	$ 2,383,000	[40]
Acquisition date		Jun. 21, 2019	[3]	Jun. 21, 2019	[40]
Shares | shares		547,880	[3]	547,880	[40]	547,880	[3]	547,880	[40]
Investment, Identifier [Axis]: Equity Investments Information Services and Yipit, LLC, Equity, Acquisition Date 12/30/2021, Series Preferred Series E
Summary of Investment Holdings
Investment cost		$ 3,825,000	[2]	$ 3,825,000	[6]
Investments, at fair value:		$ 4,890,000		$ 3,375,000
Acquisition date		Dec. 30, 2021	[3]	Dec. 30, 2021	[40]
Shares | shares		41,021		41,021		41,021		41,021
Investment, Identifier [Axis]: Equity Investments Information Services and Zeta Global Corp., Equity, Acquisition Date 11/20/2007, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 0
Investments, at fair value:	[40]			$ 2,417,000
Acquisition date	[40]			Nov. 20, 2007
Shares | shares	[40]			295,861				295,861
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.01%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.01%				0.01%
Investment cost	[2]	$ 250,000
Investments, at fair value:		262,000
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment (0.07%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.07%				0.07%
Investment cost	[6]			$ 2,953,000
Investments, at fair value:				915,000
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Common Units
Summary of Investment Holdings
Investment cost		0	[2],[32]	0	[6],[34]
Investments, at fair value:		$ 2,000	[32]	$ 6,000	[34]
Acquisition date		Oct. 15, 2021	[3],[32]	Oct. 15, 2021	[34],[40]
Shares | shares		180,000	[32]	180,000	[34]	180,000	[32]	180,000	[34]
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Summary of Investment Holdings
Investment cost	[2],[32]	$ 250,000
Investments, at fair value:	[32]	$ 260,000
Acquisition date	[3],[32]	Oct. 15, 2021
Shares | shares	[32]	5,000,000				5,000,000
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Flowonix Medical Incorporated, Equity, Acquisition Date 11/3/2014, Series Preferred Series AA
Summary of Investment Holdings
Investment cost	[6]			$ 1,499,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Nov. 03, 2014
Shares | shares				221,893				221,893
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and Gelesis, Inc., Equity, Acquisition Date 11/30/2009, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 871,000
Investments, at fair value:	[40]			$ 433,000
Acquisition date	[40]			Nov. 30, 2009
Shares | shares	[40]			1,490,700				1,490,700
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment and ViewRay, Inc., Equity, Acquisition Date 12/16/2013, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 333,000
Investments, at fair value:	[40]			$ 163,000
Acquisition date	[40]			Dec. 16, 2013
Shares | shares	[40]			36,457				36,457
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Coronado Aesthetics, LLC
Summary of Investment Holdings
Investment cost	[6]			$ 250,000
Investments, at fair value:				$ 319,000
Shares | shares				5,180,000				5,180,000
Investment, Identifier [Axis]: Equity Investments Medical Devices & Equipment, Total Coronado Aesthetics, LLC
Summary of Investment Holdings
Investment cost	[2]	$ 250,000
Investments, at fair value:		$ 262,000
Shares | shares		5,180,000				5,180,000
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.01%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.01%				0.01%
Investment cost	[6]			$ 160,000
Investments, at fair value:				205,000
Investment, Identifier [Axis]: Equity Investments Semiconductors (0.02%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.02%				0.02%
Investment cost	[2]	$ 160,000
Investments, at fair value:		394,000
Investment, Identifier [Axis]: Equity Investments Semiconductors and Achronix Semiconductor Corporation, Equity, Acquisition Date 7/1/2011, Series Preferred Series C
Summary of Investment Holdings
Investment cost		160,000	[2]	160,000	[6]
Investments, at fair value:		$ 394,000		$ 205,000
Acquisition date		Jul. 01, 2011	[3]	Jul. 01, 2011	[40]
Shares | shares		277,995		277,995		277,995		277,995
Investment, Identifier [Axis]: Equity Investments Software (1.27%)
Summary of Investment Holdings
Investment owned, percent of net assets		1.27%				1.27%
Investment cost	[2]	$ 23,210,000
Investments, at fair value:		22,919,000
Investment, Identifier [Axis]: Equity Investments Software (2.07%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			2.07%				2.07%
Investment cost	[6]			$ 32,498,000
Investments, at fair value:				28,966,000
Investment, Identifier [Axis]: Equity Investments Software and 3GTMS, LLC, Equity, Acquisition Date 8/9/2021, Series Common Stock
Summary of Investment Holdings
Investment cost		1,000,000	[2]	1,000,000	[6]
Investments, at fair value:		$ 863,000		$ 793,000
Acquisition date		Aug. 09, 2021	[3]	Aug. 09, 2021	[40]
Shares | shares		1,000,000		1,000,000		1,000,000		1,000,000
Investment, Identifier [Axis]: Equity Investments Software and Black Crow AI, Inc. affiliates, Equity, Acquisition Date 3/24/2021, Series Preferred Note
Summary of Investment Holdings
Investment cost		$ 2,406,000	[2],[41]	$ 3,000,000	[6],[42]
Investments, at fair value:		$ 2,406,000	[41]	$ 3,000,000	[42]
Acquisition date		Mar. 24, 2021	[3],[41]	Mar. 24, 2021	[40],[42]
Shares | shares		3	[41]	3	[42]	3	[41]	3	[42]
Investment, Identifier [Axis]: Equity Investments Software and CapLinked, Inc., Equity, Acquisition Date 10/26/2012, Series Preferred Series A-3
Summary of Investment Holdings
Investment cost		$ 51,000	[2]	$ 51,000	[6]
Investments, at fair value:		$ 0		$ 6,000
Acquisition date		Oct. 26, 2012	[3]	Oct. 26, 2012	[40]
Shares | shares		53,614		53,614		53,614		53,614
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 11/20/2018, Series Preferred Series D
Summary of Investment Holdings
Investment cost		$ 500,000	[2],[26],[27]	$ 500,000	[6],[24],[25]
Investments, at fair value:		$ 842,000	[26],[27]	$ 732,000	[24],[25]
Acquisition date		Nov. 20, 2018	[3],[26],[27]	Nov. 20, 2018	[24],[25],[40]
Shares | shares		108,500	[26],[27]	108,500	[24],[25]	108,500	[26],[27]	108,500	[24],[25]
Investment, Identifier [Axis]: Equity Investments Software and Contentful Global, Inc., Equity, Acquisition Date 12/22/2020, Series Preferred Series C
Summary of Investment Holdings
Investment cost		$ 138,000	[2],[26],[27]	$ 138,000	[6],[24],[25]
Investments, at fair value:		$ 303,000	[26],[27]	$ 258,000	[24],[25]
Acquisition date		Dec. 22, 2020	[3],[26],[27]	Dec. 22, 2020	[24],[25],[40]
Shares | shares		41,000	[26],[27]	41,000	[24],[25]	41,000	[26],[27]	41,000	[24],[25]
Investment, Identifier [Axis]: Equity Investments Software and Docker, Inc., Equity, Acquisition Date 11/29/2018, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 4,284,000	[2]	$ 4,284,000	[6]
Investments, at fair value:		$ 636,000		$ 503,000
Acquisition date		Nov. 29, 2018	[3]	Nov. 29, 2018	[40]
Shares | shares		20,000		20,000		20,000		20,000
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 10/22/2015, Series Preferred Series 2
Summary of Investment Holdings
Investment cost		$ 1,000,000	[2]	$ 1,000,000	[6]
Investments, at fair value:		$ 2,752,000		$ 1,764,000
Acquisition date		Oct. 22, 2015	[3]	Oct. 22, 2015	[40]
Shares | shares		458,841		458,841		458,841		458,841
Investment, Identifier [Axis]: Equity Investments Software and Druva Holdings, Inc., Equity, Acquisition Date 8/24/2017, Series Preferred Series 3
Summary of Investment Holdings
Investment cost		$ 300,000	[2]	$ 300,000	[6]
Investments, at fair value:		$ 587,000		$ 395,000
Acquisition date		Aug. 24, 2017	[3]	Aug. 24, 2017	[40]
Shares | shares		93,620		93,620		93,620		93,620
Investment, Identifier [Axis]: Equity Investments Software and HighRoads, Inc., Equity, Acquisition Date 1/18/2013, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 307,000	[2]	$ 307,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Jan. 18, 2013	[3]	Jan. 18, 2013	[40]
Shares | shares		190		190		190		190
Investment, Identifier [Axis]: Equity Investments Software and Leapwork ApS., Equity, Acquisition Date 8/25/2023, Series Preferred Series B2
Summary of Investment Holdings
Investment cost	[2],[26],[27]	$ 250,000
Investments, at fair value:	[26],[27]	$ 231,000
Acquisition date	[3],[26],[27]	Aug. 25, 2023
Shares | shares	[26],[27]	183,073				183,073
Investment, Identifier [Axis]: Equity Investments Software and Lightbend, Inc., Equity, Acquisition Date 12/4/2020, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 265,000	[2]	$ 265,000	[6]
Investments, at fair value:		$ 23,000		$ 24,000
Acquisition date		Dec. 04, 2020	[3]	Dec. 04, 2020	[40]
Shares | shares		38,461		38,461		38,461		38,461
Investment, Identifier [Axis]: Equity Investments Software and Nextdoor.com, Inc., Equity, Acquisition Date 8/1/2018, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 4,854,000	[2],[3]	$ 4,854,000	[6],[40]
Investments, at fair value:		$ 1,927,000	[3]	$ 2,100,000	[40]
Acquisition date		Aug. 01, 2018	[3]	Aug. 01, 2018	[40]
Shares | shares		1,019,255	[3]	1,019,255	[40]	1,019,255	[3]	1,019,255	[40]
Investment, Identifier [Axis]: Equity Investments Software and Palantir Technologies, Equity, Acquisition Date 9/23/2020, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 3,474,000	[2],[3]	$ 8,670,000	[6],[40]
Investments, at fair value:		$ 9,758,000	[3]	$ 9,106,000	[40]
Acquisition date		Sep. 23, 2020	[3]	Sep. 23, 2020	[40]
Shares | shares		568,337	[3]	1,418,337	[40]	568,337	[3]	1,418,337	[40]
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 11/25/2020, Series Preferred Series E
Summary of Investment Holdings
Investment cost		$ 2,000,000	[2]	$ 2,000,000	[6]
Investments, at fair value:		$ 1,721,000		$ 1,940,000
Acquisition date		Nov. 25, 2020	[3]	Nov. 25, 2020	[40]
Shares | shares		580,983		580,983		580,983		580,983
Investment, Identifier [Axis]: Equity Investments Software and SingleStore, Inc., Equity, Acquisition Date 8/12/2021, Series Preferred Series F
Summary of Investment Holdings
Investment cost		$ 280,000	[2]	$ 280,000	[6]
Investments, at fair value:		$ 196,000		$ 221,000
Acquisition date		Aug. 12, 2021	[3]	Aug. 12, 2021	[40]
Shares | shares		52,956		52,956		52,956		52,956
Investment, Identifier [Axis]: Equity Investments Software and Sprinklr, Inc., Equity, Acquisition Date 3/22/2017, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 3,748,000
Investments, at fair value:	[40]			$ 5,719,000
Acquisition date	[40]			Mar. 22, 2017
Shares | shares	[40]			700,000				700,000
Investment, Identifier [Axis]: Equity Investments Software and Verana Health, Inc., Equity, Acquisition Date 7/8/2021, Series Preferred Series E
Summary of Investment Holdings
Investment cost		$ 2,000,000	[2]	$ 2,000,000	[6]
Investments, at fair value:		$ 422,000		$ 1,023,000
Acquisition date		Jul. 08, 2021	[3]	Jul. 08, 2021	[40]
Shares | shares		952,562		952,562		952,562		952,562
Investment, Identifier [Axis]: Equity Investments Software and ZeroFox, Inc., Equity, Acquisition Date 5/7/2020, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 101,000	[2],[3]	$ 101,000	[6],[40],[43]
Investments, at fair value:		$ 252,000	[3]	$ 1,382,000	[40],[43]
Acquisition date		May 07, 2020	[3]	May 07, 2020	[40],[43]
Shares | shares		289,992	[3]	289,992	[40],[43]	289,992	[3]	289,992	[40],[43]
Investment, Identifier [Axis]: Equity Investments Software, Contentful Global, Inc.
Summary of Investment Holdings
Investment cost	[6]			$ 638,000
Investments, at fair value:				$ 990,000
Shares | shares				149,500				149,500
Investment, Identifier [Axis]: Equity Investments Software, Druva Holdings, Inc.
Summary of Investment Holdings
Investment cost	[6]			$ 1,300,000
Investments, at fair value:				$ 2,159,000
Shares | shares				552,461				552,461
Investment, Identifier [Axis]: Equity Investments Software, SingleStore, Inc.
Summary of Investment Holdings
Investment cost	[6]			$ 2,280,000
Investments, at fair value:				$ 2,161,000
Shares | shares				633,939				633,939
Investment, Identifier [Axis]: Equity Investments Software, Total Contentful Global, Inc.
Summary of Investment Holdings
Investment cost	[2]	$ 638,000
Investments, at fair value:		$ 1,145,000
Shares | shares		149,500				149,500
Investment, Identifier [Axis]: Equity Investments Software, Total Druva Holdings, Inc.
Summary of Investment Holdings
Investment cost	[2]	$ 1,300,000
Investments, at fair value:		$ 3,339,000
Shares | shares		552,461				552,461
Investment, Identifier [Axis]: Equity Investments Software, Total SingleStore, Inc.
Summary of Investment Holdings
Investment cost	[2]	$ 2,280,000
Investments, at fair value:		$ 1,917,000
Shares | shares		633,939				633,939
Investment, Identifier [Axis]: Equity Investments Surgical Devices (0.18%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.18%				0.18%
Investment cost	[6]			$ 2,479,000
Investments, at fair value:				2,546,000
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 1/18/2007, Series Preferred Series B
Summary of Investment Holdings
Investment cost	[6]			250,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Jan. 18, 2007
Shares | shares				219,298				219,298
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F
Summary of Investment Holdings
Investment cost	[6]			$ 118,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Dec. 18, 2018
Shares | shares				1,523,693				1,523,693
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 12/18/2018, Series Preferred Series F-1
Summary of Investment Holdings
Investment cost	[6]			$ 150,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Dec. 18, 2018
Shares | shares				2,418,125				2,418,125
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 2/8/2013, Series Preferred Series D
Summary of Investment Holdings
Investment cost	[6]			$ 712,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Feb. 08, 2013
Shares | shares				1,991,157				1,991,157
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 6/16/2010, Series Preferred Series C
Summary of Investment Holdings
Investment cost	[6]			$ 282,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Jun. 16, 2010
Shares | shares				656,538				656,538
Investment, Identifier [Axis]: Equity Investments Surgical Devices and Gynesonics, Inc., Equity, Acquisition Date 7/14/2015, Series Preferred Series E
Summary of Investment Holdings
Investment cost	[6]			$ 429,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Jul. 14, 2015
Shares | shares				2,786,367				2,786,367
Investment, Identifier [Axis]: Equity Investments Surgical Devices and TransMedics Group, Inc., Equity, Acquisition Date 11/7/2012, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 538,000
Investments, at fair value:	[40]			$ 2,546,000
Acquisition date	[40]			Nov. 07, 2012
Shares | shares	[40]			50,000				50,000
Investment, Identifier [Axis]: Equity Investments Surgical Devices, Gynesonics, Inc.
Summary of Investment Holdings
Investment cost	[6]			$ 1,941,000
Investments, at fair value:				$ 0
Shares | shares				9,595,178				9,595,178
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.22%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.22%				0.22%
Investment cost	[2]	$ 11,508,000
Investments, at fair value:		3,881,000
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology (0.57%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.57%				0.57%
Investment cost	[6]			$ 11,508,000
Investments, at fair value:				7,984,000
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Equity, Acquisition Date 9/13/2012, Series Preferred Series C-1
Summary of Investment Holdings
Investment cost		711,000	[2]	711,000	[6]
Investments, at fair value:		$ 529,000		$ 995,000
Acquisition date		Sep. 13, 2012	[3]	Sep. 13, 2012	[40]
Shares | shares		187,265		187,265		187,265		187,265
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Impossible Foods, Inc., Equity, Acquisition Date 5/10/2019, Series Preferred Series E-1
Summary of Investment Holdings
Investment cost		$ 2,000,000	[2]	$ 2,000,000	[6]
Investments, at fair value:		$ 479,000		$ 2,173,000
Acquisition date		May 10, 2019	[3]	May 10, 2019	[40]
Shares | shares		188,611		188,611		188,611		188,611
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Modumetal, Inc., Equity, Acquisition Date 6/1/2015, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 500,000	[2]	$ 500,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Jun. 01, 2015	[3]	Jun. 01, 2015	[40]
Shares | shares		1,035		1,035		1,035		1,035
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and NantEnergy, LLC, Equity, Acquisition Date 8/31/2013, Series Common Units
Summary of Investment Holdings
Investment cost		$ 102,000	[2]	$ 102,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Aug. 31, 2013	[3]	Aug. 31, 2013	[40]
Shares | shares		59,665		59,665		59,665		59,665
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pineapple Energy LLC, Equity, Acquisition Date 12/10/2020, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 3,153,000	[2],[3]	$ 3,153,000	[6],[40],[43]
Investments, at fair value:		$ 180,000	[3]	$ 634,000	[40],[43]
Acquisition date		Dec. 10, 2020	[3]	Dec. 10, 2020	[40],[43]
Shares | shares		304,487	[3]	304,486	[40],[43]	304,487	[3]	304,486	[40],[43]
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Pivot Bio, Inc., Equity, Acquisition Date 6/28/2021, Series Preferred Series D
Summary of Investment Holdings
Investment cost		$ 4,500,000	[2]	$ 4,500,000	[6]
Investments, at fair value:		$ 2,684,000		$ 2,456,000
Acquisition date		Jun. 28, 2021	[3]	Jun. 28, 2021	[40]
Shares | shares		593,080		593,080		593,080		593,080
Investment, Identifier [Axis]: Equity Investments Sustainable and Renewable Technology and Proterra, Inc., Equity, Acquisition Date 5/28/2015, Series Common Stock
Summary of Investment Holdings
Investment cost		$ 542,000	[2],[3]	$ 542,000	[6],[40]
Investments, at fair value:		$ 9,000	[3]	$ 1,726,000	[40]
Acquisition date		May 28, 2015	[3]	May 28, 2015	[40]
Shares | shares		457,841	[3]	457,841	[40]	457,841	[3]	457,841	[40]
Investment, Identifier [Axis]: Equity Investments and Drug Discovery & Development and BridgeBio Pharma, Inc., Equity, Acquisition Date 6/21/2018, Series Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 2,255,000
Investments, at fair value:	[40]			$ 1,763,000
Acquisition date	[40]			Jun. 21, 2018
Shares | shares	[40]			231,329				231,329
Investment, Identifier [Axis]: Equity Investments and Medical Devices & Equipment and Coronado Aesthetics, LLC, Equity, Acquisition Date 10/15/2021, Series Preferred Series A-2
Summary of Investment Holdings
Investment cost	[6],[34]			$ 250,000
Investments, at fair value:	[34]			$ 313,000
Acquisition date	[34],[40]			Oct. 15, 2021
Shares | shares	[34]			5,000,000				5,000,000
Investment, Identifier [Axis]: Investment Fund After Cash & Cash Equivalents (183.28%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	183.28%				183.28%
Investment cost	[2]	$ 3,303,033,000
Investments, at fair value:		3,304,046,000
Investment, Identifier [Axis]: Investment Fund Cash & Cash Equivalent and GS Financial Square Government Fund, FGTXX/38141W273
Summary of Investment Holdings
Investment cost	[2]	56,000,000
Investments, at fair value:		$ 56,000,000
Investment, Identifier [Axis]: Investment Fund In Cash & Cash Equivalents (3.11%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	3.11%				3.11%
Investment cost	[2]	$ 56,000,000
Investments, at fair value:		$ 56,000,000
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.26%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.26%				0.26%
Investment cost	[2]	$ 4,483,000
Investments, at fair value:		$ 4,608,000
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments (0.28%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.28%				0.28%
Investment cost	[6]			$ 3,499,000
Investments, at fair value:				$ 3,893,000
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.23%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.23%				0.23%
Investment cost	[2]	$ 4,102,000
Investments, at fair value:		4,230,000
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development (0.25%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.25%				0.25%
Investment cost	[6]			$ 3,118,000
Investments, at fair value:				3,518,000
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund I C.V., Investment Funds & Vehicles, Acquisition Date 11/16/2020
Summary of Investment Holdings
Investment cost		3,783,000	[2],[22],[26],[27]	2,699,000	[6],[7],[24],[25]
Investments, at fair value:		$ 3,619,000	[22],[26],[27]	$ 3,080,000	[7],[24],[25]
Acquisition date		Nov. 16, 2020	[3],[22],[26],[27]	Nov. 16, 2020	[7],[24],[25],[40]
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Drug Discovery & Development and Forbion Growth Opportunities Fund II C.V., Investment Funds & Vehicles, Acquisition Date 6/23/2022
Summary of Investment Holdings
Investment cost		$ 319,000	[2],[22],[26],[27]	$ 419,000	[6],[7],[24],[25]
Investments, at fair value:		$ 611,000	[22],[26],[27]	$ 438,000	[7],[24],[25]
Acquisition date		Jun. 23, 2022	[3],[22],[26],[27]	Jun. 23, 2022	[7],[24],[25],[40]
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.02%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.02%				0.02%
Investment cost	[2]	$ 381,000
Investments, at fair value:		378,000
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software (0.03%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.03%				0.03%
Investment cost	[6]			$ 381,000
Investments, at fair value:				375,000
Investment, Identifier [Axis]: Investment Funds & Vehicles Investments and Software and Liberty Zim Co-Invest L.P., Investment Funds & Vehicles, Acquisition Date 7/21/2022
Summary of Investment Holdings
Investment cost		381,000	[2],[26],[27]	381,000	[6],[24],[25]
Investments, at fair value:		$ 378,000	[26],[27]	$ 375,000	[24],[25]
Acquisition date		Jul. 21, 2022	[3],[26],[27]	Jul. 21, 2022	[24],[25],[40]
Investment, Identifier [Axis]: Investments (180.18%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	180.18%				180.18%
Investment cost	[2]	$ 3,247,033,000
Investments, at fair value:		$ 3,248,046,000
Investment, Identifier [Axis]: Investments (211.49%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			211.49%				211.49%
Investment cost	[6]			$ 3,005,696,000
Investments, at fair value:				$ 2,963,955,000
Investment, Identifier [Axis]: Investments in Securities (179.92%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	179.92%				179.92%
Investment cost	[2]	$ 3,242,550,000
Investments, at fair value:		$ 3,243,438,000
Investment, Identifier [Axis]: Investments in Securities (211.21%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			211.21%				211.21%
Investment cost	[6]			$ 3,002,197,000
Investments, at fair value:				$ 2,960,062,000
Investment, Identifier [Axis]: Warrant Investments (1.88%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	1.88%				1.88%
Investment cost	[2]	$ 28,954,000
Investments, at fair value:		$ 33,969,000
Investment, Identifier [Axis]: Warrant Investments (2.19%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			2.19%				2.19%
Investment cost	[6]			$ 30,964,000
Investments, at fair value:				$ 30,646,000
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.02%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.02%				0.02%
Investment cost	[2]	$ 496,000
Investments, at fair value:		354,000
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools (0.03%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.03%				0.03%
Investment cost	[6]			$ 485,000
Investments, at fair value:				486,000
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and Alamar Biosciences, Inc., Warrant, Acquisition Date 6/21/2022, Preferred Series B
Summary of Investment Holdings
Investment cost		36,000	[2]	24,000	[6]
Investments, at fair value:		$ 20,000		$ 23,000
Acquisition date		Jun. 21, 2022	[3]	Jun. 21, 2022	[40]
Shares | shares		46,197		15,399		46,197		15,399
Investment, Identifier [Axis]: Warrant Investments and Biotechnology Tools and PathAI, Inc., Warrant, Acquisition Date 12/23/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 460,000	[2],[12]	$ 461,000	[6]
Investments, at fair value:		$ 334,000	[12]	$ 463,000
Acquisition date		Dec. 23, 2022	[3],[12]	Dec. 23, 2022	[40]
Shares | shares		53,418	[12]	53,418		53,418	[12]	53,418
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking (0.01%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.01%		0.01%	[5]	0.01%		0.01%	[5]
Investment cost		$ 123,000	[2]	$ 541,000	[6]
Investments, at fair value:		128,000		99,000
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Aryaka Networks, Inc., Warrant, Acquisition Date 6/28/2022, Common Stock
Summary of Investment Holdings
Investment cost		123,000	[2],[12]	123,000	[6]
Investments, at fair value:		$ 128,000	[12]	$ 99,000
Acquisition date		Jun. 28, 2022	[3],[12]	Jun. 28, 2022	[40]
Shares | shares		229,611	[12]	229,611		229,611	[12]	229,611
Investment, Identifier [Axis]: Warrant Investments and Communications & Networking and Spring Mobile Solutions, Inc., Warrant, Acquisition Date 4/19/2013, Common Stock
Summary of Investment Holdings
Investment cost	[6]			$ 418,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Apr. 19, 2013
Shares | shares				2,834,375				2,834,375
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.02%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.02%				0.02%
Investment cost	[2]	$ 611,000
Investments, at fair value:		325,000
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products (0.17%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.17%				0.17%
Investment cost	[6]			$ 1,712,000
Investments, at fair value:				2,323,000
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Gadget Guard, LLC, Warrant, Acquisition Date 6/3/2014, Common Stock
Summary of Investment Holdings
Investment cost		228,000	[2]	228,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Jun. 03, 2014	[3]	Jun. 03, 2014	[40]
Shares | shares		1,662,441		1,662,441		1,662,441		1,662,441
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Savage X Holding, LLC, Warrant, Acquisition Date 6/27/2014, Class A Units
Summary of Investment Holdings
Investment cost	[6]			$ 0
Investments, at fair value:				$ 1,103,000
Acquisition date	[40]			Jun. 27, 2014
Shares | shares				206,185				206,185
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and TFG Holding, Inc., Warrant, Acquisition Date 6/27/2014, Common Stock
Summary of Investment Holdings
Investment cost	[6]			$ 0
Investments, at fair value:				$ 0
Acquisition date	[40]			Jun. 27, 2014
Shares | shares				206,185				206,185
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and TechStyle, Inc., Warrant, Acquisition Date 7/16/2013, Preferred Series B
Summary of Investment Holdings
Investment cost	[6]			$ 1,101,000
Investments, at fair value:				$ 745,000
Acquisition date	[40]			Jul. 16, 2013
Shares | shares				206,185				206,185
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and The Neat Company, Warrant, Acquisition Date 8/13/2014, Common Stock
Summary of Investment Holdings
Investment cost		$ 365,000	[2]	$ 365,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Aug. 13, 2014	[3]	Aug. 13, 2014	[40]
Shares | shares		54,054		54,054		54,054		54,054
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Products and Whoop, Inc., Warrant, Acquisition Date 6/27/2018, Preferred Series C
Summary of Investment Holdings
Investment cost		$ 18,000	[2]	$ 18,000	[6]
Investments, at fair value:		$ 325,000		$ 475,000
Acquisition date		Jun. 27, 2018	[3]	Jun. 27, 2018	[40]
Shares | shares		686,270		686,270		686,270		686,270
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.19%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.19%				0.19%
Investment cost	[6]			$ 4,248,000
Investments, at fair value:				2,639,000
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services (0.23%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.23%				0.23%
Investment cost	[2]	$ 4,208,000
Investments, at fair value:		4,217,000
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Carwow LTD, Warrant, Acquisition Date 12/14/2021, Common Stock
Summary of Investment Holdings
Investment cost		164,000	[2],[26],[27]	164,000	[6],[24],[25]
Investments, at fair value:		$ 75,000	[26],[27]	$ 34,000	[24],[25]
Acquisition date		Dec. 14, 2021	[3],[26],[27]	Dec. 14, 2021	[24],[25],[40]
Shares | shares		174,163	[26],[27]	174,163	[24],[25]	174,163	[26],[27]	174,163	[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Houzz, Inc., Warrant, Acquisition Date 10/29/2019, Common Stock
Summary of Investment Holdings
Investment cost		$ 20,000	[2]	$ 20,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Oct. 29, 2019	[3]	Oct. 29, 2019	[40]
Shares | shares		529,661		529,661		529,661		529,661
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Landing Holdings Inc., Warrant, Acquisition Date 3/12/2021, Common Stock
Summary of Investment Holdings
Investment cost		$ 116,000	[1],[2]	$ 116,000	[6],[30]
Investments, at fair value:		$ 298,000	[1]	$ 127,000	[30]
Acquisition date		Mar. 12, 2021	[1],[3]	Mar. 12, 2021	[30],[40]
Shares | shares		11,806	[1]	11,806	[30]	11,806	[1]	11,806	[30]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Lendio, Inc., Warrant, Acquisition Date 3/29/2019, Preferred Series D
Summary of Investment Holdings
Investment cost		$ 39,000	[2]	$ 39,000	[6]
Investments, at fair value:		$ 33,000		$ 19,000
Acquisition date		Mar. 29, 2019	[3]	Mar. 29, 2019	[40]
Shares | shares		127,032		127,032		127,032		127,032
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Plentific Ltd, Warrant, Acquisition Date 10/3/2023, Ordinary shares
Summary of Investment Holdings
Investment cost	[2],[26],[27]	$ 48,000
Investments, at fair value:	[26],[27]	$ 51,000
Acquisition date	[3],[26],[27]	Oct. 03, 2023
Shares | shares	[26],[27]	19,499				19,499
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Provi, Warrant, Acquisition Date 12/22/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 166,000	[1],[2]	$ 166,000	[6],[30]
Investments, at fair value:		$ 74,000	[1]	$ 155,000	[30]
Acquisition date		Dec. 22, 2022	[1],[3]	Dec. 22, 2022	[30],[40]
Shares | shares		117,042	[1]	117,042	[30]	117,042	[1]	117,042	[30]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Rhino Labs, Inc., Warrant, Acquisition Date 3/12/2021, Common Stock
Summary of Investment Holdings
Investment cost		$ 470,000	[1],[2]	$ 470,000	[6],[30]
Investments, at fair value:		$ 4,000	[1]	$ 308,000	[30]
Acquisition date		Mar. 12, 2021	[1],[3]	Mar. 12, 2021	[30],[40]
Shares | shares		13,106	[1]	13,106	[30]	13,106	[1]	13,106	[30]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and RumbleON, Inc., Warrant, Acquisition Date 4/30/2018, Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 88,000
Investments, at fair value:	[40]			$ 0
Acquisition date	[40]			Apr. 30, 2018
Shares | shares	[40]			5,139				5,139
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and SeatGeek, Inc., Warrant, Acquisition Date 6/12/2019, Common Stock
Summary of Investment Holdings
Investment cost		$ 842,000	[2],[31]	$ 842,000	[6],[18],[19]
Investments, at fair value:		$ 3,065,000	[31]	$ 1,332,000	[18],[19]
Acquisition date		Jun. 12, 2019	[3],[31]	Jun. 12, 2019	[18],[19],[40]
Shares | shares		1,379,761	[31]	1,379,761	[18],[19]	1,379,761	[31]	1,379,761	[18],[19]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc.
Summary of Investment Holdings
Investment cost	[6]			$ 140,000
Investments, at fair value:				$ 43,000
Shares | shares				2,051,587				2,051,587
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 11/14/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 57,000	[2]	$ 57,000	[6]
Investments, at fair value:		$ 58,000		$ 43,000
Acquisition date		Nov. 14, 2022	[3]	Nov. 14, 2022	[40]
Shares | shares		1,607,143		1,607,143		1,607,143		1,607,143
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Skyword, Inc., Warrant, Acquisition Date 8/23/2019, Preferred Series B
Summary of Investment Holdings
Investment cost		$ 83,000	[2]	$ 83,000	[6]
Investments, at fair value:		$ 5,000		$ 0
Acquisition date		Aug. 23, 2019	[3]	Aug. 23, 2019	[40]
Shares | shares		444,444		444,444		444,444		444,444
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc.
Summary of Investment Holdings
Investment cost	[6]			$ 860,000
Investments, at fair value:				$ 118,000
Shares | shares				3,611,537				3,611,537
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 4/20/2020, Common Stock
Summary of Investment Holdings
Investment cost		$ 16,000	[2]	$ 16,000	[6]
Investments, at fair value:		$ 0		$ 43,000
Acquisition date		Apr. 20, 2020	[3]	Apr. 20, 2020	[40]
Shares | shares		600,000		600,000		600,000		600,000
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 6/30/2016, Preferred Series A
Summary of Investment Holdings
Investment cost		$ 782,000	[2]	$ 782,000	[6]
Investments, at fair value:		$ 0		$ 50,000
Acquisition date		Jun. 30, 2016	[3]	Jun. 30, 2016	[40]
Shares | shares		1,800,000		1,800,000		1,800,000		1,800,000
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Snagajob.com, Inc., Warrant, Acquisition Date 8/1/2018, Preferred Series B
Summary of Investment Holdings
Investment cost		$ 62,000	[2]	$ 62,000	[6]
Investments, at fair value:		$ 0		$ 25,000
Acquisition date		Aug. 01, 2018	[3]	Aug. 01, 2018	[40]
Shares | shares		1,211,537		1,211,537		1,211,537		1,211,537
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Thumbtack, Inc., Warrant, Acquisition Date 5/1/2018, Common Stock
Summary of Investment Holdings
Investment cost		$ 844,000	[2],[12]	$ 844,000	[6],[18]
Investments, at fair value:		$ 515,000	[12]	$ 280,000	[18]
Acquisition date		May 01, 2018	[3],[12]	May 01, 2018	[18],[40]
Shares | shares		267,225	[12]	267,225	[18]	267,225	[12]	267,225	[18]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Skyword, Inc.
Summary of Investment Holdings
Investment cost	[2]	$ 140,000
Investments, at fair value:		$ 63,000
Shares | shares		2,051,587				2,051,587
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Snagajob.com, Inc.
Summary of Investment Holdings
Investment cost	[2]	$ 860,000
Investments, at fair value:		$ 0
Shares | shares		3,611,537				3,611,537
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Total Worldremit Group Limited
Summary of Investment Holdings
Investment cost	[2]	$ 155,000
Investments, at fair value:		$ 23,000
Shares | shares		79,083				79,083
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Udacity, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock
Summary of Investment Holdings
Investment cost		$ 218,000	[2],[12]	$ 218,000	[6],[18]
Investments, at fair value:		$ 0	[12]	$ 4,000	[18]
Acquisition date		Sep. 25, 2020	[3],[12]	Sep. 25, 2020	[18],[40]
Shares | shares		486,359	[12]	486,359	[18]	486,359	[12]	486,359	[18]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Veem, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 126,000	[2],[12]	$ 126,000	[6]
Investments, at fair value:		$ 16,000	[12]	$ 25,000
Acquisition date		Mar. 31, 2022	[3],[12]	Mar. 31, 2022	[40]
Shares | shares		98,428	[12]	98,428		98,428	[12]	98,428
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited
Summary of Investment Holdings
Investment cost	[6]			$ 155,000
Investments, at fair value:				$ 194,000
Shares | shares				79,083				79,083
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 2/11/2021, Preferred Series D
Summary of Investment Holdings
Investment cost		$ 129,000	[2],[12],[26],[27],[31]	$ 129,000	[6],[18],[19],[24],[25]
Investments, at fair value:		$ 23,000	[12],[26],[27],[31]	$ 192,000	[18],[19],[24],[25]
Acquisition date		Feb. 11, 2021	[3],[12],[26],[27],[31]	Feb. 11, 2021	[18],[19],[24],[25],[40]
Shares | shares		77,215	[12],[26],[27],[31]	77,215	[18],[19],[24],[25]	77,215	[12],[26],[27],[31]	77,215	[18],[19],[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Consumer & Business Services and Worldremit Group Limited, Warrant, Acquisition Date 8/27/2021, Preferred Series E
Summary of Investment Holdings
Investment cost		$ 26,000	[2],[26],[27],[31]	$ 26,000	[6],[24],[25]
Investments, at fair value:		$ 0	[26],[27],[31]	$ 2,000	[24],[25]
Acquisition date		Aug. 27, 2021	[3],[26],[27],[31]	Aug. 27, 2021	[24],[25],[40]
Shares | shares		1,868	[26],[27],[31]	1,868	[24],[25]	1,868	[26],[27],[31]	1,868	[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services (0.03%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.03%				0.03%
Investment cost	[2]	$ 214,000
Investments, at fair value:		554,000
Investment, Identifier [Axis]: Warrant Investments and Diversified Financial Services and Next Insurance, Inc., Warrant, Acquisition Date 2/3/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2]	214,000
Investments, at fair value:		$ 554,000
Acquisition date	[3]	Feb. 03, 2023
Shares | shares		522,930				522,930
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery (0.00%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.00%	[4]	0.00%	[5]	0.00%	[4]	0.00%	[5]
Investment cost		$ 392,000	[2]	$ 465,000	[6]
Investments, at fair value:		0		1,000
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 6/1/2016, Common Stock
Summary of Investment Holdings
Investment cost	[2]	0
Investments, at fair value:		$ 0
Acquisition date	[3]	Jun. 01, 2016
Shares | shares		67,069				67,069
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and Aerami Therapeutics Holdings, Inc., Warrant, Acquisition Date 9/30/2015, Common Stock
Summary of Investment Holdings
Investment cost	[6]			74,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Sep. 30, 2015
Shares | shares				110,882				110,882
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and BioQ Pharma Incorporated, Warrant, Acquisition Date 10/27/2014, Common Stock
Summary of Investment Holdings
Investment cost		$ 2,000	[2]	$ 1,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Oct. 27, 2014	[3]	Oct. 27, 2014	[40]
Shares | shares		459,183		459,183		459,183		459,183
Investment, Identifier [Axis]: Warrant Investments and Drug Delivery and PDS Biotechnology Corporation, Warrant, Acquisition Date 8/28/2014, Common Stock
Summary of Investment Holdings
Investment cost		$ 390,000	[2],[3]	$ 390,000	[6],[40]
Investments, at fair value:		$ 0	[3]	$ 1,000	[40]
Acquisition date		Aug. 28, 2014	[3]	Aug. 28, 2014	[40]
Shares | shares		3,929	[3]	3,929	[40]	3,929	[3]	3,929	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.46%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.46%				0.46%
Investment cost	[2]	$ 7,517,000
Investments, at fair value:		8,302,000
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development (0.60%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.60%				0.60%
Investment cost	[6]			$ 7,466,000
Investments, at fair value:				8,444,000
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and ADMA Biologics, Inc., Warrant, Acquisition Date 2/24/2014, Common Stock
Summary of Investment Holdings
Investment cost		166,000	[2],[3]	166,000	[6],[40]
Investments, at fair value:		$ 11,000	[3]	$ 10,000	[40]
Acquisition date		Feb. 24, 2014	[3]	Feb. 24, 2014	[40]
Shares | shares		58,000	[3]	58,000	[40]	58,000	[3]	58,000	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Acacia Pharma Inc., Warrant, Acquisition Date 6/29/2018, Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[25]			$ 304,000
Investments, at fair value:	[24],[25]			$ 0
Acquisition date	[24],[25],[40]			Jun. 29, 2018
Shares | shares	[24],[25]			201,330				201,330
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Akero Therapeutics, Inc., Warrant, Acquisition Date 6/15/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 175,000	[2],[3],[26]	$ 56,000	[6],[24],[40]
Investments, at fair value:		$ 335,000	[3],[26]	$ 674,000	[24],[40]
Acquisition date		Jun. 15, 2022	[3],[26]	Jun. 15, 2022	[24],[40]
Shares | shares		22,949	[3],[26]	18,360	[24],[40]	22,949	[3],[26]	18,360	[24],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Albireo Pharma, Inc., Warrant, Acquisition Date 6/8/2020, Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[40]			$ 61,000
Investments, at fair value:	[24],[40]			$ 31,000
Acquisition date	[24],[40]			Jun. 08, 2020
Shares | shares	[24],[40]			5,311				5,311
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and AmplifyBio, LLC, Warrant, Acquisition Date 12/27/2022, Class A Units
Summary of Investment Holdings
Investment cost	[6],[30]			$ 238,000
Investments, at fair value:	[30]			$ 256,000
Acquisition date	[30],[40]			Dec. 27, 2022
Shares | shares	[30]			69,239				69,239
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Axsome Therapeutics, Inc., Warrant, Acquisition Date 9/25/2020, Common Stock
Summary of Investment Holdings
Investment cost		$ 1,290,000	[2],[3],[12],[26],[31]	$ 880,000	[6],[18],[19],[24],[40]
Investments, at fair value:		$ 1,657,000	[3],[12],[26],[31]	$ 1,590,000	[18],[19],[24],[40]
Acquisition date		Sep. 25, 2020	[3],[12],[26],[31]	Sep. 25, 2020	[18],[19],[24],[40]
Shares | shares		61,004	[3],[12],[26],[31]	40,396	[18],[19],[24],[40]	61,004	[3],[12],[26],[31]	40,396	[18],[19],[24],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and COMPASS Pathways plc, Warrant, Acquisition Date 6/30/2023, Ordinary Shares
Summary of Investment Holdings
Investment cost	[2],[3],[26],[27]	$ 278,000
Investments, at fair value:	[3],[26],[27]	$ 285,000
Acquisition date	[3],[26],[27]	Jun. 30, 2023
Shares | shares	[3],[26],[27]	75,376				75,376
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Cellarity, Inc., Warrant, Acquisition Date 12/8/2021, Preferred Series B
Summary of Investment Holdings
Investment cost		$ 287,000	[1],[2]	$ 287,000	[6],[30]
Investments, at fair value:		$ 201,000	[1]	$ 318,000	[30]
Acquisition date		Dec. 08, 2021	[1],[3]	Dec. 08, 2021	[30],[40]
Shares | shares		100,000	[1]	100,000	[30]	100,000	[1]	100,000	[30]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Century Therapeutics, Inc., Warrant, Acquisition Date 9/14/2020, Common Stock
Summary of Investment Holdings
Investment cost		$ 37,000	[2],[3]	$ 37,000	[6],[40]
Investments, at fair value:		$ 1,000	[3]	$ 3,000	[40]
Acquisition date		Sep. 14, 2020	[3]	Sep. 14, 2020	[40]
Shares | shares		16,112	[3]	16,112	[40]	16,112	[3]	16,112	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Curevo, Inc., Warrant, Acquisition Date 6/9/2023, Common Stock
Summary of Investment Holdings
Investment cost	[1],[2]	$ 233,000
Investments, at fair value:	[1]	$ 251,000
Acquisition date	[1],[3]	Jun. 09, 2023
Shares | shares	[1]	95,221				95,221
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Dermavant Sciences Ltd., Warrant, Acquisition Date 5/31/2019, Common Stock
Summary of Investment Holdings
Investment cost		$ 101,000	[2],[26],[27]	$ 101,000	[6],[24],[25]
Investments, at fair value:		$ 7,000	[26],[27]	$ 199,000	[24],[25]
Acquisition date		May 31, 2019	[3],[26],[27]	May 31, 2019	[24],[25],[40]
Shares | shares		223,642	[26],[27]	223,642	[24],[25]	223,642	[26],[27]	223,642	[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Evofem Biosciences, Inc., Warrant, Acquisition Date 6/11/2014, Common Stock
Summary of Investment Holdings
Investment cost		$ 266,000	[2],[3]	$ 266,000	[6],[40]
Investments, at fair value:		$ 0	[3]	$ 0	[40]
Acquisition date		Jun. 11, 2014	[3]	Jun. 11, 2014	[40]
Shares | shares		3	[3]	520	[40]	3	[3]	520	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Fresh Tracks Therapeutics, Inc. (p.k.a. Brickell Biotech, Inc.), Warrant, Acquisition Date 2/18/2016, Common Stock
Summary of Investment Holdings
Investment cost		$ 119,000	[2],[3]	$ 119,000	[6],[40]
Investments, at fair value:		$ 0	[3]	$ 0	[40]
Acquisition date		Feb. 18, 2016	[3]	Feb. 18, 2016	[40]
Shares | shares		201	[3]	200	[40]	201	[3]	200	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Heron Therapeutics, Inc., Warrant, Acquisition Date 8/9/2023, Common Stock
Summary of Investment Holdings
Investment cost	[1],[2],[3]	$ 228,000
Investments, at fair value:	[1],[3]	$ 223,000
Acquisition date	[1],[3]	Aug. 09, 2023
Shares | shares	[1],[3]	238,095				238,095
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kineta, Inc., Warrant, Acquisition Date 12/20/2019, Common Stock
Summary of Investment Holdings
Investment cost		$ 110,000	[2],[3]	$ 110,000	[6],[40]
Investments, at fair value:		$ 0	[3]	$ 0	[40]
Acquisition date		Dec. 20, 2019	[3]	Dec. 20, 2019	[40]
Shares | shares		2,202	[3]	2,202	[40]	2,202	[3]	2,202	[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Kura Oncology, Inc., Warrant, Acquisition Date 11/2/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 88,000	[1],[2],[3],[26]	$ 88,000	[24],[30],[40]
Investments, at fair value:		$ 63,000	[1],[3],[26]	$ 59,000	[24],[30],[40]
Acquisition date		Nov. 02, 2022	[1],[3],[26]	Nov. 02, 2022	[24],[30],[40]
Shares | shares		14,342	[1],[3],[26]	14,342	[24],[30],[40]	14,342	[1],[3],[26]	14,342	[24],[30],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Madrigal Pharmaceutical, Inc., Warrant, Acquisition Date 5/9/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 570,000	[2],[3],[26]	$ 177,000	[6],[24],[40]
Investments, at fair value:		$ 1,842,000	[3],[26]	$ 1,977,000	[24],[40]
Acquisition date		May 09, 2022	[3],[26]	May 09, 2022	[24],[40]
Shares | shares		13,229	[3],[26]	10,131	[24],[40]	13,229	[3],[26]	10,131	[24],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Myovant Sciences, Ltd., Warrant, Acquisition Date 10/16/2017, Common Stock
Summary of Investment Holdings
Investment cost	[6],[24],[25],[40]			$ 460,000
Investments, at fair value:	[24],[25],[40]			$ 958,000
Acquisition date	[24],[25],[40]			Oct. 16, 2017
Shares | shares	[24],[25],[40]			73,710				73,710
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Paratek Pharmaceuticals, Inc., Warrant, Acquisition Date 8/1/2018, Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 520,000
Investments, at fair value:	[40]			$ 34,000
Acquisition date	[40]			Aug. 01, 2018
Shares | shares	[40]			426,866				426,866
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Phathom Pharmaceuticals, Inc., Warrant, Acquisition Date 9/17/2021, Common Stock
Summary of Investment Holdings
Investment cost		$ 848,000	[1],[2],[3],[12],[26],[31]	$ 848,000	[6],[18],[19],[24],[30],[40]
Investments, at fair value:		$ 68,000	[1],[3],[12],[26],[31]	$ 101,000	[18],[19],[24],[30],[40]
Acquisition date		Sep. 17, 2021	[1],[3],[12],[26],[31]	Sep. 17, 2021	[18],[19],[24],[30],[40]
Shares | shares		64,687	[1],[3],[12],[26],[31]	64,687	[18],[19],[24],[30],[40]	64,687	[1],[3],[12],[26],[31]	64,687	[18],[19],[24],[30],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Provention Bio, Inc., Warrant, Acquisition Date 9/15/2022, Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 281,000
Investments, at fair value:	[40]			$ 677,000
Acquisition date	[40]			Sep. 15, 2022
Shares | shares	[40]			111,934				111,934
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Redshift Bioanalytics, Inc., Warrant, Acquisition Date 3/23/2022, Preferred Series E
Summary of Investment Holdings
Investment cost		$ 20,000	[1],[2]	$ 20,000	[6],[30]
Investments, at fair value:		$ 6,000	[1]	$ 21,000	[30]
Acquisition date		Mar. 23, 2022	[1],[3]	Mar. 23, 2022	[30],[40]
Shares | shares		475,510	[1]	475,510	[30]	475,510	[1]	475,510	[30]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Scynexis, Inc., Warrant, Acquisition Date 5/14/2021, Common Stock
Summary of Investment Holdings
Investment cost		$ 296,000	[2],[3]	$ 296,000	[6],[18],[40]
Investments, at fair value:		$ 28,000	[3]	$ 15,000	[18],[40]
Acquisition date		May 14, 2021	[3]	May 14, 2021	[18],[40]
Shares | shares		106,035	[3]	106,035	[18],[40]	106,035	[3]	106,035	[18],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and TG Therapeutics, Inc., Warrant, Acquisition Date 2/28/2019, Common Stock
Summary of Investment Holdings
Investment cost		$ 1,284,000	[2],[3],[12],[26]	$ 1,033,000	[6],[18],[24],[40]
Investments, at fair value:		$ 2,583,000	[3],[12],[26]	$ 1,084,000	[18],[24],[40]
Acquisition date		Feb. 28, 2019	[3],[12],[26]	Feb. 28, 2019	[18],[24],[40]
Shares | shares		264,226	[3],[12],[26]	231,613	[18],[24],[40]	264,226	[3],[12],[26]	231,613	[18],[24],[40]
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Tricida, Inc., Warrant, Acquisition Date 3/27/2019, Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 280,000
Investments, at fair value:	[40]			$ 1,000
Acquisition date	[40]			Mar. 27, 2019
Shares | shares	[40]			31,352				31,352
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and Valo Health, LLC, Warrant, Acquisition Date 6/15/2020, Common Units
Summary of Investment Holdings
Investment cost		$ 256,000	[2]	$ 256,000	[6]
Investments, at fair value:		$ 153,000		$ 127,000
Acquisition date		Jun. 15, 2020	[3]	Jun. 15, 2020	[40]
Shares | shares		102,216		102,216		102,216		102,216
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 12/9/2022, Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 510,000
Investments, at fair value:	[40]			$ 281,000
Acquisition date	[40]			Dec. 09, 2022
Shares | shares	[40]			1,392,787				1,392,787
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and X4 Pharmaceuticals, Inc., Warrant, Acquisition Date 3/18/2019, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 510,000
Investments, at fair value:	[3]	$ 225,000
Acquisition date	[3]	Mar. 18, 2019
Shares | shares	[3]	1,392,787				1,392,787
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene, Inc., Warrant, Acquisition Date 12/30/2021, Preferred Series 3
Summary of Investment Holdings
Investment cost	[6],[18],[24],[25]			$ 72,000
Investments, at fair value:	[18],[24],[25]			$ 28,000
Acquisition date	[18],[24],[25],[40]			Dec. 30, 2021
Shares | shares	[18],[24],[25]			133,692				133,692
Investment, Identifier [Axis]: Warrant Investments and Drug Discovery & Development and enGene,Inc, Warrant, Acquisition Date 12/22/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3],[26],[27]	$ 118,000
Investments, at fair value:	[3],[26],[27]	$ 179,000
Acquisition date	[3],[26],[27]	Dec. 22, 2023
Shares | shares	[3],[26],[27]	43,689				43,689
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.02%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.02%				0.02%
Investment cost	[2]	$ 692,000
Investments, at fair value:		391,000
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware (0.09%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.09%				0.09%
Investment cost	[6]			$ 692,000
Investments, at fair value:				1,273,000
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and 908 Devices, Inc., Warrant, Acquisition Date 3/15/2017, Common Stock
Summary of Investment Holdings
Investment cost		101,000	[2],[3]	101,000	[6],[40]
Investments, at fair value:		$ 175,000	[3]	$ 86,000	[40]
Acquisition date		Mar. 15, 2017	[3]	Mar. 15, 2017	[40]
Shares | shares		49,078	[3]	49,078	[40]	49,078	[3]	49,078	[40]
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Locus Robotics Corp., Warrant, Acquisition Date 6/21/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 34,000	[2]	$ 34,000	[6]
Investments, at fair value:		$ 102,000		$ 212,000
Acquisition date		Jun. 21, 2022	[3]	Jun. 21, 2022	[40]
Shares | shares		8,503		8,511		8,503		8,511
Investment, Identifier [Axis]: Warrant Investments and Electronics & Computer Hardware and Skydio, Inc., Warrant, Acquisition Date 11/08/2021, Common Stock
Summary of Investment Holdings
Investment cost		$ 557,000	[2]	$ 557,000	[6]
Investments, at fair value:		$ 114,000		$ 975,000
Acquisition date		Nov. 08, 2021	[3]	Nov. 08, 2021	[40]
Shares | shares		622,255		622,255		622,255		622,255
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.00%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.00%				0.00%
Investment cost	[6]			$ 114,000
Investments, at fair value:				14,000
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other (0.03%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.03%				0.03%
Investment cost	[2]	$ 750,000
Investments, at fair value:		596,000
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Modern Life, Inc., Warrant, Acquisition Date 3/30/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2]	164,000
Investments, at fair value:		$ 165,000
Acquisition date	[3]	Mar. 30, 2023
Shares | shares		37,618				37,618
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Recover Together, Inc.., Warrant, Acquisition Date 7/3/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2]	$ 382,000
Investments, at fair value:		$ 327,000
Acquisition date	[3]	Jul. 03, 2023
Shares | shares		194,830				194,830
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Strive Health Holdings, LLC., Warrant, Acquisition Date 9/28/2023, Common Units
Summary of Investment Holdings
Investment cost	[1],[2]	$ 83,000
Investments, at fair value:	[1]	$ 95,000
Acquisition date	[1],[3]	Sep. 28, 2023
Shares | shares	[1]	51,760				51,760
Investment, Identifier [Axis]: Warrant Investments and Healthcare Services, Other and Vida Health, Inc., Warrant, Acquisition Date 3/28/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 121,000	[2]	114,000	[6]
Investments, at fair value:		$ 9,000		$ 14,000
Acquisition date		Mar. 28, 2022	[3]	Mar. 28, 2022	[40]
Shares | shares		192,431		100,618		192,431		100,618
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.03%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.03%				0.03%
Investment cost	[2]	$ 694,000
Investments, at fair value:		486,000
Investment, Identifier [Axis]: Warrant Investments and Information Services (0.04%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.04%				0.04%
Investment cost	[6]			$ 680,000
Investments, at fair value:				509,000
Investment, Identifier [Axis]: Warrant Investments and Information Services and Capella Space Corp., Warrant, Acquisition Date 10/21/2021, Common Stock
Summary of Investment Holdings
Investment cost		207,000	[1],[2]	207,000	[6],[30]
Investments, at fair value:		$ 33,000	[1]	$ 114,000	[30]
Acquisition date		Oct. 21, 2021	[1],[3]	Oct. 21, 2021	[30],[40]
Shares | shares		176,200	[1]	176,200	[30]	176,200	[1]	176,200	[30]
Investment, Identifier [Axis]: Warrant Investments and Information Services and INMOBI Inc., Warrant, Acquisition Date 11/19/2014, Common Stock
Summary of Investment Holdings
Investment cost		$ 82,000	[2],[26],[27]	$ 82,000	[6],[24]
Investments, at fair value:		$ 0	[26],[27]	$ 0	[24]
Acquisition date		Nov. 19, 2014	[3],[26],[27]	Nov. 19, 2014	[24],[40]
Shares | shares		65,587	[26],[27]	65,587	[24]	65,587	[26],[27]	65,587	[24]
Investment, Identifier [Axis]: Warrant Investments and Information Services and NetBase Solutions, Inc., Warrant, Acquisition Date 8/22/2017, Preferred Series 1
Summary of Investment Holdings
Investment cost		$ 356,000	[2]	$ 356,000	[6]
Investments, at fair value:		$ 362,000		$ 380,000
Acquisition date		Aug. 22, 2017	[3]	Aug. 22, 2017	[40]
Shares | shares		60,000		60,000		60,000		60,000
Investment, Identifier [Axis]: Warrant Investments and Information Services and Signal Media Limited, Warrant, Acquisition Date 6/29/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 49,000	[2],[26],[27]	$ 35,000	[6],[24],[25]
Investments, at fair value:		$ 91,000	[26],[27]	$ 15,000	[24],[25]
Acquisition date		Jun. 29, 2022	[3],[26],[27]	Jun. 29, 2022	[24],[25],[40]
Shares | shares		113,828	[26],[27]	94,857	[24],[25]	113,828	[26],[27]	94,857	[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.17%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.17%				0.17%
Investment cost	[2]	$ 1,112,000
Investments, at fair value:		3,000,000
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology (0.30%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.30%				0.30%
Investment cost	[6]			$ 1,112,000
Investments, at fair value:				4,156,000
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Bright Machines, Inc., Warrant, Acquisition Date 3/31/2022, Common Stock
Summary of Investment Holdings
Investment cost		537,000	[2]	537,000	[6]
Investments, at fair value:		$ 279,000		$ 1,154,000
Acquisition date		Mar. 31, 2022	[3]	Mar. 31, 2022	[40]
Shares | shares		392,308		392,308		392,308		392,308
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and MacroFab, Inc., Warrant, Acquisition Date 3/23/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 528,000	[2]	$ 528,000	[6]
Investments, at fair value:		$ 677,000		$ 1,202,000
Acquisition date		Mar. 23, 2022	[3]	Mar. 23, 2022	[40]
Shares | shares		1,111,111		1,111,111		1,111,111		1,111,111
Investment, Identifier [Axis]: Warrant Investments and Manufacturing Technology and Xometry, Inc., Warrant, Acquisition Date 5/9/2018, Common Stock
Summary of Investment Holdings
Investment cost		$ 47,000	[2],[3]	$ 47,000	[6],[40]
Investments, at fair value:		$ 2,044,000	[3]	$ 1,800,000	[40]
Acquisition date		May 09, 2018	[3]	May 09, 2018	[40]
Shares | shares		87,784	[3]	87,784	[40]	87,784	[3]	87,784	[40]
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.00%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.00%				0.00%
Investment cost	[6]			$ 35,000
Investments, at fair value:				35,000
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info (0.01%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.01%				0.01%
Investment cost	[2]	$ 67,000
Investments, at fair value:		235,000
Investment, Identifier [Axis]: Warrant Investments and Media/Content/Info and Fever Labs, Inc., Warrant, Acquisition Date 12/30/2022, Preferred Series E-1
Summary of Investment Holdings
Investment cost		67,000	[2]	35,000	[6]
Investments, at fair value:		$ 235,000		$ 35,000
Acquisition date		Dec. 30, 2022	[3]	Dec. 30, 2022	[40]
Shares | shares		369,370		221,622		369,370		221,622
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.01%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.01%				0.01%
Investment cost	[2]	$ 956,000
Investments, at fair value:		262,000
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment (0.07%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.07%				0.07%
Investment cost	[6]			$ 2,034,000
Investments, at fair value:				919,000
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Aspire Bariatrics, Inc., Warrant, Acquisition Date 1/28/2015, Common Stock
Summary of Investment Holdings
Investment cost	[6]			455,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Jan. 28, 2015
Shares | shares				22,572				22,572
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated
Summary of Investment Holdings
Investment cost	[6]			$ 713,000
Investments, at fair value:				$ 0
Shares | shares				836,752				836,752
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 11/3/2014, Preferred Series AA
Summary of Investment Holdings
Investment cost	[6]			$ 362,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Nov. 03, 2014
Shares | shares				110,946				110,946
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Flowonix Medical Incorporated, Warrant, Acquisition Date 9/21/2018, Preferred Series BB
Summary of Investment Holdings
Investment cost	[6]			$ 351,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Sep. 21, 2018
Shares | shares				725,806				725,806
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Intuity Medical, Inc., Warrant, Acquisition Date 12/29/2017, Preferred Series B-1
Summary of Investment Holdings
Investment cost		294,000	[2]	$ 294,000	[6]
Investments, at fair value:		$ 0		$ 54,000
Acquisition date		Dec. 29, 2017	[3]	Dec. 29, 2017	[40]
Shares | shares		3,076,323		3,076,323		3,076,323		3,076,323
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Lucira Health, Inc., Warrant, Acquisition Date 2/4/2022, Common Stock
Summary of Investment Holdings
Investment cost	[6],[40]			$ 110,000
Investments, at fair value:	[40]			$ 0
Acquisition date	[40]			Feb. 04, 2022
Shares | shares	[40]			59,642				59,642
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Outset Medical, Inc., Warrant, Acquisition Date 9/27/2013, Common Stock
Summary of Investment Holdings
Investment cost		$ 401,000	[2],[3]	$ 401,000	[6],[40]
Investments, at fair value:		$ 78,000	[3]	$ 864,000	[40]
Acquisition date		Sep. 27, 2013	[3]	Sep. 27, 2013	[40]
Shares | shares		62,794	[3]	62,794	[40]	62,794	[3]	62,794	[40]
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Senseonics Holdings, Inc., Warrant, Acquisition Date 9/8/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2],[3]	$ 200,000
Investments, at fair value:	[3]	$ 184,000
Acquisition date	[3]	Sep. 08, 2023
Shares | shares	[3]	728,317				728,317
Investment, Identifier [Axis]: Warrant Investments and Medical Devices & Equipment and Tela Bio, Inc., Warrant, Acquisition Date 3/31/2017, Common Stock
Summary of Investment Holdings
Investment cost		$ 61,000	[2],[3]	$ 61,000	[6],[40]
Investments, at fair value:		$ 0	[3]	$ 1,000	[40]
Acquisition date		Mar. 31, 2017	[3]	Mar. 31, 2017	[40]
Shares | shares		15,712	[3]	15,712	[40]	15,712	[3]	15,712	[40]
Investment, Identifier [Axis]: Warrant Investments and Semiconductors (0.04%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.04%		0.04%	[5]	0.04%		0.04%	[5]
Investment cost		$ 99,000	[2]	$ 850,000	[6]
Investments, at fair value:		811,000		524,000
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Achronix Semiconductor Corporation, Warrant, Acquisition Date 6/26/2015, Preferred Series D-2
Summary of Investment Holdings
Investment cost		99,000	[2]	99,000	[6]
Investments, at fair value:		$ 811,000		$ 524,000
Acquisition date		Jun. 26, 2015	[3]	Jun. 26, 2015	[40]
Shares | shares		750,000		750,000		750,000		750,000
Investment, Identifier [Axis]: Warrant Investments and Semiconductors and Fungible, Inc., Warrant, Acquisition Date 12/16/2021, Common Stock
Summary of Investment Holdings
Investment cost	[6],[30]			$ 751,000
Investments, at fair value:	[30]			$ 0
Acquisition date	[30],[40]			Dec. 16, 2021
Shares | shares	[30]			800,000				800,000
Investment, Identifier [Axis]: Warrant Investments and Software (0.59%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.59%				0.59%
Investment cost	[6]			$ 9,761,000
Investments, at fair value:				8,244,000
Investment, Identifier [Axis]: Warrant Investments and Software (0.75%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.75%				0.75%
Investment cost	[2]	$ 10,445,000
Investments, at fair value:		13,549,000
Investment, Identifier [Axis]: Warrant Investments and Software and Aria Systems, Inc., Warrant, Acquisition Date 5/22/2015, Preferred Series G
Summary of Investment Holdings
Investment cost		74,000	[2]	74,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		May 22, 2015	[3]	May 22, 2015	[40]
Shares | shares		231,535		231,535		231,535		231,535
Investment, Identifier [Axis]: Warrant Investments and Software and Automation Anywhere, Inc., Warrant, Acquisition Date 9/23/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 448,000	[2]	$ 448,000	[6]
Investments, at fair value:		$ 430,000		$ 365,000
Acquisition date		Sep. 23, 2022	[3]	Sep. 23, 2022	[40]
Shares | shares		254,778		254,778		254,778		254,778
Investment, Identifier [Axis]: Warrant Investments and Software and Bitsight Technologies, Inc., Warrant, Acquisition Date 11/18/2020, Common Stock
Summary of Investment Holdings
Investment cost		$ 284,000	[2]	$ 284,000	[6]
Investments, at fair value:		$ 666,000		$ 398,000
Acquisition date		Nov. 18, 2020	[3]	Nov. 18, 2020	[40]
Shares | shares		29,691		29,691		29,691		29,691
Investment, Identifier [Axis]: Warrant Investments and Software and Brain Corporation, Warrant, Acquisition Date 10/4/2021, Common Stock
Summary of Investment Holdings
Investment cost		$ 165,000	[1],[2]	$ 165,000	[6],[30]
Investments, at fair value:		$ 47,000	[1]	$ 61,000	[30]
Acquisition date		Oct. 04, 2021	[1],[3]	Oct. 04, 2021	[30],[40]
Shares | shares		194,629	[1]	194,629	[30]	194,629	[1]	194,629	[30]
Investment, Identifier [Axis]: Warrant Investments and Software and CloudBolt Software, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock
Summary of Investment Holdings
Investment cost		$ 117,000	[2]	$ 117,000	[6]
Investments, at fair value:		$ 12,000		$ 1,000
Acquisition date		Sep. 30, 2020	[3]	Sep. 30, 2020	[40]
Shares | shares		211,342		211,342		211,342		211,342
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudian, Inc., Warrant, Acquisition Date 11/6/2018, Common Stock
Summary of Investment Holdings
Investment cost		$ 71,000	[2]	$ 71,000	[6]
Investments, at fair value:		$ 29,000		$ 14,000
Acquisition date		Nov. 06, 2018	[3]	Nov. 06, 2018	[40]
Shares | shares		477,454		477,454		477,454		477,454
Investment, Identifier [Axis]: Warrant Investments and Software and Cloudpay, Inc., Warrant, Acquisition Date 4/10/2018, Preferred Series B
Summary of Investment Holdings
Investment cost		$ 54,000	[2],[26],[27]	$ 54,000	[6],[24],[25]
Investments, at fair value:		$ 844,000	[26],[27]	$ 400,000	[24],[25]
Acquisition date		Apr. 10, 2018	[3],[26],[27]	Apr. 10, 2018	[24],[25],[40]
Shares | shares		6,763	[26],[27]	6,763	[24],[25]	6,763	[26],[27]	6,763	[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Software and Convoy, Inc., Warrant, Acquisition Date 3/30/2022, Common Stock
Summary of Investment Holdings
Investment cost	[6],[19]			$ 974,000
Investments, at fair value:	[19]			$ 364,000
Acquisition date	[19],[40]			Mar. 30, 2022
Shares | shares	[19]			165,456				165,456
Investment, Identifier [Axis]: Warrant Investments and Software and Couchbase, Inc., Warrant, Acquisition Date 4/25/2019, Common Stock
Summary of Investment Holdings
Investment cost		$ 462,000	[2],[3]	$ 462,000	[6],[40]
Investments, at fair value:		$ 1,225,000	[3]	$ 488,000	[40]
Acquisition date		Apr. 25, 2019	[3]	Apr. 25, 2019	[40]
Shares | shares		105,350	[3]	105,350	[40]	105,350	[3]	105,350	[40]
Investment, Identifier [Axis]: Warrant Investments and Software and Cutover, Inc., Warrant, Acquisition Date 9/21/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 26,000	[2],[12],[26],[27]	$ 26,000	[6],[18],[24],[25]
Investments, at fair value:		$ 62,000	[12],[26],[27]	$ 19,000	[18],[24],[25]
Acquisition date		Sep. 21, 2022	[3],[12],[26],[27]	Sep. 21, 2022	[18],[24],[25],[40]
Shares | shares		102,898	[12],[26],[27]	102,898	[18],[24],[25]	102,898	[12],[26],[27]	102,898	[18],[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Software and DNAnexus, Inc., Warrant, Acquisition Date 3/21/2014, Preferred Series C
Summary of Investment Holdings
Investment cost		$ 97,000	[2]	$ 97,000	[6]
Investments, at fair value:		$ 47,000		$ 131,000
Acquisition date		Mar. 21, 2014	[3]	Mar. 21, 2014	[40]
Shares | shares		909,091		909,091		909,091		909,091
Investment, Identifier [Axis]: Warrant Investments and Software and Dashlane, Inc., Warrant, Acquisition Date 3/11/2019, Common Stock
Summary of Investment Holdings
Investment cost		$ 461,000	[2]	$ 353,000	[6]
Investments, at fair value:		$ 258,000		$ 168,000
Acquisition date		Mar. 11, 2019	[3]	Mar. 11, 2019	[40]
Shares | shares		770,838		453,641		770,838		453,641
Investment, Identifier [Axis]: Warrant Investments and Software and Delphix Corp., Warrant, Acquisition Date 10/8/2019, Common Stock
Summary of Investment Holdings
Investment cost		$ 1,594,000	[2]	$ 1,594,000	[6]
Investments, at fair value:		$ 3,801,000		$ 2,657,000
Acquisition date		Oct. 08, 2019	[3]	Oct. 08, 2019	[40]
Shares | shares		718,898		718,898		718,898		718,898
Investment, Identifier [Axis]: Warrant Investments and Software and Demandbase, Inc., Warrant, Acquisition Date 8/2/2021, Common Stock
Summary of Investment Holdings
Investment cost		$ 545,000	[2]	$ 545,000	[6]
Investments, at fair value:		$ 396,000		$ 180,000
Acquisition date		Aug. 02, 2021	[3]	Aug. 02, 2021	[40]
Shares | shares		727,047		727,047		727,047		727,047
Investment, Identifier [Axis]: Warrant Investments and Software and Dragos, Inc., Warrant, Acquisition Date 6/28/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2]	$ 1,452,000
Investments, at fair value:		$ 1,207,000
Acquisition date	[3]	Jun. 28, 2023
Shares | shares		49,309				49,309
Investment, Identifier [Axis]: Warrant Investments and Software and DroneDeploy, Inc., Warrant, Acquisition Date 6/30/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 278,000	[2]	$ 278,000	[6]
Investments, at fair value:		$ 413,000		$ 300,000
Acquisition date		Jun. 30, 2022	[3]	Jun. 30, 2022	[40]
Shares | shares		95,911		95,911		95,911		95,911
Investment, Identifier [Axis]: Warrant Investments and Software and Eigen Technologies Ltd., Warrant, Acquisition Date 4/13/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 8,000	[2],[26],[27]	$ 8,000	[6],[24],[25]
Investments, at fair value:		$ 4,000	[26],[27]	$ 6,000	[24],[25]
Acquisition date		Apr. 13, 2022	[3],[26],[27]	Apr. 13, 2022	[24],[25],[40]
Shares | shares		522	[26],[27]	522	[24],[25]	522	[26],[27]	522	[24],[25]
Investment, Identifier [Axis]: Warrant Investments and Software and Elation Health, Inc., Warrant, Acquisition Date 9/12/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 583,000	[2]	$ 583,000	[6]
Investments, at fair value:		$ 188,000		$ 382,000
Acquisition date		Sep. 12, 2022	[3]	Sep. 12, 2022	[40]
Shares | shares		362,837		362,837		362,837		362,837
Investment, Identifier [Axis]: Warrant Investments and Software and Esme Learning Solutions, Inc., Warrant, Acquisition Date 1/27/2022, Common Stock
Summary of Investment Holdings
Investment cost	[6]			$ 198,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Jan. 27, 2022
Shares | shares				56,765				56,765
Investment, Identifier [Axis]: Warrant Investments and Software and Evernote Corporation, Warrant, Acquisition Date 9/30/2016, Common Stock
Summary of Investment Holdings
Investment cost	[6]			$ 107,000
Investments, at fair value:				$ 6,000
Acquisition date	[40]			Sep. 30, 2016
Shares | shares				62,500				62,500
Investment, Identifier [Axis]: Warrant Investments and Software and First Insight, Inc., Warrant, Acquisition Date 5/10/2018, Preferred Series B
Summary of Investment Holdings
Investment cost		$ 96,000	[2]	$ 96,000	[6]
Investments, at fair value:		$ 77,000		$ 39,000
Acquisition date		May 10, 2018	[3]	May 10, 2018	[40]
Shares | shares		75,917		75,917		75,917		75,917
Investment, Identifier [Axis]: Warrant Investments and Software and Fulfil Solutions, Inc., Warrant, Acquisition Date 7/29/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 325,000	[2]	$ 325,000	[6]
Investments, at fair value:		$ 456,000		$ 314,000
Acquisition date		Jul. 29, 2022	[3]	Jul. 29, 2022	[40]
Shares | shares		84,995		84,995		84,995		84,995
Investment, Identifier [Axis]: Warrant Investments and Software and Kore.ai, Inc., Warrant, Acquisition Date 3/31/2023, Preferred Series C
Summary of Investment Holdings
Investment cost	[2]	$ 208,000
Investments, at fair value:		$ 243,000
Acquisition date	[3]	Mar. 31, 2023
Shares | shares		64,293				64,293
Investment, Identifier [Axis]: Warrant Investments and Software and Leapwork ApS, Warrant, Acquisition Date 1/23/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2],[12],[26],[27]	$ 16,000
Investments, at fair value:	[12],[26],[27]	$ 35,000
Acquisition date	[3],[12],[26],[27]	Jan. 23, 2023
Shares | shares	[12],[26],[27]	39,948				39,948
Investment, Identifier [Axis]: Warrant Investments and Software and Lightbend, Inc., Warrant, Acquisition Date 2/14/2018, Preferred Series D
Summary of Investment Holdings
Investment cost		$ 131,000	[2]	$ 131,000	[6]
Investments, at fair value:		$ 49,000		$ 1,000
Acquisition date		Feb. 14, 2018	[3]	Feb. 14, 2018	[40]
Shares | shares		89,685		89,685		89,685		89,685
Investment, Identifier [Axis]: Warrant Investments and Software and Mixpanel, Inc., Warrant, Acquisition Date 9/30/2020, Common Stock
Summary of Investment Holdings
Investment cost		$ 252,000	[2]	$ 252,000	[6]
Investments, at fair value:		$ 306,000		$ 225,000
Acquisition date		Sep. 30, 2020	[3]	Sep. 30, 2020	[40]
Shares | shares		82,362		82,362		82,362		82,362
Investment, Identifier [Axis]: Warrant Investments and Software and Nuvolo Technologies Corporation, Warrant, Acquisition Date 3/29/2019, Common Stock
Summary of Investment Holdings
Investment cost	[6],[18]			$ 172,000
Investments, at fair value:	[18]			$ 175,000
Acquisition date	[18],[40]			Mar. 29, 2019
Shares | shares	[18]			70,000				70,000
Investment, Identifier [Axis]: Warrant Investments and Software and Onna Technologies, Inc., Warrant 7/5/2023 Common Stock
Summary of Investment Holdings
Acquisition date	[3]	Jul. 05, 2023
Investment, Identifier [Axis]: Warrant Investments and Software and Onna Technologies, Inc.Warrant 7/5/2023 Common Stock
Summary of Investment Holdings
Investment cost	[2]	$ 60,000
Investments, at fair value:		$ 39,000
Shares | shares		172,867				172,867
Investment, Identifier [Axis]: Warrant Investments and Software and Poplicus, Inc., Warrant, Acquisition Date 5/28/2014, Common Stock
Summary of Investment Holdings
Investment cost		$ 0	[2]	$ 0	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		May 28, 2014	[3]	May 28, 2014	[40]
Shares | shares		132,168		132,168		132,168		132,168
Investment, Identifier [Axis]: Warrant Investments and Software and Reltio, Inc., Warrant, Acquisition Date 6/30/2020, Common Stock
Summary of Investment Holdings
Investment cost		$ 215,000	[2]	$ 215,000	[6]
Investments, at fair value:		$ 447,000		$ 298,000
Acquisition date		Jun. 30, 2020	[3]	Jun. 30, 2020	[40]
Shares | shares		69,120		69,120		69,120		69,120
Investment, Identifier [Axis]: Warrant Investments and Software and SignPost, Inc., Warrant, Acquisition Date 1/13/2016, Series Junior 1 Preferred
Summary of Investment Holdings
Investment cost	[6]			$ 314,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Jan. 13, 2016
Shares | shares				474,019				474,019
Investment, Identifier [Axis]: Warrant Investments and Software and Simon Data, Inc., Warrant, Acquisition Date 3/22/2023, Common Stock
Summary of Investment Holdings
Investment cost	[2],[12]	$ 96,000
Investments, at fair value:	[12]	$ 76,000
Acquisition date	[3],[12]	Mar. 22, 2023
Shares | shares	[12]	77,934				77,934
Investment, Identifier [Axis]: Warrant Investments and Software and SingleStore, Inc., Warrant, Acquisition Date 4/28/2020, Preferred Series D
Summary of Investment Holdings
Investment cost		$ 103,000	[2]	$ 103,000	[6]
Investments, at fair value:		$ 386,000		$ 426,000
Acquisition date		Apr. 28, 2020	[3]	Apr. 28, 2020	[40]
Shares | shares		312,596		312,596		312,596		312,596
Investment, Identifier [Axis]: Warrant Investments and Software and Sisense Ltd., Warrant, Acquisition Date 6/28/2023, Ordinary Shares
Summary of Investment Holdings
Investment cost	[2],[26],[27]	$ 174,000
Investments, at fair value:	[26],[27]	$ 128,000
Acquisition date	[3],[26],[27]	Jun. 08, 2023
Shares | shares	[26],[27]	321,956				321,956
Investment, Identifier [Axis]: Warrant Investments and Software and Suzy, Inc. Warrant, Acquisition Date 8/24/2023 Common Stock
Summary of Investment Holdings
Investment cost	[1],[2]	$ 367,000
Investments, at fair value:	[1]	$ 354,000
Acquisition date	[1],[3]	Aug. 24, 2023
Shares | shares	[1]	292,936				292,936
Investment, Identifier [Axis]: Warrant Investments and Software and Tact.ai Technologies, Inc., Warrant, Acquisition Date 2/13/2020, Common Stock
Summary of Investment Holdings
Investment cost	[6]			$ 206,000
Investments, at fair value:				$ 69,000
Acquisition date	[40]			Feb. 13, 2020
Shares | shares				1,041,667				1,041,667
Investment, Identifier [Axis]: Warrant Investments and Software and The Faction Group LLC, Warrant, Acquisition Date 11/3/2014, Preferred Series AA
Summary of Investment Holdings
Investment cost		$ 234,000	[2]	$ 234,000	[6]
Investments, at fair value:		$ 904,000		$ 436,000
Acquisition date		Nov. 03, 2014	[3]	Nov. 03, 2014	[40]
Shares | shares		8,076		8,076		8,076		8,076
Investment, Identifier [Axis]: Warrant Investments and Software and Tipalti Solutions Ltd., Warrant, Acquisition Date 3/22/2023, Ordinary Shares
Summary of Investment Holdings
Investment cost	[2],[26],[27]	$ 174,000
Investments, at fair value:	[26],[27]	$ 234,000
Acquisition date	[3],[26],[27]	Mar. 22, 2023
Shares | shares	[26],[27]	254,877				254,877
Investment, Identifier [Axis]: Warrant Investments and Software and VideoAmp, Inc., Warrant, Acquisition Date 1/21/2022, Common Stock
Summary of Investment Holdings
Investment cost		$ 1,275,000	[1],[2]	$ 1,275,000	[6],[30]
Investments, at fair value:		$ 186,000	[1]	$ 321,000	[30]
Acquisition date		Jan. 21, 2022	[1],[3]	Jan. 21, 2022	[30],[40]
Shares | shares		152,048	[1]	152,048	[30]	152,048	[1]	152,048	[30]
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices (0.04%)
Summary of Investment Holdings
Investment owned, percent of net assets		0.04%	[4]	0.04%	[5]	0.04%	[4]	0.04%	[5]
Investment cost		$ 39,000	[2]	$ 46,000	[6]
Investments, at fair value:		676,000		492,000
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and Gynesonics, Inc., Warrant, Acquisition Date 1/16/2013, Preferred Series C
Summary of Investment Holdings
Investment cost	[6]			7,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Jan. 16, 2013
Shares | shares				16,835				16,835
Investment, Identifier [Axis]: Warrant Investments and Surgical Devices and TransMedics Group, Inc., Warrant, Acquisition Date 9/11/2015, Common Stock
Summary of Investment Holdings
Investment cost		39,000	[2],[3]	$ 39,000	[6],[40]
Investments, at fair value:		$ 676,000	[3]	$ 492,000	[40]
Acquisition date		Sep. 11, 2015	[3]	Sep. 11, 2015	[40]
Shares | shares		14,440	[3]	14,440	[40]	14,440	[3]	14,440	[40]
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.00%)
Summary of Investment Holdings
Investment owned, percent of net assets	[4]	0.00%				0.00%
Investment cost	[2]	$ 539,000
Investments, at fair value:		83,000
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology (0.03%)
Summary of Investment Holdings
Investment owned, percent of net assets	[5]			0.03%				0.03%
Investment cost	[6]			$ 723,000
Investments, at fair value:				488,000
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Ampion, PBC, Warrant, Acquisition Date 4/15/2022, Common Stock
Summary of Investment Holdings
Investment cost		52,000	[2]	52,000	[6]
Investments, at fair value:		$ 36,000		$ 44,000
Acquisition date		Apr. 15, 2022	[3]	Apr. 15, 2022	[40]
Shares | shares		18,472		18,472		18,472		18,472
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Fulcrum Bioenergy, Inc., Warrant, Acquisition Date 4/30/2013, Preferred Series C-1
Summary of Investment Holdings
Investment cost	[6]			$ 64,000
Investments, at fair value:				$ 275,000
Acquisition date	[40]			Apr. 30, 2013
Shares | shares				93,632				93,632
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc.
Summary of Investment Holdings
Investment cost	[6]			$ 218,000
Investments, at fair value:				$ 169,000
Shares | shares				456,883				456,883
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/22/2014, Preferred Series A
Summary of Investment Holdings
Investment cost		$ 155,000	[2]	$ 155,000	[6]
Investments, at fair value:		$ 36,000		$ 126,000
Acquisition date		Apr. 22, 2014	[3]	Apr. 22, 2014	[40]
Shares | shares		325,000		325,000		325,000		325,000
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Halio, Inc., Warrant, Acquisition Date 4/7/2015, Preferred Series B
Summary of Investment Holdings
Investment cost		$ 63,000	[2]	$ 63,000	[6]
Investments, at fair value:		$ 11,000		$ 43,000
Acquisition date		Apr. 07, 2015	[3]	Apr. 07, 2015	[40]
Shares | shares		131,883		131,883		131,883		131,883
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and IngredientWerks Holdings, Inc. (p.k.a Agrivida, Inc.), Warrant, Acquisition Date 6/20/2013, Preferred Series D
Summary of Investment Holdings
Investment cost	[6]			$ 120,000
Investments, at fair value:				$ 0
Acquisition date	[40]			Jun. 20, 2013
Shares | shares				471,327				471,327
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Polyera Corporation, Warrant, Acquisition Date 3/24/2015, Preferred Series C
Summary of Investment Holdings
Investment cost		$ 269,000	[2]	$ 269,000	[6]
Investments, at fair value:		$ 0		$ 0
Acquisition date		Mar. 24, 2015	[3]	Mar. 24, 2015	[40]
Shares | shares		150,036		150,036		150,036		150,036
Investment, Identifier [Axis]: Warrant Investments and Sustainable and Renewable Technology and Total Halio, Inc.
Summary of Investment Holdings
Investment cost	[2]	$ 218,000
Investments, at fair value:		$ 47,000
Shares | shares		456,883				456,883
[1] Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company. [2] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized appreciation for federal income tax purposes totaled $118.3 million, $115.9 million, and $2.4 million, respectively. The tax cost of investments is $3.2 billion. [3] Except for warrants in 24 publicly traded companies and common stock in 36 publicly traded companies, all investments are restricted as of December 31, 2023 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s valuation committee (the “Valuation Committee”) and approved by the board of directors (the “Board”). [4] Value as a percent of net assets. All amounts are stated in U.S. Dollars unless otherwise noted. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies. [5] Value as a percent of net assets. The Company uses the Standard Industrial Code for classifying the industry grouping of its portfolio companies. [6] Gross unrealized appreciation, gross unrealized depreciation, and net unrealized depreciation for federal income tax purposes totaled $72.2 million, $112.0 million, and $39.8 million, respectively. The tax cost of investments is $3.0 billion. [7] Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2022. Refer to “Note 11 — Commitments and Contingencies”. [8] Interest rate PRIME represents 7.50% as of December 31, 2022. 1-month LIBOR, 3-month LIBOR, and 6-month LIBOR represent, 4.40%, 4.77%, and 5.14%, respectively, as of December 31, 2022. [9] Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments. [10] Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”). [11] Interest rate PRIME represents 8.50% as of December 31, 2023. 1-month SOFR, 3-month SOFR, and 6-month SOFR represent 5.34%, 5.36%, and 5.35%, respectively, as of December 31, 2023. [12] Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”). [13] Denotes second lien senior secured debt. [14] Denotes that all or a portion of the debt investment principal includes accumulated PIK interest and is net of repayments. [15] Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”). [16] Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition. [17] Denotes that all or a portion of the debt investment secures the 2031 Asset-Backed Notes (as defined in “Note 5 — Debt”). [18] Denotes that all or a portion of the investment is pledged as collateral under the MUFG Bank Facility (as defined in “Note 5 — Debt”). [19] Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2022. [20] Denotes second lien senior secured debt. [21] Denotes that all or a portion of the debt investment is pledged as collateral under the SMBC Facility (as defined in “Note 5 — Debt”). [22] Denotes that there is an unfunded contractual commitment available at the request of this portfolio company as of December 31, 2023 (Refer to “Note 11 — Commitments and Contingencies”). [23] Denotes unitranche debt with first lien “last-out” senior secured position and security interest in all assets of the portfolio company whereby the “last-out” portion will be subordinated to the “first-out” portion in a liquidation, sale or other disposition. [24] Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. [25] Non-U.S. company or the company’s principal place of business is outside the United States. [26] Indicates assets that the Company deems not “qualifying assets” under section 55(a) of 1940 Act. Qualifying assets must represent at least 70% of the Company’s total assets at the time of acquisition of any additional non-qualifying assets. [27] Non-U.S. company or the company’s principal place of business is outside the United States. [28] Denotes that all or a portion of the debt investment is convertible debt. [29] Denotes that all or a portion of the debt investment is convertible debt. [30] Denotes that all or a portion of the investment in this portfolio company is held by Hercules Capital IV, L.P., the Company’s wholly owned small business investment company. [31] Denotes that the fair value of the Company’s total investments in this portfolio company represent greater than 5% of the Company’s total net assets as of December 31, 2023. [32] Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board. [33] Debt is on non-accrual status as of December 31, 2022, and is therefore considered non-income producing. Note that only the PIK portion is on non-accrual for the Company’s debt investment in Tectura Corporation and Pineapple Energy LLC. [34] Control investment as defined under the 1940 Act in which Hercules owns at least 25% of the company’s voting securities or has greater than 50% representation on its board. [35] Gibraltar Acquisition LLC is a wholly-owned subsidiary, which is the holding company for their wholly-owned affiliated portfolio companies, Gibraltar Business Capital, LLC and Gibraltar Equipment Finance, LLC. [36] Hercules Adviser LLC is owned by Hercules Capital Management LLC and presented with Hercules Partner Holdings, LLC which are both wholly owned by the Company. Please refer to “Note 1” for additional disclosure. [37] Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $4.6 million and $3.4 million, respectively. [38] Denotes the security holds rights to royalty fee income associated with certain products of the portfolio company. The approximate cost and fair value of the royalty contract are $12.0 million and $9.4 million, respectively. [39] Debt is on non-accrual status as of December 31, 2023, and is therefore considered non-income producing. [40] Except for warrants in 27 publicly traded companies and common stock in 43 publicly traded companies, all investments are restricted as of December 31, 2022 and were valued at fair value using Level 3 significant unobservable inputs as determined in good faith by the Company’s Board. [41] Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock for Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2023, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $2.4 million. [42] Denotes investment in a non-voting security in the form of a promissory note. The terms of the notes provide the Company with a lien on the issuers' shares of Common Stock in portfolio company Black Crow AI, Inc., subject to release upon repayment of the outstanding balance of the notes. As of December 31, 2022, the Black Crow AI, Inc. affiliates promissory notes had an outstanding balance of $3.0 million. [43] Denotes all or a portion of the public equity or warrant investment was acquired in a transaction exempt from registration under the Securities Act of 1933 (“Securities Act”) and may be deemed to be “restricted securities” under the Securities Act.